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SUMMARY 
 
The fungus Ashbya gossypii is an important industrial producer of riboflavin, i.e. vitamin B2. 
Here, we developed and then used a highly sophisticated set-up of parallel 13C tracer studies 
with labeling analysis by GC/MS, LC/MS, 1D, and 2D NMR to resolve carbon fluxes and obtain 
a detailed picture of the underlying metabolism in the overproducing strain A. gossypii B2 
during growth and riboflavin production from a complex industrial medium using vegetable oil 
as carbon source. Glycine was exclusively used as carbon-two – but not carbon-one (C1) – 
donor of the vitamin’s pyrimidine ring due to the proven absence of a functional glycine 
cleavage system. Yeast extract was the main carbon source during growth, while still 
contributing 8 % overall carbon to riboflavin. Overall carbon flux from rapeseed oil into 
riboflavin equaled 80 %. Transmembrane formate flux simulations revealed that the C1-supply 
displayed a severe bottleneck during the initial riboflavin production, which was overcome in 
later phases of the cultivation by intrinsic formate accumulation. The transiently limiting C1-
pool was successfully replenished by time-resolved feeding of formate or serine. This 
increased the intracellular precursor availability and resulted in a riboflavin titer increase of 
45 %. This study is the first that successfully sheds light on carbon fluxes during the growth 
and riboflavin production phase by use of 13C tracers and a complementary platform of 
analytical techniques. 
 
IX 
 
ZUSAMMENFASSUNG 
 
Der Pilz Ashbya gossypii ist ein wichtiger industrieller Produzent für Riboflavin. In dieser Studie 
wurde eine anspruchsvolle Kombination an parallelen 13C Tracerexperimenten entwickelt und 
durchgeführt, wobei die Markierungen mittels GC/MS, LC/MS, 1D und 2D NMR analysiert 
wurden, um die Kohlenstoffflüsse in dem Überproduzenten A. gossypii B2 sowohl im 
Wachstum als auch während der Riboflavinproduktion auf Komplexmedium mit Pflanzenöl als 
Kohlenstoffquelle, auflösen zu können. Glycin wurde ausschließlich als Zwei-Kohlenstoff-
Donor – aber nicht C1-Donor – für den Pyrimidinring des Vitamins verwendet, was das Fehlen 
eines funktionalen Glycin-Decarboxylase-Komplexes bewies. Hefeextrakt (YE) war die 
wichtigste Kohlenstoffquelle während des Wachstums. Der Gesamtkohlenstofffluss von YE 
und Rüböl zu Riboflavin betrug entsprechend 8 % bzw. 80 %. Simulationen des 
transmembranen Formiatflusses zeigten, dass die C1-Bereitstellung während der frühen 
Riboflavinproduktion limitierend war, was in der späten Kultivierungsphase durch intrinsische 
Formiatbildung überwunden wurde. Der transient limitierende C1-Pool wurde erfolgreich durch 
die zeitaufgelöste Zugabe von Formiat oder Serin aufgefüllt. Dies steigerte den Produkttiter 
um 45 % durch erhöhte Verfügbarkeit von Vorläufermolekülen. Diese Studie ist die Erste, die 
Aufschluss über Stofflüsse während des Wachstums und der Riboflavinproduktion durch den 
Gebrauch von 13C Tracersubstanzen und komplementären analytischen Techniken gibt. 
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1 INTRODUCTION 
1.1 General Introduction 
Riboflavin, also known as vitamin B2, is a water-soluble compound, which can be synthesized 
by plants and microorganisms, but is essential for animals as they lack an endogenous 
biosynthetic pathway. It plays an important role in multiple cellular functions. Pioneering 
discovery and research dates back almost 150 years, and throughout the past decade, 
increasing interest has turned riboflavin meanwhile into one of the most important products in 
biotechnology. The two active forms of riboflavin, flavin adenine dinucleotide (FAD) and flavin 
mononucleotide (FMN), act as cofactors for oxidoreductases as well as prosthetic groups for 
enzymes in the β-oxidation pathway (Massey, 2000). Moreover, riboflavin is part of a 
flavoprotein called cryptochrome, a photoreceptor in charge of the upkeep of the circadian 
clock (Banerjee and Batschauer, 2005; Miyamoto and Sancar, 1998). Natural sources of 
riboflavin are for example milk, eggs, and leafy vegetables (O'Neil, 2006). According to the 
Food and Nutrition Board (1998), the recommended daily allowance of riboflavin lies between 
1.1 and 1.3 mg for women and men assuming a healthy person. In humans, riboflavin 
deficiency amongst other symptoms is associated with skin lesions and corneal 
vascularization. Riboflavin, which is exclusively synthesized biotechnologically using 
microorganisms, is mainly used as feed additive (about 70 % of today’s market), whereas 
about 30 % are used as food additive and for pharmaceutical applications (Revuelta et al., 
2016). The world market for riboflavin has more than doubled in a little over a decade from 
4000 t a-1 to 9000 t a-1 in 2002 and 2015, respectively (Schwechheimer et al., 2016). Hereby, 
the production has come a long way from chemical synthesis on fossil fuels to the exclusive 
biotechnological production today. One of the industrial microbes for riboflavin is Ashbya 
gossypii, a natural overproducer. It accumulates up to 20 g L-1 riboflavin, explaining the high 
interest in this filamentous fungus (Abbas and Sibirny, 2011; Kato and Park, 2012; Lim et al., 
2001; Revuelta et al., 2016; Schwechheimer et al., 2016; Stahmann et al., 2000). The chemical 
company BASF has installed a plant in South Korea, which is specialized in riboflavin 
production on industrial scale using A. gossypii (Schwechheimer et al., 2016). The 
biochemistry of riboflavin biosynthesis as well as the empirically derived fermentation set-up 
for A. gossypii are extremely complex. Several subcellular compartments contribute to the 
production of the vitamin, including the peroxisome, the mitochondrion, and the cytosol (Kato 
and Park, 2012). Furthermore, industrial production is based on a complex mixture of various 
raw materials: corn steep liquor, peptone, yeast extract in addition to the main carbon source 
vegetable oil (Epstein et al., 1979; Malzahn et al., 1959; O'Neil, 2006; Tanner et al., 1948). At 
INTRODUCTION 
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the starting point of biosynthesis, the major carbon precursors of the vitamin are ribulose 5-
phosphate and guanosine triphosphate (GTP). These intermediates are converted into 
riboflavin in a total number of seven steps. Glucose has been described as alternative carbon 
source (Demain, 1972; Tanner et al., 1949) and the sugar is the dominant substrate used for 
research of A. gossypii (Bacher et al., 1985; Ledesma-Amaro et al., 2015c; Schlüpen et al., 
2003; Silva et al., 2015). So far, classical strain improvement by random mutagenesis and 
selection (Schmidt et al., 1996a; Schmidt et al., 1996b; Sugimoto et al., 2010) and empirical 
optimization of the fermentation process (Sahm et al., 2013; Storhas and Metz, 2006) have 
displayed the dominant strategies towards better production (Abbas and Sibirny, 2011; Kato 
and Park, 2012; Lim et al., 2001; Revuelta et al., 2016; Schwechheimer et al., 2016; Stahmann 
et al., 2000). Only a few success cases have managed to improve riboflavin production using 
rational approaches, such as metabolic engineering (Buey et al., 2015; Jiménez et al., 2008; 
Monschau et al., 1998; Sugimoto et al., 2009). This might result from the fact that the molecular 
processes involved in production of the vitamin are only partly understood. Admittedly, a huge 
complexity is faced inside and outside the cells: a multi-compartment biosynthesis meets a 
multi-substrate process environment. Without doubt, tailored strain and process engineering, 
strongly desired to keep up with market demands, will benefit from a better understanding of 
riboflavin production in A. gossypii. 
1.2 Objectives 
The aim of this work was the resolution of carbon fluxes of growth and riboflavin production by 
A. gossypii under industrial process conditions. Such flux studies typically require well-defined 
conditions, such as minimal media and only one carbon source. In this regard, the industrial 
process, i.e. medium with complex compounds and several carbon sources, posed an 
additional level of complexity. In order to tackle this challenge on a systems biology level, 
reproducible data are of utmost importance. To this end, a reliable cultivation and sampling 
scheme should be developed prior to the flux studies. A number of technical developments 
provided an experimental approach for tailored 13C isotope studies on a complex medium with 
a deep assessment of 13C labeling in various metabolites by complementary gas 
chromatography/mass spectrometry (GC/MS), liquid chromatography/mass spectrometry 
(LC/MS), and nuclear magnetic resonance (NMR) approaches. The integration of the data 
gained from the various analytical methods should provide deeper insight into the riboflavin 
metabolism in A. gossypii and optimally offer new starting points and targets for process 
optimization. 
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2 THEORETICAL BACKGROUND 
2.1 Vitamin B2: discovery and pioneering chemical synthesis 
Riboflavin was first mentioned by Blyth in 1879, who isolated a yellow-fluorescing substance 
from milk whey, which he called lactochrome (Northrop-Clewes and Thurnham, 2012). 
However, it took almost half a century until the vitamin was isolated, its structure described, 
and its nutritional function revealed. Early micronutrition studies with rats showed growth 
impairment upon ariboflavinosis. These findings led to more intensive research in the field of 
vitamins in general and of riboflavin in particular. In the early 1930s riboflavin was successfully 
isolated from egg white (Kuhn et al., 1933b), milk whey, and vegetables (Eggersdorfer et al., 
2012; Kuhn et al., 1933a), which was followed by the discovery of its structure (then called 
lactoflavin): a methylated isoalloxazine ring with a ribityl-sidechain (Figure 1) (Karrer et al., 
1935; Kuhn, 1936). Soon afterwards, vitamin B2 officially became “riboflavin” (from Latin flavus 
for yellow and “ribo” for the ribityl-sidechain) by the Council of Pharmacy and Chemistry of the 
American Medical Association (Northrop-Clewes and Thurnham, 2012). The high interest in 
the molecule was a major driver to derive it by chemical synthesis (Karrer et al., 1935; Kuhn, 
1936). The initially developed and still major multi-step large-scale chemical route starts either 
from D-glucose or D-ribose (Figure 1). Glucose is first oxidized to arabonate, which is 
subsequently epimerized to ribonate and transformed into ribonolactone. This intermediate is 
reduced to D-ribose using amalgam. After addition of xylidine, the product ribitylxylidine and 
an aniline derivative together form phenylazo-ribitylxylidine. The final reaction step of the 
chemical synthesis is a cyclocondensation of phenylazo-ribitylxylidine with barbituric acid, 
which yields riboflavin as a product (Wolf et al., 1983). For many years, with a few alterations, 
this was the only way to synthesize riboflavin. Nowadays, the production of riboflavin is 
exclusively done using fermentation as it is economically and ecologically more feasible. 
While the production of riboflavin via fermentation was only 5 % of the annual production in 
1990, the percentage of biotechnological production has increased to 75 % of the market 
volume in 2002 within just twelve years due to metabolic engineering of the production strains 
(Schwechheimer et al., 2016). The two dominating processes employ the Gram positive 
bacterium Bacillus subtilis and the hemiascomycete Ashbya gossypii. Today, due to further 
optimization of the bio-based production in the past years, chemical synthesis has been 
replaced completely. Most of today’s riboflavin market is used as feed additive (Sahm et al., 
2013), but also as food fortification, dietary supplement, pharmaceutical applications as well 
as food colorant (E-101) in yoghurt and drinks. 
THEORETICAL BACKGROUND 
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Figure 1: Chemical versus biotechnological riboflavin synthesis by fermentation. The microscopic image 
depicts a wild type A. gossypii in a vegetable oil medium. Mycelia, oil droplets, and riboflavin crystals 
are shown in a 600-fold magnification (Schwechheimer et al., 2016). 
 
2.2 Ashbya gossypii – a fungal riboflavin overproducer 
The filamentous hemiascomycete A. gossypii was first isolated from cotton as phytopathogen 
causing stigmatomycosis in 1926 in the British West Indies (Ashby and Nowell, 1926). Later, 
it was also discovered on other crops in tropic and sub-tropic regions (Pridham and Raper, 
THEORETICAL BACKGROUND 
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1950). The use of insecticides efficiently reduced the role of A. gossypii as phytopathogen, 
because the fungus relies on insect vectors for transmission. It is incapable of penetrating 
intact plant cell walls, which can be explained by the low amount of extracellular enzymes 
secreted by A. gossypii (Aguiar et al., 2014b). Its ability to produce large amounts of volatile 
aroma compounds might be advantageous when attracting insects for transmission (Ravasio 
et al., 2014; Wendland et al., 2011). 
The life cycle of A. gossypii starts from a needle-shaped spore. After germ bubble and germ 
tube formation, a mycelium is generated by lateral branching of the initial hyphae (Figure 2A), 
which also leads to dichotomous tip branching. Each hyphal cell, which is separated by septa 
from neighboring cells, contains several haploid nuclei. In the late growth phase, sporangia 
usually containing eight spores each are formed by fragmentation of old hyphae. These 
spores, which are linked by actin filaments, are then released (Figure 2C) (Wendland and 
Walther, 2005). The transition from vegetative growth to sporulation is linked to nutrient 
depletion, however, the exact underlying mechanisms are still poorly understood. Recent 
studies on the genome suggest that A. gossypii displays two different mating types and thus, 
may also exhibit sexual reproduction (Dietrich et al., 2013). 
 
A B CGrowth Production Sporulation
 
Figure 2: Microscopic images of A. gossypii B2 grown on complex medium and vegetable oil (A, B) or 
glucose (C). 6 h after inoculation, lateral branching can be observed in the growing culture (A). The low 
solubility of riboflavin leads to formation of vitamin crystals after 72 h (B). At the end of cultivation on 
glucose, the needle-shaped spores, which are connected by actin, are released from sporangia (C). 
Images A and B are shown in a 100-fold magnification. The spores in image C are 600-fold magnified. 
 
A. gossypii belongs to the family of Saccharomycetaceae and shares more than 90 % synteny 
of protein coding genes with the budding yeast Saccharomyces cerevisiae. Due to its very 
small genome size (9 Mb), close relationship with S. cerevisiae, and readily available 
molecular tools, it has become a model organism for filamentous growth (Wendland and 
Walther, 2005).  
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Overproduction of riboflavin by A. gossypii was first reported in 1946. The production starts 
once vegetative growth has ceased and cells start sporulating (Figure 2B). Originally, it was 
hypothesized that overproduction of riboflavin protected the hyaline spores against ultraviolet 
(UV) light (Stahmann et al., 2001). However, since also non-sporulating cells accumulate 
riboflavin, these two events are not exclusively connected (Nieland and Stahmann, 2013; 
Walther and Wendland, 2012). Over the past years, it was shown that nutritional and oxidative 
stress induce riboflavin overproduction in the fungus (Kavitha and Chandra, 2014; Schlösser 
et al., 2007). Walther and Wendland (2012) even suggested that riboflavin plays a role in stress 
defence against oxidative burst of plants upon infection with A. gossypii cells. 
 
In recent years, the potential of A. gossypii as host for other high-value products has been 
investigated and its spectrum was tremendously broadened (Aguiar et al., 2017). This entails 
flavor compounds derived from the Ehrlich pathway (2-phenylethanol and isoamyl alcohol) 
(Ravasio et al., 2014) and purine biosynthesis (inosine and guanosine contribute to the umami 
flavor) (Ledesma-Amaro et al., 2015a; Ledesma-Amaro et al., 2016), but also single cell oil 
(SCO) production (Díaz-Fernández et al., 2017; Ledesma-Amaro et al., 2015b; Ledesma-
Amaro et al., 2014b; Lozano-Martínez et al., 2016). The expression performance of 
recombinant cell wall degrading enzymes was inspected (Aguiar et al., 2014a; Ribeiro et al., 
2010). In contrast to other filamentous fungi, A. gossypii secretes only a small amount of 
extracellular enzymes, which makes it a promising host for recombinant protein production. 
However, current titers still leave room for improvement. Most recently, the overproduction of 
folic acid (vitamin B9) was reported (Serrano-Amatriain et al., 2016). Genetic engineering 
towards vitamin B9 production seems obvious, considering the high potential of the purine 
biosynthetic pathway in this organism and the shared precursor, GTP, with riboflavin. 
2.3 Riboflavin biosynthesis – pathways and regulations 
Many microorganisms are capable to synthesize riboflavin. Candida famata, Clostridium 
acetobutylicum, and Lactobacillus fermentum are able to overproduce the vitamin (Demain, 
1972). It is, however, easy to understand that most of the knowledge on riboflavin biosynthesis 
has been collected for the two major industrial producers: A. gossypii (Figure 5) and B. subtilis 
share two important precursors for riboflavin biosynthesis: ribulose 5-phosphate (Ru5P) is 
derived from the pentose phosphate (PP) pathway and GTP originates in the purine 
biosynthesis (Bacher et al., 2000). 
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2.3.1 Terminal biosynthesis 
The terminal riboflavin biosynthetic chain comprises a total of seven enzymatic steps starting 
from two different branches: the purine biosynthesis and the PP pathway (Figure 3). The GTP 
cyclohydrolase catalyzes the cleavage of GTP with release of formate. This step is encoded 
by RIB1 in A. gossypii and by ribA in B. subtilis. The first reaction is followed by a reduction 
reaction in the fungus, carried out by the gene product of RIB7 (DARPP reductase), and a 
subsequent deamination (RIB2, DarPP deaminase). In B. subtilis, these latter two steps are in 
reverse order and are catalyzed by a bifunctional enzyme encoded by ribG. The phosphatase 
that cleaves ArPP (2,5-diamino-6-ribityl-amino-2,4(1H,3H)pyrimidinedione 5’-phosphate) into 
ArP (5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione) is the only, still unknown, enzyme in 
the riboflavin biosynthetic pathway. Ribulose 5-phosphate is converted to DHBP (3,4-
dihydroxy-2-butanone 4-phosphate) by the DHBP synthase (RIB3 or ribA for A. gossypii and 
B. subtilis, respectively). At this point the two different branches of the riboflavin pathway merge 
into one. The condensation of DHBP and ArP yields one molecule of DRL (6,7-dimethyl-8-
ribityllumazine) and is catalyzed by the lumazine synthase (RIB4 for A. gossypii, ribH for 
B. subtilis). In the final step of the riboflavin biosynthetic pathway the enzyme riboflavin 
synthase converts two mole DRL into one mole riboflavin and one mole ArP, which is recycled 
in the previous step (Fischer and Bacher, 2005). 
 
 
Figure 3: Terminal biosynthesis of riboflavin in A. gossypii. Ru5P is converted into DHBP and 
condensed with ArP to yield DRL. In the final step, riboflavin synthase catalyzes the conversion of DRL 
to riboflavin. Note that the pentose phosphate pathway branch is undergone twice, since two molecules 
DHBP are needed for one molecule of riboflavin. ArP, 5-amino-6-ribitylamino-2,4(1H,3H)-
pyrimidinedione; ArPP, 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione 5-phosphate; DARPP, 2,5-
diamino-6-ribosylamino-4(3H)-pyrimidinone 5-phosphate; DarPP, 2,5-diamino-6-ribitylamino-
pyrimidinone 5-phosphate; DHBP, 3,4-dihydroxybutanone 4-phosphate; DRL, 6,7-dimethyl-8-
ribityllumazine; FOR, formate; GTP, guanosine triphosphate; NADPH, nicotinamide adenine 
dinucleotide phosphate; PP pathway, pentose phosphate pathway; Ru5P, ribulose 5-phosphate; RF, 
riboflavin; RIB1, GTP cyclohydrolase II; RIB2, DarPP deaminase; RIB3, DHBP synthase; RIB4, 
lumazine synthase; RIB5, riboflavin synthase; RIB7, DARPP reductase. 
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2.3.2 Precursor supply 
 
 
Figure 4: Schematic riboflavin biosynthesis from vegetable oil in A. gossypii. The multi-compartment 
process ends with the terminal riboflavin biosynthesis starting from ribulose 5-phosphate and GTP. 
Dashed lines indicate exchange of metabolites between different compartments. Note that the one-
carbon metabolism is only drawn in the cytosol. It can be assumed, however, that there is also a one-
carbon metabolism in the mitochondrion. The circles in the riboflavin molecule designate the carbon 
atoms and their respective molecular origin: ribulose 5-phosphate (dark grey), carbon dioxide (light 
grey), glycine metabolism (blue), one-carbon metabolism (red). The ribityl side chain originates from 
ribose 5-phosphate. 3PG, 3-phosphoplycerate; CH2-THF, 5,10-methylenetetrahydrofolate; AcCoA, acetyl-CoA; 
CHO-THF, 10-formyltetrahydrofolate; FA, fatty acid; FOR, formate; GAR, glycineamide ribonucleotide; GLY, 
glycine; GTP, guanosine-5’-triphosphate; OAA, oxaloacetate; PYR, pyruvate; Ru5P, ribulose 5-phosphate; SER, 
serine; THF, tetrahydrofolate. 
 
For the overproduction of riboflavin, A. gossypii prefers oil as substrate, which is cleaved into 
fatty acids and glycerol by an extracellular lipase (Stahmann et al., 1997). The fatty acids are 
transported into the cell and oxidized into acetyl-CoA via the β-oxidation pathway, located in 
the peroxisome. Acetyl-CoA is further metabolized via the glyoxylate shunt, gluconeogenesis, 
and the PP pathway (Figure 4, Figure 5). In addition, supplementation with glycine is frequently 
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used for riboflavin production (Demain, 1972; Malzahn et al., 1959). The amino acid is 
supposed to have two functions. One molecule glycine is incorporated into the pyrimidine ring 
of riboflavin (Plaut, 1954a). Furthermore, glycine is linked to the folate-dependent carbon-one 
(C1) metabolism, which supplies 10-formyltetrahydrofolate (CHO-THF) as essential C1 donor 
for the biosynthesis (Pasternack et al., 1996; Schlüpen et al., 2003). In more detail, the enzyme 
serine hydroxymethyltransferase (SHMT) forms serine from glycine. The terminal carbon atom 
of serine then contributes to the C1 pool via 5,10-methylenetetrahydrofolate (CH2-THF), which 
in turn is converted into CHO-THF, the immediate C1 donor for riboflavin (Figure 4). Moreover, 
a potential glycine cleavage system (GCS) has been suggested as alternative route in the 
fungus (Schlüpen et al., 2003), but to date has neither been proven nor disproven 
experimentally. 
2.3.3 Regulation 
Regulation of the riboflavin biosynthetic pathway is not completely solved for the 
hemiascomycete A. gossypii. However, a few studies have dealt with unraveling the regulatory 
mechanisms behind riboflavin overproduction, which has been linked to nutritional (Schlösser 
et al., 2007) as well as oxidative stress (Kavitha and Chandra, 2009; Kavitha and Chandra, 
2014). It was reported that the beginning of riboflavin oversynthesis and sporulation were 
linked, which was proven by addition of the second messenger cyclic adenosine 
monophosphate (cAMP) that is known to inhibit sporulation in fungi: riboflavin biosynthesis as 
well as sporulation were negatively affected (Stahmann et al., 2001). Supplementation of 
riboflavin to spore suspensions had a positive effect on spore viability upon UV light exposure 
(Stahmann et al., 2001). The regulation of pathway-specific enzymes was also investigated. 
DHBP synthase (encoded by the gene RIB3) catalyzes the first step in riboflavin biosynthesis 
starting from the ribulose 5-phosphate derived branch and carries twice the metabolic burden 
compared to the GTP branch of this pathway. Therefore, its regulation was of special interest. 
RIB3 exhibited increased mRNA levels during the riboflavin production phase, caused by 
induction of the promoter (Schlösser et al., 2001). In a different study, upregulation of the three 
RIB genes involved in the PP pathway branch (RIB3, RIB4, RIB5) were upregulated upon 
cessation of growth due to nutrient depletion and entry into the riboflavin production phase 
(Schlösser et al., 2007). A more recent study, however, reported that there is no significant 
increase at the transcriptional level for all RIB genes except RIB4 during the riboflavin 
biosynthetic phase (Ledesma-Amaro et al., 2015c). Two transcription factors have been 
described in the literature as having direct or indirect regulatory functions in the production of 
riboflavin: BAS1 and YAP1. The Myb-related factor BAS1 is involved in the adenine-dependent 
transcriptional control of the genes SHM2 and ADE4, which play important roles in the glycine 
and purine metabolism, respectively, both of which contribute to the riboflavin precursor GTP. 
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A C-terminal deletion of the BAS1 gene resulted in increased riboflavin titers due to constitutive 
activation of SHM2 and ADE4 (Mateos et al., 2006). The second transcription factor, YAP1, is 
known to be involved in oxidative stress response and targeted exposure of A. gossypii to 
oxidative stress led to increased riboflavin titers in a Yap1-dependent manner. The Yap-
regulon comprises more than 100 genes, amongst others RIB4. This gene of the riboflavin 
pathway contains three Yap-binding domains and is transcriptionally controlled by YAP1 
(Walther and Wendland, 2012). 
2.3.4 Biosynthesis in B. subtilis 
Since B. subtilis is the other major industrial riboflavin producer next to A. gossypii, its riboflavin 
biosynthesis should be discussed briefly. Starting from its preferred carbon source glucose 
B. subtilis forms glucose 6-phosphate, which then enters into the PP pathway toward riboflavin 
biosynthesis. The bacterial riboflavin biosynthesis is organized in the so-called rib operon, 
which entails five genes (ribGBAHT) (Abbas and Sibirny, 2011; Perkins et al., 1999; Yakimov 
et al., 2014). The riboflavin biosynthesis in B. subtilis includes two bifunctional enzymes: the 
gene product of ribA shows GTP cyclohydrolase II activity as well as DHBP synthase activity 
(Hümbelin et al., 1999). The second bifunctional enzyme is the above mentioned gene product 
of ribG: the combined reductase and deaminase (Richter et al., 1997). As for A. gossypii, the 
regulation of riboflavin biosynthesis is not fully understood in B. subtilis, either. The rib operon 
of B. subtilis itself at least seems to be regulated by a “riboswitch” (Mironov et al., 2002). A 
conserved sequence within the 5‘-untranslated region of the rib operon is likely to fold into a 
secondary structure. FMN, which is the product of a kinase reaction of the gene product of 
ribC, is able to directly bind to this secondary structure, thus repressing transcription of the rib 
operon (Mack et al., 1998; Mironov et al., 2002). RibR, a protein that is not part of the rib 
operon, is believed to act as a regulatory protein since it seems to be able to bind to this 
riboswitch (Higashitsuji et al., 2007). The gene ribR is part of a transcription unit that entails 
gene products involved in sulphur uptake and degradation. Recently it was shown that when 
sulphur is present, ribR expression increases, the FMN demand of the cell rises, and the rib 
operon is expressed even with high FMN levels (Pedrolli et al., 2015). 
2.4 Biotechnology and industrial production of riboflavin 
2.4.1 Metabolic engineering of A. gossypii 
The availability and advance in the development of molecular tools have made it very easy to 
modify and engineer prokaryotes and eukaryotes like B. subtilis and the model organism for 
filamentous fungi A. gossypii (Figure 5, Table 1). In A. gossypii, riboflavin production was 
increased in the wild type by medium supplementation with riboflavin precursors such as 
THEORETICAL BACKGROUND 
11 
 
glycine or hypoxanthine (Stahmann et al., 2000). Since structural analogs of purines or 
riboflavin were not suitable for the selection of overproducing strains, other anti-metabolites 
were successfully implemented. Itaconate and oxalate, both inhibitors of the key-enzyme of 
the glyoxylic pathway isocitrate lyase (ICL), were applied to yield higher producing strains. 
(Schmidt et al., 1996a; Schmidt et al., 1996b; Sugimoto et al., 2010). Early metabolic 
engineering strategies included the overexpression of GLY1. This gene codes for a threonine 
aldolase and catalyzes the formation of glycine from threonine. An additional supplementation 
of threonine had a positive effect on riboflavin biosynthesis as well (Monschau et al., 1998). 
A. gossypii tends to accumulate riboflavin intracellularly in vacuoles, which is 
counterproductive especially for industrial processes. Therefore, the vacuolar ATPase subunit 
A (VMA1) was disrupted, leading to an increase in secreted riboflavin. Interestingly, disruption 
of the same gene in S. cerevisiae is lethal (Förster et al., 1999). Research interest in metabolic 
engineering of A. gossypii has focused on the PP pathway, the glycine biosynthetic pathway, 
and the purine biosynthesis. Overexpression of the PRS gene (PRPP synthetase) as well as 
ADE4 (PRPP amidotransferase) increased the carbon flux through the PP and purine 
biosynthetic pathways (Jiménez et al., 2005; Jiménez et al., 2008). Knock-out of a Myb-related 
transcription factor also led to an enhanced carbon flow through the purine biosynthesis to 
GTP as immediate precursor of riboflavin as well as glycine biosynthesis (Mateos et al., 2006). 
A successful strategy to increase glycine precursor supply has been the deletion of SHM2, a 
gene that codes for a serine hydroxymethyltransferase in A. gossypii. The deletion mutant 
showed a reduced activity for the conversion of glycine to serine and ensured a larger glycine 
pool and 10-fold increase in the riboflavin titer (Schlüpen et al., 2003). Since A. gossypii uses 
vegetable oil as substrate for riboflavin synthesis, the glyoxylic pathway plays a crucial role in 
its metabolism. Overexpression of the malate synthase MLS1 improved riboflavin productivity 
about 1.7-fold (Sugimoto et al., 2009). Recently, the alteration of the pyrimidine pathway 
resulted in an increased precursor supply for the purine biosynthesis and thus riboflavin 
production (Silva et al., 2015). Disparity mutagenesis rendered a strain with higher levels of 
the gene products of ADE1, RIB1, and RIB5, which also led to more riboflavin (Park et al., 
2011). Recently, all RIB genes but RIB4 have been overexpressed in A. gossypii, leading to a 
3.1-fold increase in riboflavin compared to the wild type. The riboflavin titer could be enhanced 
even more by underexpression of ADE12, a gene, which codes for an enzyme that catalyzes 
the conversion of inosine monophosphate (IMP) to adenosine monophosphate (AMP). 
Together, these modifications could increase the final riboflavin concentration by a factor of 
5.4 (Ledesma-Amaro et al., 2015c). In addition, GTP precursor supply and thus riboflavin 
synthesis could be enhanced by overexpression of the IMP dehydrogenase, which plays a key 
role in the nucleotide biosynthesis (Buey et al., 2015). Overall this has resulted in strains, which 
accumulate up to 700 mg L-1 of riboflavin (Table 1). 
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Figure 5: Riboflavin biosynthesis in Ashbya gossypii. The symbols + and – indicate increased or 
decreased fluxes or activities both with positive effect on riboflavin biosynthesis. Note that the conversion 
of citrate to isocitrate via aconitase most likely does not occur in the peroxisome (Murakami and Yoshino, 1997). 
3PG, 3-phosphoglycerate; AcCoA, acetyl-coenzyme A; AKG, α-ketoglutarate; AMP, adenosine monophosphate; 
ArP, 5-Amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione; CIT, citrate; DHAP, dihydroxyacetone phosphate; DHBP, 
3,4-Dihydroxy-2-butanone-4-phosphate; DLR, 6,7-Dimethyl-8-ribityllumazine; F6P, fructose 6-phosphate; FA, fatty 
acids; G3P, glyceraldehyde 3-phosphate; G6P, glucose 6-phosphate; GLY, glycine; GLYC, glycerol; GLYOX, 
glyoxylate; GTP, guanosine triphosphate; ICIT, isocitrate; IMP, inosine monophosphate; MAL, malate; OAA, 
oxaloacetate; OMP, orothidine monophosphate; PEP, phosphoenolpyruvate; PP pathway, pentose phosphate 
pathway; PRA, 5-phosphpribosylamine; PRPP, phosphoribosylpyrophosphate; PYR, pyruvate; R5P, ribose 5-
phosphate; Ru5P, ribulose 5-phosphate; SER, serine; TCA cycle, tricarboxylic acid cycle; THR, threonine; UMP, 
uridine monophosphate; XMP, xanthosine monophosphate; ADE4, PRPP amidotransferase; ADE12, 
adenylosuccinate synthase; GLY1, threonine aldolase; ICL1, isocitrate lyase; IMPDH, IMP dehydrogenase; MLS1, 
malate synthase; PRS, PRPP synthetase; RIB1, GTP cyclohydrolase II; RIB2, DarPP deaminase; RIB3, DHBP 
synthase; RIB5, riboflavin synthase; RIB7, DARPP reductase; SHM2, serine hydroxymethyltransferase; URA3, 
orotidine-5-phosphate decarboxylase; VMA1, vacuolar ATPase subunit A. 
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Table 1: Metabolic engineering of Ashbya gossypii for riboflavin overproduction by gene manipulation. 
Except for the overexpression of malate synthase (rapeseed oil), all engineered strains were tested on 
medium with glucose as main carbon source. 
Target gene Modification Performance Reference 
GLY Overexpression 33 mg L-1 (3.7 mg L-1)b (Monschau et al., 1998) 
SHM2 Disruption 96 mg L-1 (9 mg L-1)b (Schlüpen et al., 2003) 
ADE4 Overexpression 77.2 mg L-1/228 mg L-1 a 
(28 mg L-1)b 
(Jiménez et al., 2005) 
PRS2,4 Overexpression 42.4 mg L-1/48.6 mg L-1 a 
(28 mg L-1)b 
(Jiménez et al., 2008) 
PRS3 Overexpression 40.4 mg L-1/51.6 mg L-1 a 
(28 mg L-1)b 
(Jiménez et al., 2008) 
MLS1 Overexpression 700 mg L-1 (400 mg L-1)b (Sugimoto et al., 2009) 
URA3 Disruption 7.5 mg gmycel-1 
(1.0 mg gmycel-1)b 
(Silva et al., 2015) 
RIB1,2,3,5,7 Overexpression 327 mg L-1 (105 mg L-1)b (Ledesma-Amaro et al., 2015c) 
ADE12 Underexpression 260 mg L-1 (98 mg L-1)b (Ledesma-Amaro et al., 2015c) 
IMPDH Overexpression 18.9 mg gCDW-1  
(13.8 mg gCDW-1)b 
(Buey et al., 2015) 
CDW, cell dry weight; mycel, mycelium; ADE4, PRPP amidotransferase; ADE12, adenylosuccinate synthase; 
GLY1, threonine aldolase; ICL1, isocitrate lyase; IMPDH, inosine monophosphate dehydrogenase; MLS1, malate 
synthase; PRS, PRPP synthetase; RIB1, GTP cyclohydrolase II; RIB2, DarPP deaminase; RIB3, DHBP synthase; 
RIB5, riboflavin synthase; RIB7, DARPP reductase; SHM2, serine hydroxymethyltransferase; URA3, orotidine-5 –
phosphate decarboxylase. 
 
a Overexpression plus point mutation 
b Wild type 
 
2.4.2 Metabolic engineering of other microorganisms 
B. subtilis, which is not a natural overproducer of riboflavin, was at first optimized using 
classical breeding like exposure to purine or riboflavin analogs. Mutants resistant to the purine 
analog 8-azaguanine were able to produce more riboflavin due to deregulation of purine 
synthesis. B. subtilis mutants with a resistance to methionine sulfoxide as well as decoyinine 
showed an increased flux from IMP to GMP, probably caused by upregulation of the respective 
synthetase (Matsui et al., 1977; Matsui et al., 1979). The use of roseoflavin as structural analog 
to riboflavin rendered overproducing mutants that had a deregulated rib operon due to 
mutations in ribC or ribO. RibC is a trans-acting regulator of the operon whereas ribO, the 
leader of the 5’-untranslated region of the rib operon, functions in a cis manner to regulate the 
operon (Coquard et al., 1997; Mack et al., 1998; Stahmann et al., 2000). Genetic engineering 
for a commercially competitive B. subtilis strain was achieved through rib operon duplication 
as well as substitution of the existing promoter with a phage-derived constitutive promoter 
(Table 2) (Perkins et al., 1999).  
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Table 2: Metabolic engineering of Bacillus subtilis, Escherichia coli, and Corynebacterium glutamicum 
for riboflavin production by gene manipulation. All engineered strains were tested on glucose for 
overproduction. 
Target gene Modification Performance Reference 
B. subtilis    
rib operon Multiple copies, phage 
promoter 
14 g L-1 (0.02-0.05 g L-1)a (Perkins et al., 1999) 
ribA Overexpression 17.5 g L-1 (Hümbelin et al., 1999) 
cyd Deletion 12.3 g L-1 (8.9 g L-1)b (Zamboni et al., 2003) 
gdh Overexpression 0.047 g gCDW-1 (0.03 g gCDW-1) b (Zhu et al., 2006) 
ccpn Deletion 0.062 g gGlc-1 (0.038 g gGlc-1) b (Tännler et al., 2008b) 
purFMNHD Overexpression 0.031 g gGlc-1 (0.025 g gGlc-1) b (Shi et al., 2009b) 
prs, ywlF Overexpression 15.0 g L-1 (12.0 g L-1) b (Shi et al., 2009a) 
zwf Overexpression 0.05 g gGlc-1 (0.04 g gGlc-1) (Duan et al., 2010) 
purR Deletion 826 mg L-1 (275 mg L-1) a (Shi et al., 2014) 
gapB, fbp Overexpression 13.4 g L-1 (10.5 g L-1) (Wang et al., 2014) 
    
E. coli    
zwf1, gnd1, pgl3, pgi2, 
edd2, eda2, acs3, ribF4 
1) Heterologous 
expression, 
2) deletion, 
3) overexpression, 
4) underexpression 
1036 mg L-1 (229 mg L-1) (Lin et al., 2014) 
    
C. glutamicum    
sigH Overexpression 32.4 μmol L-1 (< 5 μmol L-1) (Taniguchi and 
Wendisch, 2015) 
Glc, glucose; acs, acetyl-CoA synthetase; ccpn, transcriptional regulator of gapB and pckA; cyd, cytochrome bd 
oxidase; edd, phosphogluconate dehydratase; eda, multifunctional 2-keto-3-deoxygluconate 6-phosphate aldolase 
and 2-keto-4-hydroxyglutarate aldolase and oxaloacetate decarboxylase; fbp, fructose-1,6-bisphosphatase; gapB, 
glyceraldehyde-3-phosphate dehydrogenase; gdh, glucose dehydrogenase; gnd, 6-phosphogluconate 
dehydrogenase; guaA, GMP synthase; guaB, inosine-monophosphate dehydrogenase; pgi, glucose-6-phosphate 
isomerase; pgl, 6-phosphogluconolactonase; prs, PRPP synthetase; purA, adenylosuccinate synthetase; purD, 
phosphoribosylglycinamide synthetase; purF, glutamine phosphoribosylpyrophosphate amidotransferase; purH, 
phosphoribosylaminoimidazole carboxy formylformyltransferase/inosine-monophosphate cyclohydrolase; purM, 
phosphoribosylaminoimidazole synthetase; purN, phosphoribosylglycinamide formyltransferase; purR, 
transcriptional repressor of pur operon; rib operon, riboflavin operon; ribA, GTP cyclohydrolase II and DHBP 
synthase; ribF, bifunctional riboflavin kinase/FMN adenylyltransferase; sigH, sigma factor H; ywlF, ribose-5-
phosphate isomerase; zwf, glucose 6-phosphate dehydrogenase. 
 
a Wild type 
b Parental producer strain 
 
 
In addition to those modifications, the overexpression of ribA, which encodes the rate-limiting 
steps of GTP cyclohydrolase II and DHBP synthase, led to a significant increase in riboflavin 
titer of about 1.25-fold (Hümbelin et al., 1999). In the following years, research interest shifted 
away from the terminal riboflavin synthesis and towards increasing energy and precursor 
supply. The wild type of B. subtilis consumes a lot of energy for its maintenance. By a knock-
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out of a terminal oxidase, this feature could be decreased and energy supply increased 
(Zamboni et al., 2003). Overexpression of following the enzymes led to a substantial increase 
of carbon flow through the PP pathway: glucose dehydrogenase (Zhu et al., 2006), glucose-6-
phosphate dehydrogenase (Duan et al., 2010), ribose-5-phosphate isomerase and 
phosphoribosylpyrophosphate (PRPP) synthetase (Shi et al., 2009a). Flux through the purine 
biosynthesis, with GTP as immediate riboflavin precursor, was genetically engineered by co-
overexpression of five genes in the pur operon: purF, purM, purN, purH, and purD (Table 2), 
which code for enzymes that catalyze reactions using cosubstrates like glutamine or glycine 
(Shi et al., 2009b). Furthermore, carbon flux through the purine biosynthetic pathway and 
riboflavin titer could be increased by disrupting the repressor of the pur operon (purR) (Shi et 
al., 2014). Concerning product export, often identified as a bottleneck in overproducing strains 
(Kind et al., 2011), a riboflavin transporter from Streptomyces davawensis, which was codon 
optimized for B. subtilis, was successfully expressed in B. subtilis and catalyzed riboflavin 
excretion into the culture medium (Hemberger et al., 2011). This might be an interesting 
starting point for further strain optimizations. Recently, genetically engineered riboflavin-
overproducing B. subtilis was successfully applied in a bacterial consortium with Escherichia 
coli and Shewanella oneidensis, generating electricity from glucose (Liu et al., 2017). 
Riboflavin, in that case, functioned as electron shuttle, which illustrates nicely the potential of 
riboflavin overproduction taken to the next level of bioeconomy.  
Another recent example of successful metabolic engineering is Escherichia coli, which does 
not accumulate riboflavin under natural conditions. A basic riboflavin producer strain (RF01S, 
with the rib operon under the control of an inducible promoter) was further genetically 
engineered to produce larger amounts of vitamin B2. Following modifications were 
implemented: expression of Corynebacterium glutamicum zwf (glucose-6-phosphate 
dehydrogenase) and gnd (6-phosphogluconate dehydrogenase), deletion of pgi (glucose-6-
phosphate isomerase), and genes of Entner-Doudoroff-pathway, overexpression of acs 
(acetyl-CoA-synthetase), and modulation of expression of ribF, a riboflavin kinase (Table 2). 
After optimizing fermentation conditions a final riboflavin concentration of 2700 mg/L was 
reached (Lin et al., 2014). More recently, Taniguchi and Wendisch (2015) investigated the 
relationship between sigma factor H and riboflavin biosynthesis in the soil bacterium 
C. glutamicum. Overexpression of the sigma factor resulted in slight accumulation of riboflavin 
(Table 2), an interesting proof-of-concept which might be exploited further. 
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2.4.3 Bioprocess engineering and industrial production of riboflavin 
From the late 1950s, the pharmaceutical company Merck established a bio-based process with 
Eremothecium ashbyii, later the related strain A. gossypii (Malzahn et al., 1959). However, 
large-scale riboflavin production using fermentation was not conducted until 1990, when the 
German company BASF commercialized the A. gossypii-process. For the following years, 
chemical and biotechnological syntheses were performed in parallel, when the chemical plant 
was eventually shut down. In 2003, the production of riboflavin using A. gossypii was moved 
from Germany to a new production site in Gunsan, Korea. The industrial process is carried out 
at around 30 °C in 100 m3 fed-batch fermenters using vegetable oils as carbon source and 
complex nitrogen sources like soy flour or corn steep liquor and lasts about eight days (Figure 
6) (Malzahn et al., 1959; Tanner et al., 1948). The process is divided into two phases: a growth 
and subsequent production phase. The feed medium ensures supplementation with limited 
precursors like glycine (Sahm et al., 2013). The industrial riboflavin synthesis using A. gossypii 
has been improved so that nowadays industrial strains and optimized process control lead to 
riboflavin titers of more than 20 g L-1 (Sahm et al., 2013). In 2002, shortly after the 
establishment of the Ashbya-process, the Swiss corporation Roche launched a riboflavin 
process using an engineered Bacillus subtilis strain, which was taken over by the Dutch 
company DSM a year later (DSM, 2015; Hohmann et al., 2011). The factory is located in 
Southern Germany in Grenzach. A new generation of riboflavin-overproducing strains do not 
contain multiple copies of the rib operon anymore, but use strong phage-derived promoters 
and an altered 5’-untranslated region of the rib operon (Sahm et al., 2013). The DSM Bacillus-
process is also conducted in fed-batch mode, which is carbon limited. As carbon sources 
molasses, but also starch hydrolysates or thick juice are utilized (Kirchner et al., 2014). Corn 
steep liquor as well as yeast extract can be used for nitrogen supply. More recently, DSM has 
patented a process, in which biomass from a previous fermentation is recycled, degraded, and 
replaces expensive yeast extract in a new fermentation cycle (DSM, 2006). The Chinese 
company Hubei Guangji Pharmaceutical employs a B. subtilis strain that shows resistance to 
a proline analog to synthesize riboflavin and produces more than 26 g L-1 riboflavin (Lee et al., 
2004). The two B. subtilis processes are conducted at 39 to 40 °C and last up to 70 hours 
(Hohmann et al., 2011; Kirchner et al., 2014; Lee et al., 2004). Another organism that was used 
in the large-scale industrial synthesis of riboflavin was the yeast Candida famata by ADM 
(USA). However, due to genetic instability of the overproducing mutants resulting in non-
overproducing strains, the company stopped the process several years ago (Abbas and 
Sibirny, 2011). Recent studies demonstrated a non-reverting strain, which is able to produce 
about 16 g L-1 riboflavin during a fed-batch cultivation in a lab-scale fermenter (Dmytruk et al., 
2014). Either one of the nowadays employed industrial strains has its advantages and 
disadvantages. The industrial process using A. gossypii takes long due to the separation of 
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growth and production phase, the main advantage being that the strain is a natural 
overproducer. B. subtilis, on the other hand, is fast growing with production being coupled to 
growth. The recombinant nature of the B. subtilis overproducing strain is disadvantageous, 
however, and has recently become precarious as a genetically modified and unknown 
B. subtilis strain was isolated from feed-grade riboflavin imported to Europe from China. Such 
strains are unauthorized in the European Union (Barbau-Piednoir et al., 2015; Paracchini et 
al., 2017). 
There are several issues that need to be considered for the large-scale production of riboflavin. 
Sterilization of such large volumes is carried out continuously with the media passing straight 
into the reaction vessel. Carbon and nitrogen sources have to be sterilized separately in order 
to avoid Maillard reaction. Temperatures for sterilization are kept high and exposure times 
short (Storhas and Metz, 2006). During the actual fermentation of riboflavin, the aeration plays 
a crucial role. The influence of the agitation speed and thus oxygen supply on a riboflavin fed-
batch production process with B. subtilis was studied by a two-stage agitation speed control 
with the lower agitation speed (600 rpm) being beneficial during the first process phase and a 
higher agitation speed (900 rpm) in the later phase yielding optimal cell growth and riboflavin 
production (Man et al., 2014). The influence of increased aeration and the resulting growth as 
biofilm, as opposed to the traditional planktonic growth, was investigated for C. famata and 
found to be favorable for riboflavin biosynthesis (Mitra et al., 2012). Downstream processing 
of vitamin B2 is fairly easy due to its low solubility (Figure 6). After the fermentation a large 
fraction of the product is already crystallized. For better separation these crystals are 
recrystallized with seed crystals in order to obtain cubic instead of needle-shaped crystals. 
Washing steps under DNA decomposing conditions (60 – 70 °C, acidic pH) are followed by 
separation using decantation, filtration, or centrifugation. In A. gossypii, the temperature 
increase also leads to the expression of glucanases amongst other lytic enzymes that break 
down the fungal cell wall (Sahm et al., 2013). For food-grade riboflavin additional washing 
and/or crystallization steps are necessary (Bretzel et al., 1999; Grimmer et al., 1993).  
For future process improvements, whether strain, media or process parameter optimization, a 
reliable and parallel screening system is of utter importance. A miniaturized system, which 
resembles production conditions of the fed-batch operated B. subtilis riboflavin biosynthesis, 
displays an interesting, straightforward development in this direction (Knorr et al., 2007). 
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Figure 6: Flowsheet of riboflavin fermentation including upstream and downstream processing and 
fermentation (Schwechheimer et al., 2016). 
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2.5 Concept of 13C isotope experiments 
In recent years, 13C tracer experiments have emerged as key technology approach to provide 
a better understanding of microbes (Bücker et al., 2014; Kohlstedt et al., 2014; Zamboni et al., 
2004) and the knowledge derived therefrom has proven valuable to rationally engineer them 
(Becker et al., 2005; Buschke et al., 2011). However, already in the early 1950s, isotope tracer 
studies were used as means of unraveling riboflavin building blocks. The molecular origin of 
the carbon atoms in certain parts of riboflavin was previously clarified by tracer experiments, 
introducing stable 13C and radioactive 14C isotopes, using glucose as well as amino acids, and 
greatly contributed to our current knowledge (Bacher et al., 2000; Bacher et al., 1985; Bacher 
et al., 1998; Plaut, 1954a; Plaut, 1954b; Plaut and Broberg, 1956). 
2.5.1 Conventional 13C metabolic flux analysis 
The conventional 13C metabolic flux analysis (13C MFA) comprises an experimental and a 
computational part. First, a stoichiometric in silico model of the carbon core metabolism and 
other relevant metabolic reactions is derived from genome information or information about 
enzyme activities from the literature. Additionally, the network is expanded by the exact carbon 
transition between metabolites, thus providing a foundation for computational metabolite and 
isotopomer balancing. Experiments are then conducted using a specifically labeled 13C tracer 
substance (e.g., [1-13C] glucose) and defined media. The cells take up the 13C-labeled 
compound and metabolize it. Depending on the metabolic pathway used in the cell, certain 
metabolites will be labeled in a characteristic manner. Hereby, the different pathways will lead 
to specific “fingerprints”. Due to their stability and abundance, proteinogenic amino acids are 
widely used for 13C labeling analysis of their respective mass isotopomer distribution (Kohlstedt 
et al., 2010). Due to the well-known enzymatic reaction mechanisms, carbon transitions are 
known and labeling of metabolic precursors can be inferred from the labeling of amino acids 
(Szyperski, 1995). Experimental 13C labeling data, as well as biomass formation, biosynthetic 
requirements, substrate uptake rate, and product formation rates are then integrated into the 
stoichiometric and isotopomer reaction model using a corresponding software. Over the years, 
different software tools have been developed for flux calculations from 13C labeling data. The 
open source software OpenFLUX relies on elementary mode units (EMU) and represents a 
particularly efficient approach regarding simulation speed (Antoniewicz et al., 2007; Quek et 
al., 2009). Other available software packages include FiatFlux (Zamboni et al., 2005), 
13CFLUX (Wiechert et al., 2001), and a Matlab-based tool (Wittmann and Heinzle, 1999), 
which are all based on different approaches. Once all data are integrated using the software, 
free fluxes are simulated and labeling distributions are iteratively calculated, until the deviation 
between simulated and experimental data is minimal. This type of 13C metabolic flux analysis 
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requires metabolic and isotopic steady-state, which is usually the case during exponential 
growth (Wittmann, 2007). 
 
Over the past decade 13C MFA has proven to be a powerful tool when it comes to gaining 
deeper insights into cellular metabolism and understanding underlying mechanisms (Becker 
et al., 2005; Buschke et al., 2011; Kohlstedt et al., 2014; Zamboni et al., 2004). Most recently, 
succinate production from sucrose with the rumen bacterium Basfia succiniciproducens was 
explored and optimized using four parallel tracer conditions. Findings regarding the sucrose 
metabolism gained from the 13C MFA were directly applied by creating a mutant strain with a 
deleted fructose phosphotransferase system (PTS), yielding a strain with improved production 
performance (Lange et al., 2017). A great example for metabolic pathway engineering based 
on 13C MFA is lysine production by C. glutamicum, where the combination of several selected 
targets led to the de novo generation of an industrially competitive hyperproducer (Becker et 
al., 2011). Rational metabolic engineering of microorganisms displays an important application 
for 13C MFA, however, it also provides better understanding of the metabolism in general. With 
the help of 13C MFA, the pyruvate-tricarboxylic acid (TCA) cycle node could be identified as 
crucial point for controlling virulence in Yersinia pseudotuberculosis (Bücker et al., 2014). 
Subsequent deletion of the gene coding for pyruvate kinase rendered strains with reduced 
virulence. This traditional 13C MFA approach, however, is only applicable for well-defined 
microbial processes that entail chemically defined media with one carbon source as well as 
isotopic and metabolic steady-state and preferably parallel growth and production.  
2.5.2 Metabolic flux studies under complex conditions 
Metabolic flux studies were, however, also conducted in rather complex scenarios that 
displayed characteristics not generally applied for 13C MFA: undefined and complex media, 
multiple carbon sources, microbial consortia, and instationary cultivation conditions. Perfused 
rat liver models were used to investigate the TCA cycle and gluconeogenic fluxes by tracing 
the hepatic glutamate labeling after perfusion with 13C-labeled lactate (Large et al., 1997). The 
study proved the validity of a model proposed by Magnusson et al. (1991), who investigated 
liver metabolism in humans using a set of equations considering carbon transitions in the TCA 
cycle and gluconeogenesis. In the field of biotechnology, recent studies have taken the 13C 
MFA approach further in order to investigate the rather complex cocoa pulp fermentation. 
Parallel labeling experiments using 13C-labeled sugars in an otherwise rather undefined cocoa 
pulp simulation medium were conducted using lactic acid bacteria strains (Adler et al., 2013). 
Metabolic fluxes of pure cultures as well as microbial consortia were calculated and revealed 
the different levels of contribution to the cocoa fermentation of single strains. Lactobacillus 
fermentum NCC 575 could be identified as a dominant contributor to the overall carbon flux in 
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the chosen set-up (Adler et al., 2013). In a subsequent study, the authors further investigated 
the cocoa fermentation with regard to consumption of a substrate mixture and carbon fluxes in 
acetic acid bacteria (Adler et al., 2014). With the help of parallel 13C tracer experiments, lactate 
could be identified as main substrate for biomass and the product acetoin, whereas ethanol 
contributed mainly to the product acetate, which is an important precursor for characteristic 
cocoa flavor compounds. This functionally separated metabolism in acetic acid bacteria could 
be attributed to the lack of two enzymes at the pyruvate node, namely phosphoenolpyruvate 
(PEP) carboxykinase and malic enzyme (Adler et al., 2014). In combination, the experiments 
successfully resolved the complex process of cocoa fermentation using complementary 13C 
tracer studies. 
2.5.3 13C Labeling analysis 
The common feature of the above-mentioned 13C labeling studies (Chapters 2.5.1 and 2.5.2) 
is the use of GC/MS to quantify mass isotopomer distributions of proteinogenic amino acids or 
other metabolites. This very robust method provides highly accurate measurements with 
excellent separation of complex reaction mixtures (Pan and Raftery, 2007; Wittmann, 2007). 
The high sensitivity of this technique enables the measurement of even less abundant 
metabolites (Dersch et al., 2016). The 13C labeling analysis with GC/MS yields information 
about the mass isotopomer distribution of a certain analyte, thus giving information about the 
number of 13C atoms in a certain molecule, but not their respective positions in the molecule 
(Figure 7). However, the information content can be increased by measuring different ion 
cluster fragments of the same molecule (Wiechert, 2001). GC/MS is only applicable for volatile 
and thermally stable compounds. In case an analyte does not meet those demands, 
derivatization is required, such as silylation of amino acids using N-methyl-N-tert-
butyldimethylsilyl-trifluoroacetamide (MBDSTFA) (Pan and Raftery, 2007; Wiechert, 2001; 
Wittmann, 2007). LC/MS shares many advantages of GC/MS, however, derivatization of 
analytes is not necessary (Pan and Raftery, 2007; Wiechert, 2001), thereby eliminating an 
additional sample preparation step (Figure 7). The soft ionization method (electrospray 
ionization) renders fully intact molecules (Alder et al., 2006), however, the use of a tandem 
mass spectrometry supplies more information on 13C labeling due to the fragmentation of the 
analytes in a collision cell. High salt concentrations of fermentation media might interfere with 
the electrospray ionization source (Mashego et al., 2007), thus desalination of samples prior 
to measurement could be necessary. While the MS-based techniques typically display high 
sensitivity (Figure 7), NMR exhibits lower sensitivity, therefore, requiring higher metabolite 
concentrations (Barding et al., 2013). However, NMR provides data on positional enrichment 
of the analyte as well as structural information (Figure 7), which offers the greatest information 
content compared to the other two techniques (Barding et al., 2013; Wiechert, 2001). In 
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addition, the method is advantageous for compounds that are difficult to ionize and no 
elaborate sample preparation is necessary (Markley et al., 2017). The information content of 
NMR can be increased even further when multinuclear and multidimensional NMR are applied 
(Dersch et al., 2016), however a skilled specialist is required to interpret the resulting complex 
spectra (Wiechert, 2001). Since even a single analyte containing several carbon atoms can 
give rise to a highly sophisticated spectrum, complex samples can lead to resonance overlap 
of different compounds (Barding et al., 2013). Each of the described techniques is 
characterized by a unique set of advantages and disadvantages. However, only the custom-
made combination of all methods and integration of the resulting data will provide the highest 
information content, especially for highly complex microbial processes.  
 
 
Figure 7: Information content and characterization of different analytical methods for 13C labeling 
analysis for metabolic flux analysis in microorganisms, i.e. nuclear magnetic resonance (NMR), gas 
chromatography/mass spectrometry (GC/MS), and liquid chromatography/mass spectrometry (LC/MS). 
As example, different isotopologues of a molecule containing five carbon atoms and their respective 
mixture are depicted. The resulting spectra reveal that NMR provides information about the positional 
enrichment of each carbon atom, whereas GC/MS and LC/MS usually yield information regarding the 
mass isotopomer distribution (MID), but is unable to differentiate between positional isomers. However, 
the combined information of different ion cluster fragments can substantially enhance the information 
content for GC/MS or LC/MS samples. 
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2.5.4 Flux analysis combining different analytical techniques 
The successful combination of different analytical methods for 13C labeling analysis has proven 
to be a powerful tool in several studies. The presence of pyruvate carboxylating activity in 
C. glutamicum could be identified and demonstrated in a 13C tracer study (Park et al., 1997). 
The 13C labeling of extracellular lysine was monitored using GC/MS as well NMR, rendering 
high resolution data. In a study using glycerol overproducing S. cerevisiae, the combined 
results of GC/MS, LC/MS, and NMR led to an accurately resolved flux distribution with 
especially precise fluxes around important metabolic nodes (Kleijn et al., 2007). The data 
provided important evidence that carbon was directed away from glycerol formation to the PP 
pathway as well as assimilatory pathways towards storage compounds. The complementary 
nature of GC/MS and LC/MS was applied for instationary 13C MFA using Pichia pastoris (Jordà 
et al., 2013). Methanol and glucose were co-metabolized and the use of LC/MS and GC/MS 
supported the simulation of a large metabolic network including trehalose recycling as well as 
reversibilities of the glycolytic/gluconeogenic pathway, the TCA cycle, and PP pathway (Jordà 
et al., 2013). In addition the ratio of methanol oxidation versus methanol utilization could be 
determined in a precise manner. Schatschneider et al. (2014) conducted 13C MFA with 
Xanthomonas campestris pv. campestris on minimal medium with 13C-labeled glucose. GC/MS 
was applied for detection of 13C labeling in proteinogenic amino acids and subsequent flux 
simulations, which confirmed the role of the Entner-Doudoroff pathway as main pathway for 
glucose utilization. However, only 13C NMR-based isotopologue profiling of amino acids was 
able to resolve glucose-utilizing pathways in greater depth (Schatschneider et al., 2014). 
2.5.5 Concept of 13C isotope tracer studies with A. gossypii 
The industrial riboflavin production with A. gossypii comprises a highly undefined culture 
medium with large amounts of yeast extract as well as a main carbon source, rapeseed oil, 
which is commercially not available as 13C-labeled substrate. In addition, growth and riboflavin 
production phase are separated (Sahm et al., 2013). Thus, this set-up does not meet the 
criteria needed for conventional 13C MFA as described above (Chapter 2.5.1). However, 
studies with challenging microbial systems such as the cocoa fermentation as well as the great 
resolution obtained by combination of complementary analytical techniques (GC/MS, LC/MS, 
NMR) as described above (Chapters 2.5.2 - 2.5.4) provide an excellent starting point for the 
13C tracer-based resolution of industrial riboflavin production with A. gossypii. 
 
In order to resolve carbon fluxes of the riboflavin overproducer A. gossypii using a complex 
medium with rapeseed oil, a sophisticated approach was developed and then applied (Figure 
8). In the first step, a suitable 13C tracer was selected (e.g. [13C2] glycine). The labeled tracer 
substituted the naturally labeled tracer in the medium. Cultivation also required non-labeled 
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replicates in order to obtain information on biomass formation, substrate consumption, product 
formation, and yields.  
 
 
Figure 8: Sophisticated set-up of 13C tracer studies for resolving carbon fluxes of the riboflavin 
overproducer A. gossypii. At first, a suitable 13C tracer is chosen, which substitutes the naturally labeled 
compound in the medium. Cultivation is carried out using the 13C labeled culture, which will be analyzed 
for amino acid and riboflavin labeling, as well as unlabeled replicates, which are used in order to derive 
yields and rates. The analytical spectrum comprises high performance liquid chromatography (HPLC) 
as means of quantifying substrate concentrations, gas chromatography/mass spectrometry (GC/MS) in 
order to gain information about mass isotopomer distributions (MID) for amino acids (proteinogenic and 
from the supernatant), liquid chromatography/mass spectrometry (LC/MS) for MIDs of riboflavin, 13C 
NMR in order to gain 13C positional enrichment information of riboflavin, and 1H NMR for 13C enrichment 
of formate and determination of formate concentration. Once all data are processed and implemented, 
qualitative carbon fluxes for a single experiment can be obtained. This includes fluxes for only certain 
parts of the metabolism. The whole workflow is then repeated using a different 13C tracer, which will 
render complementary results. In the end, combining the results of all 13C tracer studies will provide a 
thorough picture of qualitative and quantitative fluxes into biomass and product formation. 
 
The analytical spectrum comprised high performance liquid chromatography (HPLC) analyses 
for the determination of substrates. For identification of mass isotopomer distributions of amino 
acids, the conventional GC/MS measurement could be used. Riboflavin, which cannot be 
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analyzed via GC/MS, was measured using LC/MS. Due to the large amount of carbon atoms, 
single 13C incorporation effects were difficult to resolve with high precision. Thus, 13C NMR was 
also applied, which is able to provide data on 13C enrichment of single carbon atoms. Finally, 
1H NMR was the method of choice for formate quantification as well as 13C enrichment 
measurement. This complex experimental workflow was then repeated for a different 13C 
tracer. In the end, the combination of the results from the individual 13C tracer experiments, will 
allow the resolution of metabolic fluxes for this complex system. 
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3 MATERIAL AND METHODS 
3.1 Strains 
All strains were obtained from the BASF (Ludwigshafen, Germany): Ashbya gossypii WT, the 
wild type strain (ATCC 10895) and the riboflavin overproducing A. gossypii B2 (derived from 
the wild type strain). Strains were kept as glycerol stocks at -80 °C. 
3.2 Chemicals and media 
3.2.1 Chemicals 
All chemicals were purchased from Sigma-Aldrich (Taufkirchen, Germany), Roth (Karlsruhe, 
Germany), Becton Dickinson (Franklin Lakes, NJ, USA), and Merck (Darmstadt, Germany) at 
analytical grade quality, if not stated otherwise. Rapeseed oil, soy flour, yeast extract, and corn 
swell flour were obtained from BASF. Stable 13C tracers used in this work are listed in Table 3. 
Water was purified by a Milli-Q Integral water purification system (Merck). 
3.2.2 Medium composition 
Cultivation of A. gossypii on agar plates was performed using sporulation (SP) agar plates, 
which contained per liter: 3 g soy flour, 3 g yeast extract, 3 g malt extract, 20 g corn swell flour, 
30 g agar, and 10 g glucose. A stock solution of glucose (400 g L-1) was autoclaved separately 
before addition to SP medium. The pH was adjusted to 6.8.  
 
The pre-culture medium consisted of 57.9 g L-1 yeast extract, 0.5 g L-1 MgSO4 ∙ 7H2O, 
40 g L-1 rapeseed oil (pH 7). For glycerol stocks 9.5 % (v v-1) glycerol was added to the pre-
culture medium. Medium for the main culture contained per liter: 28.6 g yeast extract, 9.5 g 
glycine, 7.4 g sodium glutamate-monohydrate, 1.9 g KH2PO4, 0.5 g MgSO4 ∙ 7H2O, 1.1 g L-
methionine, 0.2 g m-inositol, 2.0 g sodium formate, 9.0 g urea, and 156.5 g rapeseed oil (pH 
7). Urea and rapeseed oil were sterilized separately by filtration and autoclaving, respectively. 
For cultivations using glucose as main carbon source, rapeseed oil was replaced with a final 
concentration of 20 g L-1 glucose (111 mM or 666 C-mM). In addition, the medium was 
buffered with N-(2-acetamido)-2-aminoethanesulfonic acid (ACES) (200 mM). Cultivations on 
glycerol and sodium acetate were carried out with the same combined C-molarity (666 C-mM) 
in a C-molar ratio of 1:27 for glycerol and acetate, assuming the main component of rapeseed 
oil being C18 fatty acids, which form esters with glycerol. Medium using glycerol and acetate 
as carbon source was buffered with 250 mM 3-(N-morpholino)propanesulfonic acid (MOPS).  
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3.3 Cultivation 
3.3.1 Shake flask cultivation 
Mycelia from cryo cultures were incubated for five to seven days on SP agar plates at 30 °C. 
With mycelia from those agar plates a pre-culture was inoculated using non baffled shake 
flasks with 10 % filling volume (40 h). All cultivations were conducted on a rotary shaker at 
200 rpm, 30 °C, and 80 % humidity (Multitron Pro, Infors, Bottmingen, Switzerland). The main 
culture was inoculated from the pre-culture with an initial inoculum size of 3.5 % (v v-1) and 
was carried out in 250 mL baffled shake flasks with a filling volume of 30 mL (144 h) (Figure 
9A). Cultivations were performed in parallel shake flasks with three flasks being sacrificed per 
sample (Figure 9). This was necessary in order to obtain reliable and reproducible data. Firstly, 
this enabled large sampling volumes in the early growth phase, required for accurate cell dry 
weight (CDW) determination. Secondly, this avoided potential sampling artefacts, otherwise 
resulting from changes in oil distribution and phase separation between aqueous and oil phase 
throughout the course of the experiments. Eventual evaporation was monitored throughout the 
cultivation by weighing the shake flask before and after each sample. All concentrations were 
corrected for the rate of evaporation. 
 
Table 3: Isotopic tracers used in this work. Stable 13C isotopes were used for qualitative 13C tracer 
experiments. 
Tracer Supplyer Labeling Purity [%] Reference 
[13C6] Glucose Omicrona 99 Chapter 4.2 
[13C2] Sodium acetate Sigma-Aldrichb 99 Chapter 4.3 
[13C3] Glycerol Sigma-Aldrichb 99 Chapter 4.3 
[13C2] Glycine Sigma-Aldrichb 99 Chapters 4.4, 4.5 
[13C3] Serine Sigma-Aldrichb 99 Chapters 4.4, 4.5 
[3-13C] Serine Sigma-Aldrichb 99 Chapter 4.5 
[13C] Sodium formate Sigma-Aldrichb 99 Chapters 4.4, 4.5 
[U13C] Yeast extract Ohlyc 99 Chapters 4.4, 4.5 
[13C5] Glutamic acid Sigma-Aldrichb 98 Chapters 4.4, 4.5 
a South Bend, IN, USA 
b Taufkirchen, Germany 
c Hamburg Germany 
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Figure 9: Inoculation (A) and sampling scheme (B) of standard cultivations with A. gossypii, using 
rapeseed oil as main carbon source for naturally labeled substrates. 
 
3.3.2 Cultivations with 13C tracer compounds 
In isotope experiments, naturally labeled ingredients were replaced by 13C labeled tracers in 
equimolar amount or were added to the medium (Table 3). Natural glycine was replaced by 
[13C2] glycine. Natural sodium glutamate was replaced by [13C5] glutamic acid. In additional 
experiments, [13C3] serine as well as [3-13C] serine were added to a tracer concentration of 
2.4 g L-1 at different time points of the cultivation (0 h or 48 h). Natural formate was either 
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replaced in the initial medium by [13C] sodium formate or was added after 48 h to a tracer 
concentration of 2.0 g L-1. In the latter case, the initial medium contained the normal amount 
of natural formate given above. The company Ohly (Hamburg, Germany) provided [U13C] yeast 
extract, which replaced the naturally labeled yeast extract. All other 13C enriched compounds 
were obtained from Sigma-Aldrich (Taufkirchen, Germany) or Omicron (South Bend, Indiana, 
USA). All the 13C tracer studies conducted in this work are listed in the appendix (Table 15). 
3.3.3 Supplementation studies 
Formate supplementation studies were done using main culture medium without formate in the 
initial medium and standard cultivation conditions. Sodium formate was then added after 0 h, 
12 h, 24 h, and 36 h in parallel experiments (final concentration 2.0 g L-1). Three flasks per 
condition were harvested after 144 h and the riboflavin titer was determined. Supplementation 
studies using serine were conducted in a similar manner. Medium without formate was 
supplemented with L-serine (final concentration 2.4 g L-1) at different time points (0 h, 12 h, 
24 h, 36 h) in parallel cultivations. The riboflavin titer was measured after 144 h. In both 
supplementation cases, the original medium (with formate in the initial medium) served as 
control. 
3.3.4 Sampling of biomass and supernatant 
Due to the unconventional nature of the cultivation set-up, the sampling scheme had to be 
designed carefully. Figure 9B shows the workflow for the naturally labeled control flasks for the 
determination of yields and rates. Sampling of the 13C tracer condition had to be adjusted: 1 mL 
to 2 mL culture broth were sampled per time point from the same flask throughout the 
cultivation. The culture broth was then centrifuged. The supernatant and pellet were used for 
GC/MS, LC/MS, and HPLC analysis (Figure 9B). 
3.3.5 Sampling for intracellular metabolites 
Samples for intracellular amino acid and formate extraction were obtained by fast filtration as 
described elsewhere (Bolten and Wittmann, 2008). Briefly, 0.7 mL cell culture was vacuum 
filtered (Whatman filter paper, Grade 3, GE Healthcare, Little Chalfont, UK) and washed with 
medium without amino acids or formate. For metabolite extraction, the harvested cells were 
then incubated in 5 mL α-aminobutyric acid (200 μM) at 100 °C. After 15 min, extracts were 
cooled, transferred to a reaction tube, centrifuged (centrifuge 5415R, Eppendorf, Hamburg, 
Germany), and filtered (0.2 μm, PES, Sarstedt, Nümbrecht, Germany). 
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3.4 Analytical methods 
3.4.1 Cell concentration 
Cell dry weight (CDW) was determined gravimetrically by filtration of culture broth (Whatman 
filter paper Grade 3, GE Healthcare). Residual rapeseed oil was removed as described below 
(Figure 9B). The remaining aqueous phase was filtered. Cells and filter were dried and weighed 
using a moisture analyzer (HB43-S, Mettler Toledo, Columbus, OH, USA) (Stahmann et al., 
1994). Dilution effects of the preceding extraction step using hexane-isopropanol were taken 
into account. 
3.4.2 Quantification of substrates and products 
3.4.2.1 Gravimetric oil determination 
Preceding CDW determination, residual oil in the flask was also measured gravimetrically by 
extracting the culture broth twice with one volume hexane-isopropanol (3:2 v v-1). The upper 
layer containing rapeseed oil was collected and the remaining solvent was evaporated until a 
constant weight was reached (Figure 9B) (Stahmann et al., 1994). 
 
3.4.2.2 Riboflavin 
Quantification of riboflavin was carried out spectrophotometrically at a wavelength of 444 nm 
(UV-1600PC spectrophotometer, VWR, Hannover, Germany). Samples were diluted using 1 N 
NaOH and neutralized by adding 0.1 M potassium phosphate buffer (pH 6) (Jeong et al., 2015). 
 
3.4.2.3 Amino acids 
Amino acids in the culture supernatant as well as in metabolite extract were quantified using 
HPLC (Agilent 1200 series, Agilent Technologies, Waldbronn, Germany) with α-aminobutyric 
acid as internal standard and pre-column derivatization (Krömer et al., 2005). The separation 
was conducted using a reversed-phase column (Gemini 5 μm C18 110 Å, 150 x 4.6 mm, 
Phenomenex, Aschaffenburg, Germany) and gradient elution (0 min: 100 % eluent A; 44.5 min: 
55.5 % eluent A; 45.0 min: 39 % eluent A; 47 min: 39 % eluent A; 48 min: 18 % eluent A; 
48.5 min: 0 % eluent A; 50.5 min: 0 % eluent A; 51 min: 100 % eluent A; 53 min: 100 % eluent 
A). The amino acid derivatives were detected via fluorescence (excitation at 340 nm, emission 
at 540 nm). All samples were filtered prior to measurement (0.2 μm, PES, Sarstedt, 
Nümbrecht, Germany). 
 
3.4.2.4 Formate 
Formate quantification in supernatant and in metabolite extract was conducted, using 1H NMR. 
Culture supernatants and extracts were filtered (0.2 μm) and the internal standard 2-
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(trimethylsilyl)propionic-2,2,3,3-d4 acid (TSP-d4) was added. The measurement was carried 
out on a Bruker Ascend Avance III 800 MHz spectrometer (Bruker, Rheinstetten, Germany) 
using the Bruker TopSpin software for data analysis (Ryffel et al., 2016) and at 293 K with a 
total of 16 scans at a flip angle of 30 ° (10 s relaxation delay, 7.53 μs and -12.55 dB hard pulse 
(90 °)). The spectral window width of the measurement was 20 ppm. Following changes were 
made for formate quantification from metabolite extracts: 128 scans at 298 K and 7.57 μs 
duration of hard pulse. 
3.4.3 Mass isotopomer distributions 
3.4.3.1 Mass isotopomers of amino acids 
Mass isotopomer distributions (MIDs) of amino acids from hydrolyzed cell protein and culture 
supernatant were quantified by GC/MS using helium as carrier gas (Gas chromatograph 
7890B, Agilent; mass selective detector 5875A, Agilent; column: HP-5-MS, 30 m x 0.25 mm x 
0.25 μm, Agilent) (Kiefer et al., 2004). Cells were harvested at the end of the exponential 
growth phase (32 to 36 h for cultivations on vegetable oil, 12 to 24 h for cultivations on other 
main carbon sources). The culture broth was centrifuged. The collected pellet was washed 
several times with deionized water, followed by hydrolysis with 6 M HCl (100 °C, 24 h). 
Hydrolysates were clarified from cell debris (0.2 μm, Merck Millipore, Darmstadt, Germany), 
dried under nitrogen, and derivatized using 0.1 % pyridine in dimethylformamide and N-methyl-
N-tert-butyldimethylsilyl-trifluoroacetamide (MBDSTFA) as previously described (Wittmann et 
al., 2002) (Figure 10A). Culture supernatant was filtered (0.2 μm) and an amount, containing 
about 30 nmol of the amino acids of interest, was dried under nitrogen and derivatized as 
mentioned above. Separation of the silylated amino acids was carried out using the following 
temperature profile: 2 min/120 °C, temperature increase to 200 °C at a rate of 8 °C/min, 
temperature increase to 323 °C at a rate of 10 °C/min. The temperature of the inlet, the 
interface, and the quadrupole was set to 280 °C. All samples were first measured in scan mode 
to check for isobaric interference with the analytes of interest and verify unbiased ion clusters 
for 13C quantification based on retention time and unique fragmentation pattern. Subsequently, 
labeling patterns of all samples were determined in technical duplicates using selective ion 
monitoring (SIM) of selected ion clusters. A GC/MS spectrum of tert-butyl-dimethylsilyl-
derivatized proteinogenic amino acids of A. gossypii grown on vegetable oil in SIM mode is 
shown in Figure 10C. 
The ion cluster [M-57] was measured for all amino acids, but leucine and isoleucine, as it 
represents the full carbon backbone of the analytes (Wittmann, 2007). The ion cluster [M-85] 
had to be measured for proline, as its [M-57] fragment overlapped with succinate. The [M-85] 
cluster was also analyzed for isoleucine and leucine as their [M-57] ion cluster represents both 
the full carbon backbone as well as the [M-residue] fragment, which contains solely carbon 
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atoms 1 and 2 (Figure 10B). The mass fragments used for further analysis are listed in Table 
4. The MIDs obtained from the measurements had to be corrected for abundance of natural 
isotopes and dilution of labeling through naturally labeled pre-culture as described in Chapter 
3.5.1. 
 
 
Figure 10: Derivatization of amino acids (A), subsequent fragmentation of tert-butyl-dimethylsilyl-
derivatized amino acids during GC/MS analysis (B), and GC/MS spectrum in SIM mode of TBDMS-
derivatized proteinogenic amino acids of A. gossypii B2 grown on complex medium with rapeseed oil as 
main carbon source (C). Amino acids were derivatized using MBDSTFA at 80 °C, rendering the 
corresponding TBDMS-derivative. Grey circles denote the carbon atom at position 1, white circles 
correspond to position 2. The subscript n designates the number of functional groups that were silylated 
in the respective amino acid (A). During electron ionization derivatized amino acids are fragmented 
yielding characteristic ion clusters (B). R, residues of the amino acid. Letters in (C) depict the one-letter 
code for amino acids. 
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Table 4: Fragment ion clusters of TBDMS derivatives of amino acids and the TMS derivative of glucose 
measured by GC/MS in SIM mode. The mass given for each analyte, M+0, represents the mass-to-
charge ratio (m/z) of the isotopomer that contains only non-labeled atoms. TBDMS, tert-butyl-
dimethylsilyl; (TMS)5-MOA-glucose, 5-trimethylsilyl-O-methyloxime glucose; residue, residue of amino 
acid. 
Analyte M+0 Fragment Carbon atoms 
 [m/z]   
Alanine-(TBDMS)2 260 [M-57] 1 – 3 
 232 [M-85] 2 – 3 
Glycine-(TBDMS)2 246 [M-57] 1 – 2 
 218 [M-85] 2 
Valine-(TBDMS)2 288 [M-57] 1 – 5 
 260 [M-85] 2 – 5 
Leucine-(TBDMS)2 274 [M-85] 2 – 6 
Isoleucine-(TBDMS)2 274 [M-85] 2 – 6 
Proline-(TBDMS)2 286 [M-57] 1 – 5 
 258 [M-85] 2 – 5 
Serine-(TBDMS)3 390 [M-57] 1 – 3 
 362 [M-85] 2 – 3 
Threonine-(TBDMS)3 404 [M-57] 1 – 4 
 376 [M-85] 2 – 4 
Phenylalanine-(TBDMS)2 336 [M-57] 1 – 9 
 234 [M-159] 2 – 9 
Aspartate-(TBDMS)3 418 [M-57] 1 – 4 
 390 [M-85] 2 – 4 
Glutamate-(TBDMS)3 432 [M-57] 1 – 5 
 330 [M-159] 2 – 5 
Lysine-(TBDMS)3 431 [M-57] 1 – 6 
 329 [M-85] 2 – 6 
Arginine-(TBDMS)3 442 [M-57] 1 – 6 
Histidine-(TBDMS)2 440 [M-57] 1 – 6 
Tyrosine-(TBDMS)3 466 [M-57] 1 – 9 
 302 [M-residue] 1 – 2 
(TMS)5-MOA-Glucose 544 [M-15] 1 – 6 
 
3.4.3.2 Mass isotopomers of glycogen-derived glucose by GC/MS 
The mass isotopomer distribution for glucose from cellular glycogen was measured with the 
same GC/MS system as described above (see Chapter 3.4.3.1). About 5 mg cells were 
harvested at the end of the exponential growth phase by centrifugation. Recovery of glycogen 
from biomass was carried out as follows: harvested cells were washed several times with 
deionized water and resuspended in 500 μL enzyme solution, containing 70 U mL-1 
amyloglucosidase (Sigma-Aldrich) and 1.2 kU mL-1 lysozyme (0.02 M Tris HCl, pH 7.0) 
(Sigma-Aldrich). Subsequent hydrolysis occurred at 37 °C for 3 h at 400 rpm. After cell debris 
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removal via filtration (0.2 μm, Merck Millipore), the glucose concentration was determined 
enzymatically, using a D-glucose assay kit according to instructions by the manufacturer (R-
Biopharm, Darmstadt, Germany). At least 40 μg glucose were then dried by lyophilization, 
followed by a two-step derivatization using first 50 μL 2 % methoxylamine in pyridine (80 °C, 
25 min) and then adding 50 μL N,O-bis-trimethylsilyl-trifluoroacetamide (BSTFA) (80 °C, 
30 min) (Figure 11A). Measurement of the obtained trimethylsilyl O-methyloxime derivative of 
glucose was carried out using the following temperature profile: 3 min/150 °C, temperature 
increase to 230 °C at a rate of 8 °C/min, temperature increase to 325 °C at a rate of 25 °C/min. 
The temperature of the inlet, the interface, and the quadrupole was set to 280 °C. All samples 
were first measured in scan mode to check for isobaric interference. The mass isotopomer 
distribution was then determined in technical duplicates using SIM of the ion cluster [M-15], 
which represents all six carbon atoms of glucose (Figure 11B, Table 4) (Laine and Sweeley, 
1971). The resulting MIDs were corrected as described below (Chapter 3.5.1). 
 
 
Figure 11: Two- step derivatization (A) of glycogen-derived cellular glucose using methoxylamine and 
BSTFA. GC/MS fragmentation (B) renders a [M-15] fragment containing all six carbon atoms of glucose 
after loss of a methyl group and the [M-250] fragment containing carbon atoms 3 to 6. 
 
3.4.3.3 Mass isotopomers of riboflavin 
The 13C labeling of riboflavin in the culture supernatant was analyzed by LC/MS (Hoffmann et 
al., 2014). Samples were filtered twice (0.2 μm) before treatment with pipet-tip columns of C18 
resin (Pierce C18 tips, 100 μL bed size, ThermoFisher Scientific, Dreieich, Germany). All 
samples were analyzed using a Dionex Ultimate 3000 RSLC (ThermoFisher Scientific) and a 
maXis 4G hr-QqToF mass spectrometer (Bruker, Rheinstetten, Germany) using the Apollo ESI 
source. Settings for LC-separation were as described previously (Hoffmann et al., 2014) with 
a modified gradient: 0 min: 5 % eluent B; 0.5 min: 5 % eluent B; 9.5 min: 95% eluent B; 
10.5 min: 95 % eluent B; 11.0 min: 5 % eluent B; 12.5 min: 5 % eluent B. With a few 
exceptions, mass spectrometric parameters were kept unchanged to the previously described 
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method (Hoffmann et al., 2014): quadrupole ion energy was set to 5 eV with a low mass of 
120 m/z. The collision cell was also set to 5 eV with a collision RF of 800 Vpp. Obtained MIDs 
for the 377 m/z parent ion of riboflavin were corrected as described below (Chapter 3.5.2). 
3.4.4 Positional isotopomers 
3.4.4.1 Positional isotopomers of riboflavin 
Positional labeling data for riboflavin were obtained by 1H and 13C NMR. For NMR analyses of 
riboflavin, rapeseed oil of the culture was extracted, cells and riboflavin crystals were filtered 
using Whatman filter paper (GE Healthcare). The filter cake was resuspended in 80 mM NaOH. 
Upon cell removal by centrifugation and filtration (0.2 μm), riboflavin was precipitated by 
addition of 80 mM HCl. The collected pellet was lyophilized and then dissolved in dimethyl 
sulfoxide for 48 h to a final concentration of 2 g L-1. NMR spectra were recorded on a Bruker 
Ascend Avance III 800 MHz spectrometer (Bruker, Rheinstetten, Germany) using the Bruker 
TopSpin software for data analysis (Ryffel et al., 2016). The 1H NMR measurements were 
carried out at 800 MHz at a nominal temperature of 300 K with a total of 4 scans at a flip angle 
of 30 ° (5 s relaxation delay, 7.31 μs and -12.55 dB hard pulse (90 °)). For every sample, 64k 
free induction decay (FID) signals were collected with a spectral width of 20 ppm. All 13C NMR 
measurements were conducted at 201.2 MHz with a total of 2304 scans and a spectral width 
of 236.6 ppm at 6 s relaxation delay, 12.3 μs and -23.01 dB hard pulse (90 °). To account for 
the exact contribution of the used tracer to the synthesis of a specific riboflavin carbon atom, 
the relative 13C enrichment of this atom was corrected (Chapter 3.5.2). 
 
3.4.4.2 Quantification of 13C enrichment of formate 
Culture supernatants were filtered (0.2 μm) and the internal standard 2-
(trimethylsilyl)propionic-2,2,3,3-d4 acid (TSP-d4) was added. The 13C enrichment of formate 
was measured indirectly via 1H NMR, which was carried out at 293 K with a total of 16 scans 
at a flip angle of 30 ° at 10 s relaxation delay, 7.53 μs and -12.55 dB hard pulse (90 °). The 
spectral window width of the measurement was 20 ppm. 
3.5 Correction of labeling data 
3.5.1 Correction of 13C labeling data from hydrolyzed cell protein and glycogen 
All MIDs were corrected for natural isotopes (van Winden et al., 2002) as well as for the fraction 
of naturally labeled amino acids originating from the inoculum. The output of the correction 
was a mass isotopomer distribution of the carbon skeleton of the analytes formed during the 
corresponding isotope experiment (MIDcorr). The total 13C enrichment of the carbon skeleton of 
a compound with n carbon atoms, termed summed fractional labeling (SFL) (Christensen et 
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al., 2000), was calculated according to Equation (1). The data were given in percent, whereby 
100 % represents a fully 13C-labeled carbon backbone and i represents the number of 13C 
atoms of this isotopomer. 
 
 
100,
1
1
¦ 
 n
MIDi
SFL corri
n
i
 (Eq. 1) 
 
To calculate the net incorporation of 13C label from the tracers glucose, acetate, and glycerol 
into the respective proteinogenic amino acids, the SFL was then corrected for the natural 13C 
background of the carbon backbone (1.07 %) (Adler et al., 2014) and the purity P of the 
respective tracer (Table 3) according to Equation (2). 
 
 ܵܨܮ௖௢௥௥ ൌ 
ܵܨܮ െ ܵܨܮ௡௔௧
ܲ ή ͳͲͲ 
(Eq. 2) 
 
For all other labeling studies, the SFL was corrected for the natural 13C background of the 
carbon backbone as well as fraction of labeling originating from unlabeled pre-culture of the 
respective tracer at the beginning of the cultivation (appendix Figure 39). Equation (3) then 
yielded the corrected SFLcorr (all SFLs are given in percent). In addition, the real contribution 
of the tracer took into account the underlying carbon transition into the target molecule as 
described in Chapter 3.5.3. 
 
 ܵܨܮ௖௢௥௥ ൌ 
ܵܨܮ െ ܵܨܮ௡௔௧
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ή ͳͲͲ (Eq. 3) 
 
with 
SFLcorr for natural background and dilution of 13C tracer enrichment through pre-culture 
corrected SFL of a proteinogenic amino acid, glucose or riboflavin [%] 
SFL SFL of a proteinogenic amino acid, glucose, or riboflavin calculated according 
to Equation (1) [%] 
SFLnat SFL of proteinogenic amino acid, glucose or riboflavin when synthesized on 
naturally labeled medium [%] 
SFLTr SFL of the respective tracer at the beginning of the cultivation (0 h), when 
glycine, formate, glutamate, and yeast extract are fully labeled [%] 
SFLTr,nat SFL of the naturally labeled respective tracer [%] 
 
 
MATERIAL AND METHODS 
37 
 
3.5.2 Correction of LC/MS and 13C NMR data of riboflavin 
LC/MS derived MIDs for the 377 m/z parent ion of riboflavin were corrected for the natural 
abundance of isotopes (van Winden et al., 2002). In case, the entire molecule was under 
investigation, e.g. when [13C6] glucose or fully 13C-labeled yeast extract were fed, all seventeen 
carbon atoms were regarded as carbon backbone. If only a certain part of the molecule was 
inspected, e.g. the two-carbon unit derived from glycine, only those carbon atoms were defined 
as carbon backbone, whereas the rest was defined as carbon atoms of the derivatization. SFLs 
were derived according to Equations (1) and (3) as described above (Chapter 3.5.1). 
 
Positional 13C enrichment data (%13Cexp) of single carbon atoms, derived from 13C NMR 
measurements were corrected in a similar manner according to Equation (4). 
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(Eq. 4) 
 
with 
%13Ccorr the real 13C enrichment of the carbon of interest of riboflavin from a given tracer 
[%] 
%13Cexp measured 13C enrichment for carbon atom of interest of riboflavin from a given 
tracer [%] 
%13Cnat the natural 13C enrichment of the carbon of interest [%] 
SFLTr SFL of the respective tracer at the beginning of the cultivation (0 h), when 
glycine, formate, glutamate, and yeast extract are fully labeled [%] 
SFLTr,nat SFL of the naturally labeled respective tracer [%] 
 
In the case of formate addition, 13C NMR results of riboflavin were also corrected for decrease 
in 13C labeling of the tracer ([13C] formate) over time (appendix Figure 42), which was detected 
by 1H NMR. Riboflavin concentrations for certain time points were interpolated. With these 
information riboflavin production was divided into intervals. For every interval the concentration 
of riboflavin synthesized was calculated (Equation 5) as well as the mean SFL of 13C tracer 
(Equation 6) and the maximum amount of riboflavin, which could be 100 % 13C labeled at the 
carbon of interest for that interval (Equation 7). 
 
 ሾܴܨሿ௜ ൌ  ሾܴܨሿ௧௜ െ ሾܴܨሿ௧௜ିଵ (Eq. 5) 
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(Eq. 7) 
 
For the entire cultivation the maximally possible amount of 100 % 13C enrichment at the carbon 
of interest was calculated by forming the sum of the intervals (Equation 8), which was then 
transformed into percentage of the final riboflavin titer in the cultivation (Equation 9) and the 
true 13C enrichment in the carbon of interest stemming from the respective 13C tracer (Equation 
10). 
 
 
ሾܴܨሿ௠௔௫ ൌ෍ሾܴܨሿ௠௔௫ǡ௜
௡
௜ୀଵ
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(Eq. 10) 
 
with 
[RF]i  riboflavin concentration produced during the interval i (appendix Figure 42) [g L-1] 
[RF]ti  riboflavin concentration at the end of the interval i [g L-1] 
[RF]ti-1  riboflavin concentration at the end of the interval i-1 [g L-1] 
SFLTr,i  mean SFL of tracer compound at interval i [%] 
P  purity of tracer (see Table 3) [%] 
SFLTr,ti  SFL of tracer at the end of interval i [%] 
SFLTr,ti-1 SFL of tracer at the end of the interval i-1 [%] 
[RF]max,i maximal riboflavin concentration with 100 % 13C enrichment from respective tracer for 
interval i [g L-1] 
[RF]max maximal overall riboflavin concentration with 100 % 13C enrichment at carbon of interest 
from respective tracer [g L-1] 
[RF]final  final riboflavin concentration after 144 h [g L-1] 
%RF13C,max percentage of final riboflavin titer that is maximally 13C enriched [%] 
%13Cmeas measured 13C enrichment for carbon atom of interest of riboflavin from given tracer [%] 
%13Ccorr  the real 13C enrichment of the carbon of interest of riboflavin from a given tracer [%] 
 
 
 
MATERIAL AND METHODS 
39 
 
3.5.3 Calculating the contribution of a 13C-labeled tracer to a target molecule 
 
Table 5: Factor for converting the summed fractional labeling (SFL) of a target molecule into the 
contribution of a 13C-labeled tracer compound taking into account the biosynthesis of the target 
molecules. Grey circles, 13C-labeled carbon atoms. White circles, naturally labeled carbon atoms. R 
indicates the ribityl side chain of riboflavin, comprising five of the seventeen carbon atoms. Ala, alanine; 
Arg, arginine; For, formate; GCS, glycine cleavage system; Glu, glutamate; Gly, glycine; Ser, serine. 
13C Tracer Target molecule Maximum SFL Correction factor F 
  [%] [-] 
 
[13C2] Gly 
 
[13C2] Ser/Ala 
67 1.5 
 
[13C] For 
 
[13C1] Ser/Ala 
33 3.0 
 
[13C2] Gly 
(no GCS)  
[13C2] Riboflavin 
12 8.5 
 
[13C2] Gly 
(with GCS)  
[13C3] Riboflavin 
18 5.7 
 
[13C] For  
[13C1] Riboflavin 
6 17 
 
[13C3] Ser  
[13C3] Riboflavin 
18 5.7 
 
[13C1] Ser  
[13C1] Riboflavin 
6 17 
 
[13C5] Glu 
 
[13C5] Arg 
83 1.2 
 
In order to take into consideration the maximally possible contribution of a tracer molecule into 
a target compound, the SFLcorr was multiplied by a correction factor F (Table 5). As an example, 
glycine, a two-carbon compound, can maximally contribute two thirds to e.g. the serine carbon 
skeleton. This takes into account the biosynthetic route of serine from glycine. Thus, its 
contribution to a certain molecule does not equal the SFL of that molecule, but can be corrected 
for the underlying carbon transition. In case of serine, a C3 molecule, the SFL would have to 
be multiplied by the factor 1.5 in order to get the true contribution (Ψ) of glycine to serine 
(Equation 11). 
 
 ߖ்௥ ൌ ܵܨܮ௖௢௥௥ ή ܨ (Eq. 11) 
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with 
ΨTR contribution of a given 13C labeled tracer to the target molecule (amino acid or riboflavin) 
[%] 
SFLcorr for natural background and decrease of 13C enrichment of tracer corrected SFL for a 
target molecule (amino acid or riboflavin) [%] 
F correction factor for underlying carbon transition between tracer and target 
molecule (see Table 5) [-] 
3.6 Transmembrane formate flux simulation 
The observed change of 13C enrichment of formate in the culture supernatant indicated an 
exchange between cell interior and the surrounding medium (Wittmann and Heinzle, 2001). 
The underlying transmembrane flux of the compound was calculated from experimental data 
using OpenFLUX (Quek et al., 2009). The model created for this purpose comprised different 
formate pools, which were fed by 13C formate added to the medium (FORFEED) and the 
intracellular formate pool from riboflavin biosynthesis (FORP5P) (Figure 12). A total of five fluxes 
were calculated using the model. Two metabolite balances could be formulated: 
 
FORINTR v2 + v4 – v3 – v5 = 0 (Eq. 12) 
FOREXTR v1 + v3 – v2 – v6 = 0 (Eq. 13) 
 
Together with two sets of measured labeling data for the different formate pools (FORFEED, 
FOREXTR) and two sets of estimated labeling data sets (FORP5P, FORINTR) this rendered an 
overdetermined network. Estimation of intracellular 13C formate labeling is described in 
Chapter 4.6.1. The deviation between the experimental and simulated data was minimized for 
the calculated fluxes by the flux software and was taken as best estimate. Subsequent Monte-
Carlo analysis provided 90 % confidence intervals for the estimated flux parameters (Wittmann 
and Heinzle, 2002). 
Flux reversibility (ζ) of the transmembrane formate flux was defined as ratio of backward flux 
to net flux in the forward direction (Equation 14) (Wittmann and Heinzle, 2001). 
 
 ߞ௩మȀ௩య ൌ 
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 (Eq. 14) 
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Figure 12: Simplified metabolic model for the simulation of formate fluxes across the plasma membrane. 
FORFEED represents the formate pool provided by 13C labeled formate added to the medium, FOREXTR, 
formate pool fed by 13C labeled feed formate and intracellular formate pool; FORINTR, intracellular 
formate pool, fed by unlabeled formate from pentose 5-phosphate (FORP5P) and extracellular formate. 
FOREXTR was measured and FORINTR was deduced from extracellular 13C labeling and riboflavin labeling 
at carbon atom C2. Those data were used as input for the model (highlighted in red). FORP5P and 
FORFEED were substrates with constant labeling (1.1 % and 99 % 13C enrichment, respectively). The 
metabolic model is described in the appendix (Chapter 6.9).  
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4 RESULTS AND DISCUSSION 
4.1 The benchmark process: growth and riboflavin production on vegetable oil 
Industrial riboflavin production with A. gossypii is conducted using vegetable oil as carbon 
source. While other substrates like glucose can also be used for production of the vitamin, 
vegetable oil is reported to yield the best titers and highest production performance (Demain, 
1972). In order to assess growth and productivity of A. gossypii WT and B2 used in this study, 
cultivations were carried out under industrially relevant conditions with complex medium and 
rapeseed oil as substrate. Furthermore, the medium contained large amounts of yeast extract 
(29 g L-1) and was supplemented with formate, glycine, and glutamate. 
A.gossypii WT and B2 exhibited a two-phase profile (Figure 13): an initial growth phase and a 
subsequent riboflavin production phase. The overproducer A. gossypii B2 achieved a final 
riboflavin titer of 5.3 g L-1 within 144 h (Figure 13A), while the wild type WT showed a titer of 
1.5 g L-1 at the end of the cultivation (Figure 13D). With a maximum growth rate of 0.07 h-1, a 
maximum biomass concentration of 20.0 gCDW L-1 was reached after 48 h for A. gossypii B2. 
While slight riboflavin production was already initiated at about 24 h, major production started 
after 36 h when cell growth was almost finished (Figure 13A). During riboflavin biosynthesis, 
A. gossypii B2 did not exhibit growth and cells were rather stationary. After 83 h of cultivation, 
the strain reached a maximum specific productivity of 17.0 μmol g-1 h-1 (6.4 mg g-1 h-1) (Figure 
13C). The different substrates were consumed in a divergent manner. Rapeseed oil was 
consumed during both phases, but was still available in large amounts at the end of the 
process. Glycine uptake was rather weak during the initial growth phase, but particularly strong 
during the riboflavin production phase. However, the observed stoichiometric ratio of 
6.1 molGlycine molRiboflavin-1 (Table 6) strongly exceeded the value of 1 mol mol-1 expected from 
the incorporation of one glycine molecule into the pyrimidine ring of the vitamin. Glycine was 
still present at substantial levels after 144 h (4 g L-1) (Figure 13B). In contrast, the level of 
glutamate mainly decreased during cell growth, but remained relatively constant towards the 
end of the process. Within the first 20 h of cultivation, the wild type A. gossypii WT reached a 
final CDW of 9.6 gCDW L-1 with a maximum growth rate of 0.17 h-1 (Figure 13D). After a transient 
lag phase, the second growth phase and coupled riboflavin production phase started after 
48 h. During this second growth phase, cells grew at a much slower rate of 0.01 h-1, reaching 
a maximum overall biomass concentration of 28.6 gCDW L-1 after 96 h. While cell growth ceased 
after that, riboflavin production was still ongoing reaching a maximum specific productivity of 
3.7 μmol g-1 h-1 (1.4 mg g-1 h-1) after 122 h (Figure 13F). A. gossypii WT consumed the 
substrates rapeseed oil, glycine, and glutamate in a similar manner compared to A. gossypii 
B2: vegetable oil was consumed throughout the cultivation, glutamate consumption was 
RESULTS AND DISCUSSION 
43 
 
strongest during the first growth phase whereas glycine consumption was greater during 
riboflavin biosynthesis (Figure 13D, E). Considering the stoichiometric ratio of 
250 molGlycine molRiboflavin-1 (Table 6), glycine uptake and conversion into riboflavin seemed much 
less efficient for A. gossypii WT than B2. The cultivations clearly show that the chosen set-up, 
i.e. complex medium with vegetable oil, resulted in good growth of the fungus as well as high 
riboflavin production compared to the riboflavin titers on glucose-containing medium described 
in the literature (up to about 300 mg L-1) (Ledesma-Amaro et al., 2015c). 
 
 
Figure 13: Growth and riboflavin production of A. gossypii B2 (A-C) and WT (D-F) on complex medium 
with rapeseed oil. The data represent mean values and the deviation for three shake flasks, sacrificed 
per data point. CDW, cell dry weight; QP, volumetric productivity; qP, specific productivity; RF, riboflavin. 
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Table 6: Growth and production kinetics of A. gossypii B2 and WT grown on complex medium with 
rapeseed oil as main carbon source. Rates (q, Q) and yield coefficients (Y) represent mean values from 
three independent replicates. RF, riboflavin; Glu, glutamate; Gly, glycine; P, product; S, substrate; X, 
biomass. 
   B2 WT 
Rates μmax,1 [h-1] 0.07 ± 0.00 0.17 ± 0.01 
 μmax,2 [h-1] - 0.01 ± 0.00 
 qS,Oil [mmol g-1 h-1] 0.43 ± 0.06 0.75 ± 0.00 
 qS,Glu [mmol g-1 h-1] 0.14 ± 0.02 0.16 ± 0.00 
 qS,Gly [mmol g-1 h-1] 0.08 ± 0.02 0.16 ± 0.00 
 qP,max [μmol g-1 h-1] 16.96 ± 1.96 3.69 ± 1.94 
 QP,max [μmol L-1 h-1] 352.04 ± 52.20 98.60 ± 49.40 
Yields YX/Oil [g mol-1] 186.1 ± 21.4 224.1 ± 35.5 
 YX/Glu [g mmol-1] 0.56 ± 0.08 1.07 ± 0.11 
 YX/Gly [g mmol-1] 0.98 ± 0.21 1.06 ± 0.12 
 YRF/Oil [mmol mol-1] 281.6 ± 36.1 183.2 ± 63.8 
 YRF/Glu [mmol mol-1] 886.4 ± 131.4 7.8 ± 1.1 
 YRF/Gly [mmol mol-1] 152.4 ± 14.4 4.0 ± 0.7 
 
4.2 Glucose as main carbon source for growth and riboflavin production 
Riboflavin production with A. gossypii on vegetable oil resulted in final riboflavin titers of 
5.3 g L-1 and 1.5 g L-1, for A. gossypii B2 and WT, respectively (Chapter 4.1). However, 
glucose has been mainly used to study the pathways for riboflavin production (Bacher et al., 
1985; Ledesma-Amaro et al., 2015c; Schlüpen et al., 2003; Silva et al., 2015), given its 
availability as 13C tracer. First experiments, therefore, aimed to elucidate to which extent 
glucose enabled to study the microbe under high-productivity conditions, as this would have 
provided a straightforward strategy for the isotope experiments to be conducted. 
The growth and production profiles of A. gossypii WT and B2 with 20 g L-1 glucose as main 
carbon source are shown in Figure 14. In order to compensate for a drastic decrease in pH the 
system was buffered with ACES (200 mM) (Good et al., 1966). The two-phase process was 
characterized by an initial growth and subsequent riboflavin production phase. Riboflavin 
biosynthesis started after about 12 h: A. gossypii B2 accumulated only 74.1 mg L-1 (0.2 mM) 
riboflavin after 144 h (Figure 14A). The wild type strain A. gossypii WT, on the other hand, 
produced twice as much riboflavin with a final titer of 155.1 mg L-1 (0.4 mM) (Figure 14C). This 
difference in production capacity on glucose is emphasized by volumetric and specific 
productivities, QP and qP, respectively (Figure 14B and D). A. gossypii WT reached the 
maximum riboflavin productivity of 1.7 μmol g-1 h-1 after 23 h, right after the growth rate had 
decreased (Figure 14D, Table 7). A. gossypii B2 exhibited its maximum productivity after 35 h 
with 0.3 μmol g-1 h-1, which was reduced 5.7-fold compared to the wild type (Figure 14B, Table 
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7). The fact that the final riboflavin titer only deviated by the factor 2 can be attributed to the 
production behavior of the two strains: A. gossypii WT synthesized about 80 % of the final 
riboflavin amount within 36 h of the process, while A. gossypii B2 continuously produced 
riboflavin. Interestingly, nearly all the glucose added to the medium was consumed at the end 
of the exponential growth phase. This left other carbon sources in the medium, like glycine and 
glutamate (final concentrations 7.2 g L-1 and 5.8 g L-1 for both strains, respectively) or 
compounds from the yeast extract for the assembly of riboflavin. A. gossypii is known to 
accumulate lipid bodies inside the cell as storage (Ledesma-Amaro et al., 2014b; Stahmann 
et al., 1994). It would appear obvious for the cell to mobilize the intracellular triacylglycerides 
for growth-decoupled riboflavin biosynthesis. Indeed, a previous study showed that the 
intracellular neutral lipid content increased during glucose consumption and decreased again 
once glucose had been fully consumed. Monitoring the respiration quotient (RQ) of A. gossypii 
cells, the same study concluded that cells were first growing on glucose, exhibiting an RQ of 1 
and once glucose was depleted in the medium, the RQ dropped below 1, indicating growth on 
a more reduced substrate, i.e. oil (Stahmann et al., 1994). 
 
Both strains exhibited a very similar growth behavior with a maximum growth rate of 0.18 h-1 
and fairly low biomass yields of 77.1 g mol-1 and 67.4 g mol-1 for WT and B2, respectively 
(Table 7). Conversely, the substrate uptake rates were almost the same differing only by a 
factor 1.1. As far as production and growth behavior are concerned, it is challenging to 
compare growth rates and productivities to literature data, since most media used differ greatly 
from the medium applied here. A recently published work compared two different A. gossypii 
strains grown on glucose. The wild type was characterized by a maximum growth rate of 
0.04 h-1, a production rate of 0.8 μmol g-1 h-1 with a final riboflavin titer of about 
10 mg L-1 (Jeong et al., 2015). However, other studies reported production performances of 30 
to 400 mg L-1, depending on the medium and carbon source used (Jiménez et al., 2005; 
Ledesma-Amaro et al., 2015c; Sugimoto et al., 2009). 
 
The results shown here, clearly demonstrate that riboflavin biosynthesis with A. gossypii on 
glucose does not support overproducing conditions. Riboflavin titers were decreased 9.7-fold 
and 71.5-fold compared to production on vegetable oil, for A. gossypii WT and B2 (Chapter 
4.1), respectively. However, the use of glucose presents an interesting starting point in order 
to gain first insights into the metabolism of the fungus. 
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Table 7: Growth and production kinetics of A. gossypii B2 and WT grown on complex medium with 
glucose as main carbon source. Rates (q, Q) and yield coefficient (Y) represent mean values from three 
independent replicates. P, product; S, substrate; X, biomass. 
Strain μmax YX/S qS qP,max QP,max 
 [h-1] [g mol-1] [mmol g-1h-1] [μmol g-1h-1] [μmol L-1h-1] 
B2 0.18 ± 0.01 67.4 ± 2.9 2.6 ± 0.2 0.3 ± 0.1 3.0 ± 0.5 
WT 0.18 ± 0.01 77.1 ± 0.6 2.4 ± 0.1 1.7 ± 0.3 15.3 ± 2.4 
 
 
 
 
Figure 14: Growth and production profiles of A. gossypii B2 (A, B) and WT (C, D). Cells were grown on 
complex medium with 20 g L-1 glucose and 200 mM ACES. The volumetric productivity (QP) and specific 
productivity (qP) are shown for strain B2 (B) and WT (D). Data were obtained from three independent 
replicates per time point. CDW, cell dry weight; RF, riboflavin. 
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4.2.1 First insights into the metabolism with 13C-labeled glucose 
In order to get a deeper understanding of the metabolism on glucose, A. gossypii WT and B2 
cells were grown on [13C6] glucose instead of the naturally labeled sugar (final concentration 
20 g L-1). All other medium components remained naturally labeled. This labeling strategy 
allowed the discrimination of carbon origin of metabolites either from glucose or other medium 
compounds (Wittmann and Heinzle, 2005). GC/MS measurements of hydrolyzed cell protein, 
harvested at the end of the exponential growth phase, conveyed valuable insights into growth 
on glucose. For qualitative inspection of the network, the SFL for each amino acid was 
calculated from measured MIDs (Table 8, Figure 15). When comparing the two strains 
investigated, they mostly exhibited a very similar distribution of 13C labeling in their respective 
metabolism. Most proteinogenic amino acids originated from the naturally labeled portion of 
the medium, i.e. yeast extract or the supplemented amino acids (Figure 15). However, there 
were a few exceptions: alanine, glutamate, and aspartate showed strong 13C enrichment with 
the respective SFLcorr ranging from 40 % to 74 % (Table 8). Thus, glucose was not only taken 
up by the cell, but acted as carbon source during growth despite the complex substrate yeast 
extract being present in the medium. While glucose transport across the plasma membrane 
occurs via the energy-dependent PTS in many bacteria (Jahreis et al., 2008), this type of 
transport has not been proven for yeast (Deutscher et al., 2006). Instead, glucose uptake 
occurs in an energy-independent manner: proteins that belong to the major facilitator 
superfamily (MFS) transport hexoses by passive facilitated diffusion along a concentration 
gradient (Özcan and Johnston, 1999). In S. cerevisiae as many as 20 putative hexose 
transporter genes (HXT genes) have been identified, among them transporters as well as 
sensor proteins (Lin and Li, 2011; Özcan and Johnston, 1999). For A. gossypii four putative 
genes for hexose transporters were identified, representing HXT1-7 as well as HXT14, and 
one putative glucose sensor gene was annotated (Lin and Li, 2011). The fact that S. cerevisiae 
contains more transporter genes is suggested to be linked to aerobic fermentation in contrast 
to complete oxidation of glucose. While S. cerevisiae is a so-called Cabtree-positive yeast (De 
Deken, 1966), A. gossypii, on the other hand, prefers to fully oxidize glucose to carbon dioxide 
through the TCA cycle and the respiratory chain (Merico et al., 2007; Mickelson, 1950). The 
observed 13C labeling in alanine, 57.3 % and 61.5 % for A. gossypii WT and B2, respectively 
(Table 8, Figure 15) indicated that glucose was taken up by the cell and degraded to pyruvate 
through glycolysis. Pyruvate was then converted into alanine through the alanine transaminase 
(Escalera-Fanjul et al., 2017). Alanine was mostly unlabeled (M+0) or fully labeled (M+3) 
(Table 8), suggesting a straightforward biosynthesis from its metabolic precursor pyruvate as 
well as uptake from unlabeled yeast extract. Glutamate, even though supplemented to the 
medium in large amounts, was also heavily 13C-enriched with a SFLcorr of 74.1 % and 67.9 % 
(for WT and B2, respectively). Apparently, the de novo formation of glutamate from α-
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ketoglutarate (AKG), catalyzed by glutamate synthase (Gomes et al., 2014), was strong. The 
13C enrichment of glutamate is also an indication for an active TCA cycle. The fact that 
aspartate also showed 13C enrichment with 48.4 % and 39.9 % for A. gossypii WT and B2, 
respectively, further underlined the active pathway as the metabolic precursor for aspartate is 
the TCA cycle intermediate oxaloacetate (OAA) (Yagi et al., 1982). The two acidic amino acids 
exhibited more diverse MIDs compared to alanine. While large fractions were non-labeled 
(M+0) or fully labeled (M+4 or M+5 for aspartate or glutamate, respectively), isotopomers with 
both 12C and 13C atoms could also be detected (Table 8). This indicated a molecular 
rearrangement of fully labeled compounds stemming from glucose and naturally labeled 
compounds from other medium ingredients of these amino acids through the TCA cycle. The 
aromatic amino acid tyrosine also showed significant amounts of 13C incorporation (30.6 % 
and 20.0 % for A. gossypii WT and B2, respectively) (Table 8, Figure 15), thus also proving 
the activity of the PP pathway, since one precursor for aromatic amino acids is erythrose 4-
phosphate (E4P) (Braus, 1991). Interestingly, only tyrosine was 13C-enriched and not 
phenylalanine. This appears noteworthy, since the two amino acids originate from the same 
pathway (Braus, 1991) and should resemble the same isotopomer distribution. As the medium 
was based on yeast extract, however, the most likely explanation would be that phenylalanine 
was not de novo synthesized during the growth phase, because it was available in the medium 
in sufficient amounts whereas the supply of tyrosine was limited.  
 
Glucose was taken up by A. gossypii and incorporated into selected amino acids. The 13C 
labeling of alanine indicated an active glycolysis. Glutamate and aspartate also showed 
significant amount of 13C enrichment despite large amounts of glutamate in the medium. This 
proved an active TCA cycle with high conversion of precursor molecules α-ketoglutarate and 
oxaloacetate into their respective amino acids. Fully labeled proteinogenic tyrosine proved that 
in addition to the glycolysis also the non-oxidative PP pathway was active.  
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Figure 15: Relative contribution of [13C6] glucose to amino acids from hydrolyzed cell protein of 
A. gossypii WT. Amino acids were obtained at the end of the growth phase of riboflavin producing 
A. gossypii after 12 h. Respective contribution of glucose (red) and other media components (grey) are 
depicted by the bar next to the respective amino acid. The full length bar represents 100 %. Data 
represent the corrected summed fractional labeling (SFLcorr) for the designated amino acids. Data were 
obtained from three individual replicates. Note that the conversion of citrate to isocitrate via aconitase most 
likely does not occur in the peroxisome (Murakami and Yoshino, 1997). 3PG, 3-phosphoplycerate; CH2-THF, 5,10-
methylenetetrahydrofolate; AcCoA, acetyl-CoA; AKG, α-ketoglutarate; ALA, alanine; ARG, arginine; ASP, 
aspartate; CHO-THF, 10-formyltetrahydrofolate; CIT, citrate; DHAP, dihydroxyacetone phosphate; E4P, erythrose 
4-phosphate; F6P, fructose 6-phosphate; FOR, formate; G3P, glyceraldehyde 3-phosphate; G6P, glucose 6-
phosphate; GAR, glycineamide ribonucleotide; GLU, glutamate; GLY, glycine; GLYOX, glyoxylate; GTP, guanosine 
triphosphate; HIS, histidine; ICIT, isocitrate; ILE, isoleucine; LEU, leucine; MAL, malate; OAA, oxaloacetate; PEP, 
phosphoenolpyruvate; PHE, phenylalanine; PP pathway, pentose phosphate pathway; PRO, proline; PYR, 
pyruvate; R5P, ribose 5-phosphate; Ru5P, ribulose 5-phosphate; S7P, sedoheptulose 7-phosphate; SER, serine; 
TCA cycle, tricarboxylic acid cycle; THF, tetrahydrofolate; THR, threonine; TYR, tyrosine; VAL, valine; Xu5P, 
xylulose 5-phosphate; YE, yeast extract. 
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Table 8: Mass isotopomer distributions (MIDs) of derivatized proteinogenic alanine, aspartate, 
glutamate, and tyrosine from A. gossypii WT and B2 grown on complex medium with [13C6] glucose. 
Cultivation on naturally labeled glucose served as control. MIDs were corrected for occurrence of natural 
isotopes. The summed fractional labeling (SFL) for WT and B2 on labeled glucose was corrected as 
described in Chapter 3.5.1. Note the SFL of the control denotes the calculated SFL of the corrected MID 
without further correction. For all measured proteinogenic amino acids see appendix Table 16. Data 
were obtained from three individual replicates. 
Analyte  Control WT B2 
Ala_260 M+0 0.967 ± 0.003 0.402 ± 0.052 0.364 ± 0.073 
 M+1 0.032 ± 0.000 0.017 ± 0.002 0.015 ± 0.002 
 M+2 0.001 ± 0.000 0.025 ± 0.004 0.022 ± 0.003 
 M+3 0.000 ± 0.000 0.556 ± 0.083 0.600 ± 0.054 
 SFLcorr [%] 1.13 ± 0.08 57.31 ± 5.81 61.46 ± 7.15 
     
Asp_418 M+0 0.962 ± 0.003 0.448 ± 0.045 0.540 ± 0.070 
 M+1 0.036 ± 0.000 0.027 ± 0.005 0.028 ± 0.004 
 M+2 0.001 ± 0.000 0.036 ± 0.003 0.028 ± 0.002 
 M+3 0.000 ± 0.000 0.098 ± 0.008 0.076 ± 0.015 
 M+4 0.000 ± 0.000 0.392 ± 0.039 0.327 ± 0.031 
 SFLcorr [%] 1.00 ± 0.08 48.37 ± 5.08 39.92 ± 4.57 
     
Glu_432 M+0 0.950 ± 0.003 0.136 ± 0.020 0.201 ± 0.020 
 M+1 0.049 ± 0.000 0.013 ± 0.001 0.014 ± 0.002 
 M+2 0.001 ± 0.000 0.077 ± 0.015 0.078 ± 0.006 
 M+3 0.000 ± 0.000 0.082 ± 0.007 0.072 ± 0.012 
 M+4 0.000 ± 0.000 0.153 ± 0.038 0.146 ± 0.023 
 M+5 0.000 ± 0.000 0.539 ± 0.081 0.489 ± 0.039 
 SFLcorr [%] 1.03 ± 0.10 74.10 ± 8.37 67.90 ± 7.71 
     
Tyr_466 M+0 0.920 ± 0.007 0.629 ± 0.064 0.731 ± 0.037 
 M+1 0.080 ± 0.000 0.054 ± 0.009 0.059 ± 0.009 
 M+2 0.000 ± 0.000 0.002 ± 0.000 0.001 ± 0.000 
 M+3 0.000 ± 0.000 0.001 ± 0.000 0.001 ± 0.000 
 M+4 0.000 ± 0.000 0.001 ± 0.000 0.001 ± 0.000 
 M+5 0.000 ± 0.000 0.002 ± 0.000 0.002 ± 0.000 
 M+6 0.000 ± 0.000 0.005 ± 0.000 0.003 ± 0.000 
 M+7 0.000 ± 0.000 0.007 ± 0.000 0.004 ± 0.000 
 M+8 0.000 ± 0.000 0.030 ± 0.005 0.019 ± 0.003 
 M+9 0.000 ± 0.000 0.270 ± 0.035 0.178 ± 0.016 
 SFLcorr [%] 1.14 ± 0.04 31.35 ± 2.97 20.03 ± 2.11 
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4.2.2 LC/MS measurements reveal first insights into riboflavin metabolism 
 
 
Figure 16: Relative mass isotopomer distributions (MIDs) of riboflavin synthesized by A. gossypii WT 
(A) and B2 (B) grown on complex medium with [13C6] glucose (red). Riboflavin was recovered from the 
culture broth after 144 h. Riboflavin produced on naturally labeled glucose served as control (grey). The 
riboflavin structure is depicted (A) with its seventeen carbon atoms, thirteen of which are derived from 
the pentose 5-phosphate pool while the remaining four have different metabolic origins (potentially 
glycine, C1, and carbon dioxide). Data were obtained from three individual replicates. 
 
Riboflavin is a derivative of the heterocyclic compound isoalloxazine and contains seventeen 
carbon atoms. Its structure is shown in Figure 16A. Pioneering research, starting in the 1950s, 
aimed to elucidate the molecular origin of all carbon atoms (Bacher et al., 1998; Plaut, 1954a; 
Plaut, 1954b; Plaut and Broberg, 1956). The vitamin can be divided into three structural parts 
that differ more or less in their potential carbon origin: the xylene ring, the pyrimidine ring, and 
the ribityl side chain. While ribulose 5-phosphate and ribose 5-phosphate are the metabolic 
precursors for the xylene ring and the ribityl side chain, respectively, the remaining four carbon 
atoms from the pyrimidine ring have a more diverse metabolic origin including the glycine and 
carbon-one metabolism. 
Riboflavin, produced by A. gossypii WT and B2 on [13C6] glucose, was recovered from the 
culture supernatant in small amounts and purified prior to LC/MS analysis. Mass isotopomer 
distributions from LC/MS spectra are depicted in Figure 16. The SFLcorr was calculated from 
the 13C labeling data: 59 % and 52 % of riboflavin were 13C labeled, for A. gossypii WT and B2, 
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respectively (appendix Table 21). This indicated a strong biosynthesis of the vitamin from fully 
labeled glucose.  
The amount of the unlabeled riboflavin isotopomer (M+0) was decreased 12-fold and 16-fold 
for strains WT and B2, respectively, when compared to riboflavin synthesized on naturally 
labeled medium. Riboflavin, produced by the two strains, showed a slightly different mass 
isotopomer distribution: A. gossypii WT exhibited a much larger fraction of the M+13 
isotopomer than A. gossypii B2 (2.3-fold increased). While for A. gossypii WT the fraction of 
isotopomer increased with increasing number of 13C-labeled carbon atoms (Figure 16A), 
A. gossypii B2 showed a more even distribution for mass isotopomers M+7 to M+13 (Figure 
16). Interestingly, neither one of the two strains showed significant amounts of isotopomers 
that had more than thirteen carbon atoms enriched. This left four carbon atoms unlabeled in 
the riboflavin molecule. These results strongly suggested that the labeled glucose was 
converted into ribulose 5-phosphate and ribose 5-phosphate and contributed to the thirteen 
carbon atoms from the ribityl side chain and the xylene ring (Figure 16A). Previous labeling 
studies using the 13C- or 14C-labeled tracer substrates glucose or ribose, had revealed that the 
ribityl side chain as well as the xylene ring originate from the same pentose 5-phosphate 
precursor pool. NMR and radioactivity measurements, which allowed the determination of 
positional 13C and 14C enrichment, confirmed that these thirteen carbon atoms displayed the 
same labeling pattern (Bacher et al., 1982; Bacher et al., 1985; Plaut, 1954b; Plaut and 
Broberg, 1956). In addition, the carbon contribution of the labeled sugars to atoms of the 
pyrimidine ring seems negligible (Bacher et al., 1982; Bacher et al., 1985). The LC/MS results 
as shown in Figure 16 match those pioneering results. However, while it can be assumed that 
the incorporation of labeling into the xylene ring as well as the ribityl side chain occurred, but 
not into the pyrimidine ring, only 13C NMR measurements would be able to confirm the 
respective positional enrichments. Unfortunately, the low riboflavin titers generated on glucose 
did not yield sufficient amounts to enrich and purify riboflavin for 13C NMR analysis. 
 
Riboflavin was more than 50 % 13C-enriched when [13C6] glucose was present in the medium. 
Thus, glucose clearly had a strong impact on the vitamin. However, this also left about 50 % 
of the product with unknown carbon origin. Taking into account the reduced production 
performance of A. gossypii on glucose compared to vegetable oil, a different approach had to 
be chosen for further investigations. 
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4.3 Replacing oil with its building blocks 
The 13C labeling experiments on glucose displayed a starting point in understanding the 
metabolism of growth and riboflavin production. However, riboflavin production was reduced 
on glucose and the sugar enters the metabolism through a rather distant pathway compared 
to vegetable oil, i.e. glycolysis and ß-oxidation, respectively. The two constituents of vegetable 
oil are glycerol and fatty acids, which are broken down into acetyl-CoA units through ß-
oxidation localized in the peroxisome (Vorapreeda et al., 2012). In an attempt to resemble the 
industrial substrate more closely, acetate and glycerol were added to the medium as major 
carbon sources, replacing the previous substrate glucose. 
4.3.1 Riboflavin production on a mixture of acetate and glycerol 
Substrate concentrations were based on the glucose concentration previously used (20 g L-1), 
with a C-molar ratio of 1:27 for glycerol:acetate (Chapter 3.2.2). In order to counteract pH 
increase throughout the cultivation MOPS was used as buffer component (250 mM). Growth 
and production of riboflavin producing A. gossypii WT and B2 are depicted in Figure 17. After 
144 h of cultivation, the final riboflavin titer was 8.1 mg L-1 and thus only 1.4-fold lower than on 
glucose for A. gossypii B2 (Figure 17A). The wild type A. gossypii WT reached a final riboflavin 
titer of 11.9 mg L-1 in the culture supernatant at the end of experiment (Figure 17C), which was 
decreased 13-fold compared to the production on glucose. In contrast to cultivation on glucose, 
the riboflavin biosynthetic phase already started after 12 h, while growth was still exponential. 
A. gossypii B2 and WT reached maximum specific productivities of 0.25 μmol g-1 h-1 (after 
24 h) and 0.31 μmol g-1 h-1 (after 120 h), respectively (Figure 17B and D, Table 9). At a 
maximum growth rate of 0.09 h-1 (Table 9), A. gossypii B2 co-consumed acetate and glycerol 
reaching a maximum CDW of 3.6 gCDW L-1 after 35 h (Figure 17A). At the end of the cultivation, 
large amounts of acetate (17 g L-1) could still be measured in the culture supernatant. Even 
though a buffer system was used, the pH increased upon glycerol and acetate uptake (data 
not shown), which might have prevented further uptake of the substrates and by that inhibited 
further growth. 
Growth of A. gossypii WT on glycerol and acetate proved to be similar to the sister strain B2. 
There was a slightly longer lag phase at the beginning of the cultivation. Acetate uptake started 
after 12 h and until then, growth was only minimal on glycerol (Figure 17C). Once, exponential 
growth had started, the two main carbon sources were consumed in parallel with a specific 
growth rate of 0.11 h-1 (maximum CDW of 2.7 gCDW L-1 after 25 h) (Table 9, Figure 17C). While 
glycerol was almost completely metabolized throughout the cultivation, more than 15 g L-1 
acetate remained in the medium. Little is known about the uptake systems of the two carbon 
sources for A. gossypii. In a study, investigating the osmoprotective behavior of A. gossypii, 
glycerol, which is the main compatible solute for the fungus as well as for S. cerevisiae 
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(Blomberg and Adler, 1989; Nevoigt and Stahl, 1997), was taken up by a highly active system, 
which was down-regulated upon hyperosmotic stress (Förster et al., 1998). Most knowledge 
about transporter systems was gained through experiments with S. cerevisiae. The close 
relative expresses a glycerol/H+ symport (Ferreira et al., 2005). While diffusion through the 
plasma membrane used to be a generally accepted transport mechanism for glycerol, the 
polyol is not considered to be able to pass through the lipid bilayer without a transport protein 
anymore (Klein et al., 2017). The proton symport would also explain the pH increase upon 
glycerol consumption. Nothing is known about acetate transporters for A. gossypii. 
S. cerevisiae contains a permease encoded by the JEN1 gene (Casal et al., 1999). The proton-
symporter also accepts other carboxylic acids such as lactate or pyruvate as substrates. 
Another gene, ADY2, was identified as potential acetate transporter, which was present in cells 
grown on non-fermentable carbon sources (Casal et al., 1996; Paiva et al., 2004). 
 
 
Figure 17: Growth and production profiles of A. gossypii B2 (A, B) and WT (C, D). Cells were grown on 
complex medium with 19.3 g L-1 acetate and 0.7 g L-1 glycerol. The medium was buffered with 250 mM 
MOPS. The volumetric productivity (QP) and specific productivity (qP) are shown for strain B2 (B) and 
WT (D). Data were obtained from three independent replicates per time point. CDW, cell dry weight; RF, 
riboflavin. 
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Table 9: Growth and production kinetics of A. gossypii B2 and WT grown on complex medium with 
acetate and glycerol as carbon sources. Rates (q, Q) and yield coefficients (Y) represent mean values 
from three independent replicates. Ac, acetate; Glyc, glycerol; P, product; S, substrate; X, biomass. 
   B2 WT 
Rates μmax [h-1] 0.09 ± 0.01 0.11 ± 0.01 
 qS,Ac [mmol g-1 h-1] 1.92 ± 0.55 1.82 ± 0.20 
 qS,Glyc [mmol g-1 h-1] 0.23 ± 0.06 0.80 ± 0.08 
 qP,max [μmol g-1 h-1] 0.25 ± 0.01 0.31 ± 0.04 
 QP,max [μmol L-1 h-1] 0.55 ± 0.02 0.43 ± 0.02 
Yields YX/Ac [g mol-1] 44.7 ± 4.6 59.7 ± 4.1 
 YX/Glyc [g mol-1] 380.3 ± 41.0 135.8 ± 7.7 
 
4.3.2 Acetate plays a major role in the lower part of the carbon core metabolism 
The contribution of the vegetable oil building blocks acetate and glycerol to the metabolism of 
A. gossypii WT was assessed in parallel tracer experiments. In a first set, [13C2] acetate 
replaced the naturally labeled substance in the medium, while glycerol remained naturally 
labeled. Most of the amino acids from cell protein were not 13C-labeled (Figure 18, appendix 
Table 16), indicating a strong uptake of amino acids from yeast extract in the medium. 
However, 13C incorporation could be detected in single amino acids throughout the 
metabolism. Acetate is converted into acetyl-coenzyme A by the enzyme acetyl-CoA 
synthetase (EC 6.2.1.1), which is annotated for A. gossypii and was described among others 
for S.cerevisiae and Schizosaccharomyces pombe (Martínez-Blanco et al., 1992; van den 
Berg et al., 1996). It then enters the metabolism either through the TCA cycle located in the 
mitochondria or the glyoxylate shunt in the peroxisome. Mickelson and Schuler (1953) 
proposed that oxidation of acetate occurred only through the TCA cycle, arguing that α-
ketoglutarate stimulated acetate oxidation the strongest and that A. gossypii produced citrate, 
when both oxaloacetate and acetate were present.  
The three amino acids that exhibited the largest 13C enrichment were alanine, aspartate, and 
glutamate (Figure 18 and Figure 19) with the calculated SFLcorr of 16.4 %, 41.3 %, and 63.7 %, 
respectively for A. gossypii WT (Table 10). The mass isotopomer distribution of aspartate 
nicely proves that acetate from the medium underwent condensation to a four-carbon moiety 
via the glyoxylate shunt giving rise to the M+4 isotopomer of oxaloacetate-derived aspartate 
(Figure 19B) (Morin et al., 1992). A study with S. cerevisiae showed that the yeast cells were 
able to grow on acetate even when certain genes of the TCA cycle were deleted, highlighting 
the potential of the glyoxylate cycle as acetate utilizing pathway (Lee et al., 2011). The 
increased M+2 fragment of aspartate could originate from the condensation of one fully and 
one naturally labeled acetyl-CoA in the glyoxylate shunt or a more complex interconversion 
and re-assembly in the metabolism of the metabolic precursor.  
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Figure 18: Relative contribution of [13C2] acetate and [13C3] glycerol to amino acids from hydrolyzed cell 
protein of A. gossypii WT grown on complex medium with glycerol and acetate. Respective contribution 
of acetate (blue), glycerol (green), and other media components (grey) are depicted by the bar next to 
the respective amino acid. The full length bar represents 100 %. Data represent corrected summed 
fractional labelings (SFLcorr) for the designated amino acids. Labeling data were obtained from individual 
labeling experiments with one of the two carbon sources being fully labeled. Amino acids were obtained 
at the end of the growth phase of riboflavin producing A. gossypii after 24 h. Data were obtained from 
three individual replicates. Note that the conversion of citrate to isocitrate via aconitase most likely does not 
occur in the peroxisome (Murakami and Yoshino, 1997). 3PG, 3-phosphoplycerate; CH2-THF, 5,10-
methylenetetrahydrofolate; AcCoA, acetyl-CoA; AKG, α-ketoglutarate; ALA, alanine; ARG, arginine; ASP, 
aspartate; CHO-THF, 10-formyltetrahydrofolate; CIT, citrate; DHAP, dihydroxyacetone phosphate; E4P, erythrose 
4-phosphate; F6P, fructose 6-phosphate; FOR, formate; G3P, glyceraldehyde 3-phosphate; G6P, glucose 6-
phosphate; GAR, glycineamide ribonucleotide; GLU, glutamate; GLY, glycine; GLYOX, glyoxylate; GTP, guanosine 
triphosphate; HIS, histidine; ICIT, isocitrate; ILE, isoleucine; LEU, leucine; MAL, malate; OAA, oxaloacetate; PEP, 
phosphoenolpyruvate; PHE, phenylalanine; PP pathway, pentose phosphate pathway; PRO, proline; PYR, 
pyruvate; R5P, ribose 5-phosphate; Ru5P, ribulose 5-phosphate; S7P, sedoheptulose 7-phosphate; SER, serine; 
TCA cycle, tricarboxylic acid cycle; THF, tetrahydrofolate; THR, threonine; TYR, tyrosine; VAL, valine; Xu5P, 
xylulose 5-phosphate; YE, yeast extract. 
 
GC/MS measurements of glutamate revealed that the M+0 isotopomer was almost 5-fold 
decreased, indicating a strong de novo synthesis from the 13C-labeled acetate (Figure 19C). 
The remaining 20 % unlabeled isotopomer could have resulted from de novo biosynthesis from 
unlabeled precursor metabolites (Figure 20A) or uptake of naturally labeled glutamate from the 
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medium. Fully labeled proteinogenic glutamate (M+5) was the result of the condensation of 
fully labeled oxaloacetate and fully labeled acetyl-CoA and subsequent decarboxylation to 
yield the glutamate precursor α-ketoglutarate (Figure 20F) (Gomes et al., 2014). The increase 
of M+2 indicated that acetate entered the metabolism at the level of the TCA cycle (Figure 
20C) and together with unlabeled oxaloacetate gave rise to [13C4] glutamate. 
 
Acetate had by far the most pronounced impact on building blocks derived from the glyoxylate 
shunt or TCA cycle. However, substantial amounts of 13C incorporation were also observed for 
alanine (SFLcorr of 16.4 %, Table 10, Figure 19A): in addition to the unlabeled isotopomer 
(M+0), the M+3 isotopomer was the most abundant, which could be explained by 
decarboxylation of fully labeled malate to pyruvate, which is the immediate precursor for 
alanine, through the malic enzyme (Figure 18) (Boles et al., 1998). Alternatively, fully labeled 
oxaloacetate could be decarboxylated via the PEP carboxykinase to yield 
phosphoenolpyruvate that in turn could be converted into pyruvate and subsequently to alanine 
(Zelle et al., 2010).The metabolically more distant amino acid tyrosine was slightly 13C-enriched 
(SFLcorr of 5.5 %), which indicated flux through the PP pathway (Figure 18, Table 10). 
 
Even though the biomass was mainly derived from unlabeled medium compounds, acetate 
had a strong impact on a few selected amino acids. Acetate played a major role in formation 
of amino acids derived from the glyoxylate shunt and the TCA cycle. The carbon source, 
however, also contributed to alanine and the more distant amino acid tyrosine. 
 
 
Figure 19: Relative mass isotopomer distributions (MIDs) of proteinogenic alanine (A), aspartate (B), 
and glutamate (C) from A. gossypii WT grown on complex medium with glycerol and acetate as main 
carbon sources. MIDs are presented for medium with naturally labeled substrates (grey) and 
[13C2] acetate (blue). Data were obtained from three independent replicates.  
 
 
 
RESULTS AND DISCUSSION 
58 
 
 
Figure 20: Simplified metabolic model of the tricarboxylic acid (TCA) cycle. Different scenarios are 
presented for growth on glycerol and fully labeled acetate, which give rise to the different mass 
isotopomers of α-ketoglutarate (AKG)-derived glutamate. The thin arrows indicate that only the reactions 
from oxaloacetate (OAA) to AKG are considered, while the origin of OAA can be diverse. White circles, 
naturally labeled carbon atoms; blue circles, 13C-labeled carbon atoms. AcCoA, acetyl-CoA; GLYOX, 
glyoxylate shunt. 
 
4.3.3 Glycerol contributes to glycolytic intermediates 
In a parallel experiment, [13C3] glycerol replaced the naturally labeled glycerol, while acetate 
remained naturally labeled. Several catabolic pathways for glycerol have been described in 
the literature for fungi (Klein et al., 2017). The dominant pathway for S. cerevisiae entails the 
phosphorylation of glycerol to glycerol 3-phosphate through glycerol kinase (encoded by 
GUT1) and subsequent oxidation to dihydroxyacetone phosphate (DHAP) via the FAD-
dependent glycerol 3-phosphate dehydrogenase, encoded by GUT2 (Klein et al., 2017). 
Glycerol can also be oxidized to dihydroxyacetone as intermediate by the NAD-dependent 
glycerol dehydrogenase, which in turn is phosphorylated to DHAP by dihydroxyacetone kinase 
(encoded by DAK1/DAK2) (Klein et al., 2017). The only experimental evidence for the 
existence of this pathway in yeast was given by a study with Schizosaccharomyces pombe 
(Matsuzawa et al., 2010). A third catabolic pathway involves the intermediate glyceraldehyde, 
which is then phosphorylated to glyceraldehyde 3-phosphate (G3P) (Klein et al., 2017; Tom et 
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al., 1978). For A. gossypii, only the enzymes for the pathway using glycerol 3-phosphate as 
intermediate are fully annoted in KEGG (Kanehisa et al., 2017; Kanehisa and Goto, 2000; 
Kanehisa et al., 2016). Due to its close relationship with S. cerevisiae, it is likely that this is 
also the preferred route of glycerol catabolism in the hemiascomycete. However, a whole-
genome reannotation study of A. gossypii in 2014 revealed two putative genes for glycerol 
dehydrogenases (Gomes et al., 2014), thereby completing the set of genes necessary for the 
second catabolic route described above. Regardless of the enzymatic steps chosen for 
glycerol utilization, glycerol enters the core carbon metabolism at the level of DHAP or G3P. 
GC/MS measurement of proteinogenic amino acids at the end of the exponential growth phase 
assessed the fate of glycerol and its metabolic intermediate DHAP and revealed a small but 
significant contribution of the substrate glycerol to the synthesis of cellular protein (Figure 18, 
Figure 21, Table 10). The pyruvate-derived amino acid alanine showed a SFLcorr of 24.4 % for 
A. gossypii WT (Table 10), indicating a significant contribution of glycerol to its formation. While 
the non-labeled isotopomer was decreased (Figure 21A), fully 13C-labeled alanine was 
enriched and accounted for 23 % of the intracellular pool. Incorporation of the 13C labeling from 
glycerol into alanine indicated an active glycolytic pathway (Figure 21D). Another proof for 
DHAP oxidation in the glycolytic direction was the observed 13C enrichment of tyrosine (SFLcorr 
of 13.0 %, Table 10). The building blocks for this aromatic amino acid are the glycolytic 
intermediate phosphoenolpyruvate, which is the immediate precursor of pyruvate, and 
erythrose 4-phosphate (Braus, 1991). With 4 % fully labeled tyrosine (appendix Table 16), the 
labeling pattern of this proteinogenic amino acid not only confirmed active glycolysis, but also 
proved carbon flux through the non-oxidative PP pathway with erythrose 4-phosphate as its 
intermediate. 
Two other proteinogenic amino acids exhibited significant 13C incorporation from glycerol: 
glutamate and aspartate (SFLcorr of 5.6 % and 4.6 % for A. gossypii WT, respectively) (Figure 
18, Figure 21, Table 10). While the SFL renders information on the carbon origin of a certain 
molecule, the measured MIDs yield more detailed information on the underlying pathway for a 
specific metabolite. Glycerol enters the glycolysis, which renders fully labeled pyruvate proven 
by a fully labeled alanine pool (Figure 21A, D). Pyruvate is then decarboxylated into acetyl-
CoA, which enters the TCA cycle (Gey et al., 2008). Thus, the expected mass isotopomer of 
glutamate for growth on fully labeled glycerol would be the M+2 fragment (Figure 21C, D). 
Indeed, this fragment is slightly enriched for the proteinogenic amino acid. The second 
observed isotopomer was M+1, which might have occurred through condensation of non-
labeled acetyl-CoA and partially labeled oxaloacetate. Apart from the TCA cycle, oxaloacetate 
can originate from various metabolic reactions: carboxylation of pyruvate, transamination of 
glutamate from the medium (Wood, 1968), assimilation of acetate from the glyoxylate shunt 
(Lee et al., 2011). The observed MID for proteinogenic aspartate revealed that the M+1 
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isotopomer was the largest 13C-labeled fraction, which indicated glycerol conversion via 
glycolysis and subsequent TCA cycle (Figure 21B, D). 
The isotope experiment with [13C3] glycerol and unlabeled acetate highlighted the intracellular 
fate of the polyol. While it contributed to the formation of amino acids derived from the TCA 
cycle, glycerol had the strongest impact on glycolytic intermediates. This was derived from the 
13C labeling of the amino acids alanine and tyrosine: both exhibited to some extent their fully 
labeled isotopomer. 
 
 
 
Figure 21: Relative mass isotopomer distributions (MIDs) of proteinogenic alanine (A), aspartate (B), 
and glutamate (C) from A. gossypii WT grown on complex medium with glycerol and acetate as main 
carbon sources. MIDs are presented for medium with naturally labeled substrates (grey) and 
[13C3] glycerol (green). (D) Depicts a simplified metabolic model for the lower glycolysis and the 
tricarboxylic acid (TCA) cycle, which highlights the fate of fully labeled glycerol in the metabolism of 
A. gossypii. The labeling of the intermediates pyruvate, oxaloacetate (OAA), and α-ketoglutarate (AKG) 
were derived from the amino acids alanine, aspartate, and glutamate, respectively. The asterisk 
indicates that here, only the condensation of fully labeled acetyl-CoA (AcCoA) with naturally labeled 
OAA was considered, which was done for reasons of simplicity. White circles, naturally labeled carbon 
atoms; green circles, 13C-labeled carbon atoms. G3P, glyceraldehyde 3-phosphate, GLYC, glycerol; 
PYR, pyruvate. 
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Table 10: Summed fractional labeling (SFL) of derivatized amino acids from hydrolyzed cell protein of 
riboflavin producing A. gossypii WT and B2, grown on complex medium with glycerol and acetate as 
main carbon sources with different 13C tracers. The SFL was determined using the original measurement 
data (appendix Table 16) (left column), and was corrected for the naturally occurring isotopes in the 
carbon backbone as well as purity of the tracer (SFLcorr, right column). The correction is described in 
Chapter 3.5.1. Data were obtained from three individual replicates. 
 Control WT B2 
  [13C3] Glycerol [13C2] Acetate [13C3] Glycerol [13C2] Acetate 
 SFL SFL SFLcorr SFL SFLcorr SFL SFLcorr SFL SFLcorr 
 [%] [%] [%] [%] [%] [%] [%] [%] [%] 
Alanine 
1.13 ± 
0.07 
25.26 ± 
2.71 
24.44 ± 
2.62 
17.31 ± 
1.44 
16.40 ± 
1.36 
12.77 ± 
1.30 
11.82 ± 
1.20 
19.42 ± 
2.02 
18.53 ± 
1.93 
          
Aspartate 
1.00 ± 
0.08 
5.62 ± 
0.72 
4.59 ± 
0.59 
41.91 ± 
4.53 
41.26 ± 
4.46 
2.53 ± 
0.41 
1.47 ± 
0.24 
39.75 ± 
4.54 
39.07 ± 
4.46 
          
Glutamate 
1.03 ± 
0.03 
6.56 ± 
0.60 
5.55 ± 
0.51 
64.08 ± 
5.71 
63.65 ± 
5.67 
2.95 ± 
0.22 
1.90 ± 
0.14 
66.63 ± 
7.00 
66.22 ± 
6.95 
          
Tyrosine 
1.14 ± 
0.08 
13.93 ± 
1.73 
12.99 ± 
1.61 
6.54 ± 
0.70 
5.53 ± 
0.59 
5.56 ± 
0.82 
4.54 ± 
0.67 
4.65 ± 
0.59 
3.61 ± 
0.46 
 
4.3.4 A. gossypii B2 has a reduced glycolytic flux on glycerol and acetate 
Cultivations with fully labeled glycerol and acetate were also carried out with A. gossypii B2 
(Table 10, appendix Table 16). Since the observed labeling patterns showed high similarity 
between the two strains, they will not be discussed in great detail. Nevertheless, it is important 
to note that while the impact of acetate on the metabolism was almost unchanged for WT and 
B2, glycerol seemed to be metabolized slightly differently. In A. gossypii WT, the polyol 
contributed one fourth to the intracellular alanine and 13 % to the intracellular tyrosine pool 
(Figure 18, Figure 21, Table 10). Both amino acids stem from the glycolytic conversion of 
glycerol to intermediates like phosphoenolpyruvate and pyruvate. When A. gossypii B2 was 
grown on fully labeled glycerol, 13C incorporation of alanine was decreased by the factor 2 
(SFL of 12.8 % compared to 25.3 % for A. gossypii WT) (Table 10). The same effect was 
observed for tyrosine (SFL of 5.6 % instead of 13.9 %). These data strongly indicated a 
reduced carbon flux from glycerol to the glycolytic intermediates phosphoenolpyruvate and 
pyruvate. This might suggest an increased utilization of carbon through gluconeogenesis, 
which would mirror growth and production physiology of A. gossypii grown on vegetable oil, 
the carbon source of choice for this process. Nevertheless, these data suggest that while there 
are small differences between the two strains, A. gossypii WT and B2 metabolize the 
alternative carbon sources acetate as well as glycerol in a very similar manner. 
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4.4 Characterization of growth physiology on vegetable oil via GC/MS analysis 
The alternative carbon sources glucose and the building blocks of oil, glycerol and acetate, 
resulted in drastically decreased production performance compared to vegetable oil. For 
A. gossypii B2, the final riboflavin titer was decreased 72-fold and 675-fold for glucose and 
acetate:glycerol, respectively. This highlighted the enormous impact of the carbon source on 
product formation and clearly showed that the investigation of the fungus under high riboflavin 
production conditions required vegetable oil as main carbon source. Consequently, for further 
investigations regarding growth and the subsequent riboflavin biosynthetic phase, complex 
medium with rapeseed oil was used. A first set of 13C tracer experiments aimed at the 
elucidation of metabolic processes during the initial growth phase. Since A. gossypii WT and 
B2 showed almost identical labeling patterns, only the results for the overproducing strain B2 
are discussed.  
4.4.1 Metabolic origin of amino acids reveals interconversion of riboflavin precursors 
The addition of [13C2] glycine, a known riboflavin building block, should investigate the potential 
withdrawal of this amino acid into other metabolic pathways. Glycine in the cell protein of 
A. gossypii, analyzed at the end of the growth phase, revealed substantial 13C enrichment and 
identified the added glycine as dominant source for the intracellular pool (Figure 22A, Figure 
23). During the same period, the 13C enrichment of glycine in the cultivation broth decreased 
from 97 % in the initial medium to 88 % at the point in time of harvesting (appendix Figure 40), 
indicating a weak but significant formation of the amino acid from other sources and exchange 
across the membrane. In order to account for dilution of labeling due to naturally labeled pre-
culture medium, in a parallel experiment glycine, formate, glutamate, and yeast extract were 
fully labeled. The 13C enrichment of the culture supernatant at the beginning of the cultivation 
was used to normalize the data from respective tracer experiments (appendix Figure 39). On 
the basis of these data, exogenous glycine obviously provided 85 % of the intracellular pool 
(Table 11). The use of [13C2] glycine further resulted in elevated 13C enrichment of 
proteinogenic serine (Figure 22B, Figure 23). The major fraction of serine was double labeled, 
i.e. [13C2] serine, indicating incorporation of the entire glycine carbon skeleton. On the basis of 
the SFL, about 63 % of serine stemmed from exogenous glycine (Table 11). This calculation 
considered the fact that 100 % enriched glycine provides 67 % enriched serine, as only two 
labeled carbons contribute to the three carbon skeleton of serine (Table 5). The observed SFL 
for serine of 42 % was corrected accordingly by a factor of 1.5. One should note that about 
1 g L-1 serine was initially present in the medium as part of the yeast extract, potentially having 
an impact on the process. 
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Figure 22: Relative mass isotopomer distributions (MIDs) of proteinogenic glycine (A, D, G), serine (B, 
E, H), and alanine (C, F, I) from A. gossypii B2 grown on complex medium with rapeseed oil as main 
carbon source. MIDs are presented for medium with naturally labeled substrates (grey), [13C2] glycine 
(blue), [13C3] serine (green), and [13C] formate (red). Data were obtained from three individual replicates. 
 
In order to study the obvious connection between glycine and serine, [13C3] serine was now 
added to the initial medium in a next experiment. It was interesting to note that intracellular 
serine did not only reflect the labeling pattern of the used serine tracer, but also contained 
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significant amounts of single labeled, i.e. [13C1] serine (Figure 22E), resulting from the 
reversible nature of serine hydroxymethyltransferase: the triple labeled serine was cleaved into 
double labeled glycine and a single labeled carbon-one unit. Both labeled products were then 
re-assembled into serine with non-labeled counterparts, providing the observed single and 
double labeled serine mass isotopomers. Overall, the externally present serine strongly 
supplied the intracellular serine pool (Figure 22E). The SFLcorr was 63 % (Table 11). The 
remaining 37 % of the serine pool originated from other sources. Obviously the impact of 
external glycine on the intracellular serine pool, i.e. 63 % versus maximally 37 %, was 
diminished when serine was supplemented in the tracer study. Exogenous serine further 
contributed 9 % to the intracellular glycine pool. Taking both experiments together, the 
interconversion was obviously highly reversible, indicating a tight metabolic connection 
between the two amino acids. 
 
A third tracer study investigated the metabolic fate of exogenous formate. When using 
[13C] formate, proteinogenic serine was strongly labeled and exhibited a SFLcorr of 14 % (Figure 
22H, Figure 23, Table 11). In order to derive the corresponding relative flux from formate to 
serine, again the dilution effect had to be considered i.e. fully 13C-labeled formate donates only 
one carbon atom to serine, leading to a maximum of 33 % enrichment. As a consequence, the 
cells derived 42 % of their intracellular serine from external formate. The observed fraction of 
non-labeled intracellular serine (Figure 22H) was an indication that A. gossypii supplied the 
carbon-one units also from other substrates, involving also serine from the added yeast extract.  
A wider analysis of the 13C labeling patterns of amino acids from the cell protein revealed that 
all three tracers contributed to the metabolically more distant amino acid alanine (4 %, 4 %, 
and 2 % from glycine, serine, and formate, respectively) (Figure 22C, F, I and Figure 23,). In 
contrast, the other amino acids were not enriched in 13C in any of the experiments (appendix 
Table 17). 
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Figure 23: Relative contribution of 13C tracers to amino acids from hydrolyzed cell protein and glycogen of 
A. gossypii B2 grown on complex medium with rapeseed oil. Metabolites were obtained at the end of the growth 
phase of riboflavin producing A. gossypii after 36 h. Respective contribution of [U13C] yeast extract (purple), 
[13C5] glutamate (light blue), [13C2] glycine (blue), [13C] formate (red), and other media components (grey) are 
depicted by the bar next to the respective amino acid. The full length bar represents 100 %. Data represent summed 
fractional labelings (SFLcorr), corrected for natural labeling and dilution effects through unlabeled pre-culture 
medium. Note that the conversion of citrate to isocitrate via aconitase most likely does not occur in the peroxisome 
(Murakami and Yoshino, 1997). Data were obtained from three independent replicates. 3PG, 3-phosphoplycerate; 
CH2-THF, 5,10-methylenetetrahydrofolate; AcCoA, acetyl-CoA; AKG, α-ketoglutarate; ALA, alanine; ARG, arginine; 
ASP, aspartate; CH2-THF, 5,10-Methylenetetrahydrofolate; CHO-THF, 10-formyltetrahydrofolate; CIT, citrate; 
DHAP, dihydroxyacetone phosphate; E4P, erythrose 4-phosphate; F6P, fructose 6-phosphate; FA, fatty acids; 
FOR, formate; G3P, glyceraldehyde 3-phosphate; G6P, glucose 6-phosphate; GAR, glycineamide ribonucleotide; 
GLU, glutamate; GLY, glycine; GLYC, glycerol; GLYOX, glyoxylate; GTP, guanosine triphosphate; HIS, histidine; 
ICIT, isocitrate; ILE, isoleucine; LEU, leucine; MAL, malate; OAA, oxaloacetate; PEP, phosphoenolpyruvate; PHE, 
phenylalanine; PP pathway, pentose phosphate pathway; PRO, proline; PYR, pyruvate; R5P, ribose 5-phosphate; 
Ru5P, ribulose 5-phosphate; S7P, sedoheptulose 7-phosphate; SER, serine; TCA cycle, tricarboxylic acid cycle; 
THF, tetrahydrofolate; THR, threonine; TYR, tyrosine; VAL, valine; Xu5P, xylulose 5-phosphate; YE, yeast extract. 
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Table 11: Summed fractional labeling (SFL) of derivatized amino acids from hydrolyzed protein of 
riboflavin producing A. gossypii B2, grown on complex medium with rapeseed oil as main carbon 
sources with different 13C tracers. The SFL was determined using the original measurement data 
(appendix Table 17) (left column), and was corrected for the naturally occurring isotopes in the carbon 
backbone as well as tracer dilution through naturally labeled pre-culture medium (center column). The 
right column displays the values that also take into consideration the biosynthetic route and carbon 
transition of the molecules. The correction is described in Chapters 3.5.1 and 3.5.3. Data were obtained 
from three individual replicates. 
  SFL SFLcorr Contribution Ψ 
  [%] [%] [%] 
[13C2] Glycine 
 Alanine 5.20 ± 0.11 4.19 ± 0.09 6.29 ± 0.13 
 Glycine 84.10 ± 10.64 85.38 ± 10.80 85.38 ± 10.80 
 Serine 41.59 ± 2.29 41.67 ± 2.29 62.51 ± 3.44 
     
[13C] Formate 
 Alanine 3.01 ± 0.11 2.00 ± 0.07 6.00 ± 0.22 
 Glycine 1.25 ± 0.16 0.00 ± 0.00 0.00 ± 0.00 
 Serine 14.70 ± 0.85 14.23 ± 0.82 42.69 ± 2.47 
     
[13C3] Serine 
 Alanine 4.89 ± 0.11 4.05 ± 0.09 4.05 ± 0.09 
 Glycine 9.44 ± 1.13 8.91 ± 1.07 8.91 ± 1.07 
 Serine 60.13 ± 3.61 63.14 ± 3.79 63.14 ± 3.79 
     
Control 
 Alanine 1.15 ± 0.08 0.05 ± 0.08  
 Glycine 1.15 ± 0.08 0.05 ± 0.08  
 Serine 1.05 ± 0.11 -0.05 ± 0.11  
 
 
4.4.2 Glycine is efficiently taken up to fuel the intracellular pool 
Glycine is a key player of riboflavin production in A. gossypii as reported before for different 
strains and cultivation conditions (Demain, 1972). Therefore, important questions revolve 
around the pathways that supply this important precursor. Intracellular glycine is accessible 
from a variety of different reactions (Figure 24A). It can be (i) either taken up directly from the 
medium or (ii) originate from serine and threonine involving SHMT (Schlüpen et al., 2003) and 
threonine aldolase (Monschau et al., 1998), respectively. In contrast, glyoxylate 
aminotransferase potentially also forming glycine is absent in A. gossypii (Gomes et al., 2014; 
Kato and Park, 2006). The conducted tracer studies allowed to distinguish between the forming 
routes. During the growth phase, 85 % of intracellular glycine were taken up from extracellular 
[13C2] glycine. In a similar way, the related yeast S. cerevisiae also exhibits a strongly regulated 
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biosynthesis. Only upon starvation of a given amino acid its biosynthetic pathway is activated 
(Ljungdahl and Daignan-Fornier, 2012). Amino acid transport systems have not been studied 
in A. gossypii. The yeast S. cerevisiae expresses a general amino acid permease (GAP1) for 
the unspecific glycine transport across the membrane (Cain and Kaiser, 2011; Wipf et al., 
2002). The other routes to intracellular glycine played only a minor role. This also included 
threonine aldolase. In previous work, overexpression of the corresponding GLY1 gene along 
with threonine supplementation resulted in 9-fold increased riboflavin productivity (Monschau 
et al., 1998), admittedly at much lower production performance. 
Once serine was present in the medium, the cells switched to uptake from the medium. Under 
these conditions, intracellular serine was largely taken up (63 %), with the remaining fraction 
being supplied from glycine (Figure 24B). In cases, where serine was not added, i.e. the 
standard production set-up, glycine supplied even larger amounts of serine (63 %) and 
seemed to function as an efficient precursor (Table 11). Glycine and serine were closely linked 
via the highly reversible SHMT. The extent to which serine or glycine were labeled from the 
respective tracer strongly depended on substrate availability (Figure 22, Figure 23). The 
enzyme adjusted the pools of glycine and serine in a highly flexible manner, depending on the 
nutrient status. It seems that the enzyme has a high balancing capacity, which is probably 
required to support the supply of both amino acids under the highly dynamic process 
conditions. Threonine, another amino acid participating in the glycine metabolism of 
A. gossypii, was not labeled, whether 13C serine or 13C glycine were fed (appendix Table 17). 
This matches the irreversibility of threonine aldolase, which catalyzes the unidirectional 
conversion of threonine to glycine (Schlüpen et al., 2003). 
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Figure 24: Contribution of different metabolic routes to glycine (A) and serine (B) in A. gossypii B2. The 
expected theoretical mass isotopomer distribution for the resulting pools, inferred from pathway 
stoichiometry and related carbon transition, are indicated as well as the actually measured labeling of 
the intracellular pool. Data were obtained from three individual replicates. Colored circles, 13C-labeled 
carbon atoms; white circles, naturally labeled carbon; 3PG, 3-phosphoglycerate; 5,10-CH2-THF, 5,10-
methylenetetrahydrofolate; ACETAL, acetaldehyde; GLY, glycine; SER, serine; SEP, 3-phosphoserine; 
THF, tetrahydrofolate; THR, threonine. 
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4.4.3 Serine degradation pathways cause undesired loss of riboflavin precursors 
In tracer studies with 13C serine, 13C glycine, and also with 13C formate, the pyruvate derived 
amino acid alanine was significantly enriched in 13C (Figure 22). Metabolically, serine, glycine, 
and formate are connected via SHMT potentially allowing for an exchange of the 13C labeling 
between the pools. Indeed, glycine and (indirectly) formate were converted into serine (Figure 
23). Since each of the different tracers donated the label to alanine, serine appeared as the 
connecting node to alanine. One way of serine utilization is reconversion to 3-
phosphoglycerate via hydroxypyruvate and glycerate. Potentially, 3-phosphoglycerate could 
indeed serve as precursor for pyruvate and then alanine through the action of enzymes of the 
lower glycolytic chain. However, growth on vegetable oil in the absence of glycolytic substrate 
rather relies on gluconeogenesis, operating the pathway in the opposite direction. Moreover, 
one might expect 13C labeled aromatic amino acids derived from 13C glycolytic intermediates, 
which were not found (Figure 23, appendix Table 17), suggesting that such a glycolytic route 
is probably not involved. Indeed, this pathway is only found in methylotrophic microbes as part 
of the serine cycle (Chistoserdova and Lidstrom, 1994) and in mammals and plants (Liepman 
and Olsen, 2001; Liepman and Olsen, 2003; Snell, 1984), but has apparently not been 
described in fungi or yeasts. Admittedly, this is not a clear disproval, because the absence of 
13C enrichment in aromatic amino acids could also be explained by the fact that they are taken 
up from yeast extract, rather than being synthesized de novo. Other pathways might lead to 
alanine formation from serine that could not be identified in this set-up. As shown, serine 
degradation, together with the reversible action of SHMT, caused continuous withdrawal of 
carbon from the glycine pool. 
4.4.4 The amino acid de novo biosynthesis is tightly regulated with a few exceptions 
Yeast extract was part of the medium in large amounts (29 g L-1). It was, therefore, of great 
importance to quantify the contribution of yeast extract to cell growth and production. In a first 
experiment, the formation of cell building blocks from yeast extract should be investigated. 
Since fully 13C-labeled yeast extract was not readily available, it was custom-synthesized in 
cooperation with the company Ohly (Hamburg, Germany). A yeast strain, typically used for the 
production of yeast extract, was grown on [13C6] glucose under fed-batch conditions. After 
centrifugation and autolysis of the cells, the biomass was dried by lyophilization. The 
composition was analyzed and compared to the conventional extract of this yeast strain, whose 
suitability for riboflavin production with A. gossypii had been tested in preliminary studies (data 
not shown). Since the differences in composition were negligible, the 13C-labeled extract was 
appropriate for the use in 13C tracer studies with A. gossypii. When fully 13C-labeled yeast 
extract was added to the medium and substituted the naturally labeled yeast extract, 
proteinogenic amino acids harvested at the end of the exponential growth phase, were largely 
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13C-labeled (Figure 23, appendix Table 18). This indicated a strong uptake of yeast extract-
based components and subsequent incorporation into the cell protein (Figure 23, appendix 
Table 18). While many amino acids were derived entirely from the complex source, a few 
selected amino acids exhibited less 13C incorporation: alanine, aspartate, and glutamate 
(Figure 25). This indicated a different metabolic origin for those amino acids. Serine and glycine 
showed comparatively low 13C enrichments with SFLcorr of 32 % and 12 %, respectively 
(appendix Table 18). This matched the observation that glycine was identified as major 
contributor to the intracellular serine and glycine pools (Chapter 4.4.1). 
 
 
Figure 25: Relative mass isotopomer distributions (MIDs) of proteinogenic alanine (A), aspartate (B), 
and glutamate (C) from A. gossypii B2 grown on complex medium with rapeseed oil as main carbon 
source. MIDs are presented for medium with naturally labeled substrates (grey) and [U13C] yeast extract 
(purple). Data were obtained from three individual replicates. 
 
The amino acids aspartate, alanine, and glutamate were less 13C-enriched, when compared to 
the other amino acids (SFLcorr of 43 %, 72 %, and 14 %, respectively) (Figure 23, Figure 25, 
appendix Table 18). Of the three, proteinogenic alanine exhibited the largest fully labeled 
isotopomer (M+3) fraction with 61 %. Unlabeled alanine from cell protein made up 31 % of the 
intracellular pool (Figure 25A). The majority of aspartate was non-labeled, however, as much 
as 30 % of the pool were fully labeled (M+4), which indicated origin from the fully labeled yeast 
extract (Figure 25B). The intracellular glutamate pool was by far the least 13C-labeled of those 
three amino acids: the unlabeled mass isotopomer (M+0) made up 73 % of the amino acid, 
thereby being reduced 1.3-fold compared to the naturally labeled control (Figure 25C). While 
also the single labeled mass isotopomer (M+1) was slightly enriched, fully labeled glutamate 
(M+5) contributed only 9 % to the proteinogenic pool (Figure 25C). Considering the obvious 
tight regulation of amino acid biosynthesis observed for the majority of amino acids including 
glycine and serine, exogenous glutamate added to the medium might be the precursor of the 
intracellular alanine, aspartate, and glutamate pools. On the other hand, labeling studies with 
acetate and glycerol as well as glucose showed that those three amino acids were derived 
through de novo biosynthesis from the main carbon source rather than amino acids added to 
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the medium (Figure 15, Figure 18). This could indicate that vegetable oil might serve as 
molecular precursor for glutamate, aspartate, and alanine. 
 
In order to resolve the uncertain molecular origin of glutamate, aspartate, and alanine more 
closely, [13C5] glutamate was added to the culture medium to replace the naturally labeled 
amino acid. Close inspection of the cell protein formed under these conditions revealed only a 
minor contribution of the exogenous glutamate to the intracellular proteinogenic pools (Figure 
23, Figure 26, appendix Table 18). The added glutamate contributed merely 12 % to the 
respective intracellular pool. This was highlighted by the small fraction of fully labeled 
glutamate from cell protein: only 8 % displayed the M+5 mass isotopomer. Unlabeled 
glutamate made up 78 % of the intracellular pool (Figure 26C). Aspartate was even less 13C-
labeled with a SFLcorr of 5 %. Here, the unlabeled mass isotopomer was only 1.1-fold reduced 
compared to the naturally labeled control. While the single (M+1) and double labeled (M+2) 
mass isotopomers were elevated, the fully 13C-labeled aspartate was only slightly enriched 
(Figure 26B). Alanine showed a 13C enrichment of 2 % (appendix Table 18) and exhibited 
almost the same mass isotopomer distribution as the naturally labeled control (Figure 26A). 
These data confirmed that, while glutamate is taken up by the cell and present in large amounts 
in the medium (Figure 13B), de novo biosynthesis of the amino acid seems to be active. In 
S. cerevisiae, α-ketoglutarate is reduced to glutamate via the NADP-dependent glutamate 
dehydrogenase, encoded by GDH1 or GDH3, assimilating ammonia (Magasanik, 2003). 
Interestingly, A. gossypii only contains the NAD-dependent isoform of this enzyme, encoded 
by the gene GDH2, catalyzing the reverse reaction: glutamate oxidation to α-ketoglutarate 
(Gomes et al., 2014; Ribeiro et al., 2012). The anabolic formation of glutamate, therefore, relies 
on transamination reactions, e.g. of α-ketoglutarate with glutamine as nitrogen donor 
(Guillamón et al., 2001). This reaction is catalyzed by the enzyme glutamate synthase 
(encoded by the gene GLT1), which was described for S. cerevisiae (Guillamón et al., 2001) 
and is annotated for A. gossypii (Gomes et al., 2014). In addition to glutamate, also alanine 
and aspartate are connected to the carbon core metabolism by a single transamination step. 
The enzyme alanine transaminase (encoded by the gene ALT) catalyzes the transamination 
of pyruvate to alanine with the nitrogen donor glutamate (Escalera-Fanjul et al., 2017; García-
Campusano et al., 2009). While S. cerevisiae contains two isoforms of this enzyme (ALT1 and 
ALT2) (Escalera-Fanjul et al., 2017), only one alanine transaminase is annotated for 
A. gossypii (Förster et al., 2014). The aspartate transaminase (encoded by the gene AAT) 
converts the metabolic precursor oxaloacetate into aspartate while glutamate serves as 
nitrogen donor (Morin et al., 1992). Two isoforms, a cytosolic and a mitochondrial enzyme, are 
present in S. cerevisiae (Morin et al., 1992; Yagi et al., 1982) and were also annotated for 
A. gossypii (Förster et al., 2014). The reason for the deregulated de novo biosynthesis of 
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glutamate and to a lesser extent also aspartate and alanine might lie in their central role as 
reactant in cellular transamination reactions. The key player glutamate accounts for 85 % of 
the cellular nitrogen demand (Ljungdahl and Daignan-Fornier, 2012), contributing its amino-
group mostly to other amino acids. Glutamine, on the other hand, donates about 15 % of its 
amide nitrogen to amino acids as well as purines and pyrimidines (Ljungdahl and Daignan-
Fornier, 2012). Alanine and also aspartate are derived from pyruvate or oxaloacetate, 
respectively, by a one-step transamination reaction (Escalera-Fanjul et al., 2017; Yagi et al., 
1982). Considering the importance of nitrogen in the cellular metabolism, it seems obvious that 
those reactions are not strongly feedback regulated. The fact that alanine was by far the most 
labeled of the three, when [U13C] yeast extract was fed, could be attributed to the absence of 
the enzyme alanine-glyoxylate aminotransferase, encoded by AGX1 (Kato and Park, 2006). 
This reduces the number of possible transaminating reactions, alanine could be involved in. 
 
 
Figure 26: Relative mass isotopomer distributions (MIDs) of proteinogenic alanine (A), aspartate (B), 
and glutamate (C) from A. gossypii B2 grown on complex medium with rapeseed oil as main carbon 
source. MIDs are presented for medium with naturally labeled substrates (grey) and [13C5] glutamate 
(light blue). Data were obtained from three individual replicates. 
 
In order to gain a deeper understanding of the metabolism of A. gossypii on rapeseed oil, the 
13C-labeling incorporation of glycogen-derived cellular glucose was also inspected. Fully 13C-
labeled yeast extract as well as [13C5] glutamate resulted both in a SFLcorr of 6 % for glucose, 
respectively (Figure 23, Table 18). The single labeled mass isotopomer (M+1) was 3-fold 
increased compared to the naturally labeled compound (Table 18). The majority of cellular 
glucose, however, originated from vegetable oil (Figure 23). 
 
These data showed that glutamate plays a central role in the metabolism of A. gossypii. The 
fact that it is taken up in large amounts during the growth phase (6 g L-1), but contributes only 
slight 13C enrichment to proteinogenic amino acids, obviously suggests strong conversion 
through the TCA cycle. Evidently, glutamate plays a central role in nitrogen metabolism, which 
would be very interesting to investigate further, especially with regard to riboflavin that contains 
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a total of four nitrogen atoms. The addition of fully 13C-labeled yeast extract to the medium 
revealed that most amino acids from the yeast extract were efficiently taken up and 
incorporated into cell protein. Thus, with the exception of alanine, aspartate, and glutamate, 
A. gossypii exhibited a tight regulation of de novo biosynthesis of amino acids. 
4.4.5 Carbon fluxes of A. gossypii B2 during growth on vegetable oil 
The previous chapters gave a detailed overview of the origin of growth associated building 
blocks. The supplemented yeast extract as well as glycine contributed greatly to the formation 
of proteinogenic amino acids, while the impact of extracellular glutamate was reduced in 
comparison (Figure 23). These 13C tracer studies also allowed the conclusion that rapeseed 
oil, the main carbon source of the process, participated in the biosynthesis of a few selected 
amino acids, like glutamate, and the formation of cellular glycogen. Taken together this 
indicated, at least on an additive level, that the TCA cycle was active (glutamate conversion) 
as also were the glyoxylate shunt and the gluconeogenic route (oil conversion into glycogen). 
On the basis of these 13C labeling data and interpreting the individual labeling information plus 
measured extracellular fluxes from the different parallel 13C tracer studies, carbon fluxes were 
calculated with respect to rapeseed oil as major carbon source. For that, the demand of 
anabolic precursors for cell growth had to be derived and converted into rates. The theoretical 
precursor demand for A. gossypii was accessible from literature data: the genome-scale 
metabolic model of A. gossypii provided most of the information for the biomass composition 
of the fungus (Ledesma-Amaro et al., 2014a). The cellular demand for acetyl-CoA and 
glyceraldehyde 3-phosphate, the building blocks of lipids, was adjusted to growth on vegetable 
oil. While growth on glucose leads to a lipid content of about 0.08 to 0.15 g gCDW-1, growth on 
vegetable oil results in a lipid content of up to 0.22 g gCDW-1 (Stahmann et al., 1994). The 
anabolic precursor demand for the riboflavin production during growth was derived from the 
literature and KEGG via the underlying pathway stoichiometry (Bacher et al., 2000; Kanehisa 
et al., 2017; Kanehisa and Goto, 2000; Kanehisa et al., 2016). The final values for the eleven 
anabolic precursors are listed in Table 12. The demand assumes that all cellular building 
blocks are synthesized de novo. However, the results in the previous chapter demonstrated 
that a large fraction of cellular protein and glycogen was covered by mere uptake of amino 
acids and yeast extract supplemented in the medium (Figure 23). This was used to correct the 
demand into the real values remaining under the given condition. The uptake of each amino 
acid was calculated by addition of the respective SFLcorr for that amino acid from the single 
isotope experiments. The remaining fraction of the amino acid was then attributed to de novo 
synthesis from vegetable oil. Each cellular building block, e.g. amino acids or nucleotides, is 
derived from one or more out of a total of eleven precursors (appendix Table 19). The demand 
for a single precursor is therefore the sum of the cellular demand of its building blocks. 
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Pyruvate, e.g., is the metabolic precursor of alanine, valine, isoleucine, and leucine (appendix 
Table 19). However, since most of these amino acids were either fully or partially taken up by 
the cell from the culture medium, the de novo pyruvate demand (1783.1 μmol gCDW-1) was 
tremendously decreased to 71.5 μmol gCDW-1 when 13C labeling data were taken into account. 
Thus, the experimental de novo precursor demand for growth on complex medium differed 
greatly from the values (Table 12), underlining the importance of taking 13C labeling data into 
consideration as well as the impact of the medium to support intracellular pools. Definition of 
metabolite balances and flux calculations leading to the final carbon flux distribution are given 
in the appendix (Chapter 6). 
 
Table 12: Estimation of the de novo demand for anabolic precursors during growth of A. gossypii on 
complex medium and rapeseed oil. First, the total precursor demand (total demand) was taken from 
literature (Ledesma-Amaro et al., 2014a) and adjusted for growth on vegetable oil based on (Stahmann 
et al., 1994). The total demand for each anabolic precursor was covered by two routes: (i) uptake of 
external building blocks from complex ingredients, which biosynthetically originate from the respective 
precursor (e.g. alanine, valine, etc. from pyruvate) and (ii) de novo synthesis of the building blocks from 
vegetable oil. Correlation of the total demand values with experimental summed fractional labeling 
(SFLcorr) data from combined results of parallel 13C isotope studies with [13C2] glycine, [13C] formate, 
[13C5] glutamate, and [U13C] yeast extract (appendix Table 17 and Table 18) yielded the measured 
percentage of (i) the anabolic precursor that could be neglected due to the uptake of advanced 
metabolites (e.g. amino acids, nucleotides) and (ii) the resulting percentage of de novo precursor 
demand for growth on complex medium and rapeseed oil, which was then converted into the resulting 
de novo demand. The full length bar indicates the individual contributions visually: the purple fraction 
depicts the percentage covered from complex ingredients, while the grey fraction depicts the resulting 
de novo biosynthetic fraction of the precursor. The de novo demand for acetyl CoA was not specified, 
which is explained in more detail in Table 20. 3PG, 3-phosphoglycerate; AcCoA, acetyl-CoA; AKG, α-
ketoglutarate; E4P, erythrose 4-phosphate; F6P, fructose 6-phosphate; G3P, glyceraldehyde 3-phosphate; G6P, 
glucose 6-phosphate; OAA, oxaloacetate; PEP, phosphoenolpyruvate; PYR, pyruvate, R5P, ribose 5-phosphate. 
Anabolic 
precursor 
Total demand  Uptakea De novo 
biosynthesis 
Resulting de 
novo demand 
 [μmol gCDW-1]  [%] [%] [μmol gCDW-1] 
G6P 604.8  12.5 ± 0.4 87.5 ± 0.4 529.2 ± 2.7 
F6Pb 821.0  0.0 100.0 821.0 
R5Pb 329.9  94.8 5.2 17.3 
E4P 238.8  98.0 ± 2.9 2.0 ± 3.4 4.8 ± 7.2 
G3Pb 240.4  0.0 100.0 240.4 
3PG 707.4  94.8 ± 5.1 5.2 ± 5.0 37.1 ± 36.0 
PEP 449.6  97.9 ± 2.9 2.1 ± 2.7 9.6 ± 14.3 
PYR 1783.1  96.0 ± 1.0 4.0 ± 1.0 71.5 ± 14.9 
AcCoA 6572.7  n.d. n.d. n.d. 
OAA 1124.5  88.5 ± 1.9 11.5 ± 1.9 129.8 ± 20.5 
AKG 800.4  60.8 ± 1.5 39.2 ± 1.5 313.7 ± 10.7 
a Percentage negligible due to uptake of advanced building blocks, i.e. amino acids or nucleotides, from the medium. 
b The demand for the precursor is assumed. Therefore, no standard deviation could be calculated for the according 
values 
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Growth of A. gossypii on vegetable oil and complex medium resulted in a strong carbon flux 
through the ß-oxidation pathway as well as TCA cycle (Figure 27). Vegetable oil was cleaved 
into three fatty acids (average chain length of 17.3 carbon atoms, denoted as FA in Figure 27) 
(Stahmann et al., 1994) and glycerol in the extracellular space (Stahmann et al., 1997). Fatty 
acids were then taken up by the cell (0.43 mmol gCDW-1h-1) and oxidized to acetyl-CoA through 
the ß-oxidation pathway, located in the peroxisome (Shen and Burger, 2009; Vorapreeda et 
al., 2012). The carbon flux from acetyl-CoA into biomass (0.506 mmol g-1 h-1) assumes that the 
intracellular storage lipids have to be synthesized de novo, which is, however, unlikely as 
described below. A small fraction of acetyl-CoA, i.e. 0.141 mmol g-1 h-1, was then assimilated 
through the glyoxylate shunt, yielding an overall carbon flux into malate of 0.141 mmol g-1 h-1. 
The majority of acetyl-CoA, however, was channeled into the TCA cycle, where it was 
decarboxylated and finally contributed to cellular respiration. The highly reduced fatty acids 
are oxidized in order to become accessible for the cell. The strong decarboxylation of acetyl-
CoA in the TCA cycle is balanced by oxygen consumption during cellular respiration. These 
facts match the typically observed RQ of < 1 for growth on lipids (Stahmann et al., 1994), which 
is characterized by high oxygen consumption and low carbon dioxide formation. Nevertheless, 
the high flux through the TCA cycle seemed surprising at first, given the low biomass yield of 
186 g mol-1 and growth rate (0.08 h-1) (Table 6) and the resulting low demand of cellular ATP. 
However, the high TCA cycle activity might indicate a high maintenance demand of the cell. In 
a 13C metabolic flux study with Sorangium cellulosum, a slow growing myxobacterium, a high 
carbon flux through the TCA cycle could also be observed, which was potentially linked to a 
high maintenance metabolism (Bolten et al., 2009). Wild type B. subtilis also requires a lot of 
energy for its maintenance (Tännler et al., 2008a). However, knockout of the terminal 
cytochrome bd oxidase in the respiratory chain of a riboflavin producing Bacillus strain, resulted 
in more efficient proton pumping, thereby decreasing the high maintenance metabolism, and 
thus, even improving riboflavin production performance (Zamboni et al., 2003). Therefore, the 
targeted reduction of the maintenance demand might also display a potential metabolic target 
and improve production performance in A. gossypii.  
The acetyl-CoA that was channeled through the TCA cycle plus the oxaloacetate from the 
glyoxylate shunt together formed citrate, which was then decarboxylated into α-ketoglutarate 
(Figure 27). The large flux from α-ketoglutarate to intracellular glutamate (0.389 mmol g-1 h-1) 
ensured the observed 13C enrichment of glutamate (combined SFLcorr of 26.5 %), which was 
largely naturally labeled, given the strong uptake of extracellular glutamate during growth 
(0.142 mmol g-1 h-1). The intracellular glutamate pool fed into biomass: while Figure 27 only 
shows lumped reactions, Figure 28A displays a more detailed picture.  
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Figure 27: Carbon fluxes during growth of A. gossypii B2 on rapeseed oil and complex medium. Fluxes are given 
in mmol gCDW-1 h-1 and are normalized to the substrate uptake rate (0.430 mmol g-1 h-1). Flux calculations were 
derived from parallel 13C tracer studies with [13C2] glycine, [13C] formate, [13C5] glutamate, and [U13C] yeast extract 
(appendix Table 17, Table 18). The arrow thickness is proportional to the corresponding flux. The direction of net 
fluxes is indicated by size of arrow head. Dashed arrows represent fluxes into biomass. Reactions at the OAA/MAL 
and PEP/PYR node could not be resolved by this approach and represent lumped fluxes. The rate of the pyruvate 
dehydrogenase could not be determined. In order to simplify the figure, only GTP uptake is depicted as immediate 
riboflavin precursor. Other nucleotides as well as cysteine and methionine, which are also taken up from the 
medium, are not shown. Note that the conversion of citrate to isocitrate via aconitase most likely does not occur in 
the peroxisome (Murakami and Yoshino, 1997). 3PG, 3-phosphoplycerate; AcCoAP/M, peroxisomal/mitochondrial 
acetyl-CoA; AKG, α-ketoglutarate; ALA, alanine; ARG, arginine; ASN, asparagine; ASP, aspartate; BM, biomass; 
CH2-THF, 5,10-methylenetetrahydrofolate; CHO-THF, 10-formyltetrahydrofolate; CIT, citrate; DHAP, 
dihydroxyacetone phosphate; DRL, 6,7-dimethyl-8-ribityllumazine; E4P, erythrose 4-phosphate; F6P, fructose 6-
phosphate; FA, fatty acids (here three FA with an average chain length of 17.3 carbon atoms); FOR, formate; G3P, 
glyceraldehyde 3-phosphate; G6P, glucose 6-phosphate; GAR, glycineamide ribonucleotide; GLN, glutamine; GLU, 
glutamate; GLY, glycine; GLYC, glycerol; GLYOX, glyoxylate; GTP, guanosine triphosphate; IMP, inosine 
monophosphate; MAL, malate; OAA, oxaloacetate; PEP, phosphoenolpyruvate; PYR, pyruvate; R5P, ribose 5-
phosphate; Ru5P, ribulose 5-phosphate; S7P, sedoheptulose 7-phosphate; SER, serine; THF, tetrahydrofolate; 
Xu5P, xylulose 5-phosphate; YE, yeast extract. 
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Carbon fluxes into the single proteinogenic amino acids illustrate the strong regulation of their 
biosynthesis: intracellular glutamate only supplied small fractions of the respective amino 
acids, while most of their demand was covered through uptake from the medium (Figure 28A). 
The strong backflux from glutamate to α-ketoglutarate resulted in an α-ketoglutarate-
synthesizing netflux (0.107 mmol g-1 h-1). Reactions involving the OAA/malate pool as well as 
the PEP/pyruvate pool could not be resolved by this approach and were calculated as lumped 
reactions, i.e. a net flux from oxaloacetate to the combined PEP/pyruvate pool (0.236 mmol g-
1 h-1). Oxaloacetate is an important anabolic precursor, contributing to the synthesis of various 
amino acids as well as pyrimidine biosynthesis (appendix Table 19). The detailed distribution 
of carbon fluxes into biomass starting from the precursor oxaloacetate is presented in Figure 
28B. Intracellular aspartate is derived from extracellular aspartate and to similar extent from 
oxaloacetate. However, there was only a small flux of 0.003 mmol g-1 h-1 from intracellular 
aspartate to asparagine and threonine, on the other hand, indicating strong uptake of these 
two amino acids from the medium (fluxes of 0.011 mmol g-1 h-1 and 0.013 mmol g-1 h-1, 
respectively) (Figure 28B). The carbon fluxes through the upper metabolism, i.e. 
gluconeogenesis and PP pathway were comparatively low. This can be attributed to the high 
uptake of amino acids from the culture medium and the resulting low de novo precursor 
demand. Here, the precursor demand for ribulose 5-phosphate, ribose 5-phosphate, and 
erythrose 4-phosphate was almost completely covered by the reactions of the non-oxidative 
part of the PP pathway (Figure 27). A small carbon flux of 0.001 mmol g-1 h-1 was assigned to 
the oxidative branch. This raises the question of NADPH supply in the cell, since the enzymes 
glucose-6-phosphate dehydrogenase as well as phosphogluconate dehydrogenase are often 
regarded as main donors for cytosolic NADPH (Panagiotou et al., 2009). Even if assuming that 
all extra carbon from the non-oxidative part of the PP pathway was channeled through 
gluconeogenesis and subsequently into the oxidative part of the PP pathway, the resulting flux 
would have been only 0.002 mmol g-1 h-1. Lipid biosynthesis requires large amounts of 
NADPH, however, storage lipids in A. gossypii are most likely not synthesized de novo, but 
formed through transesterification with fatty acids and glycerol taken up from the culture 
supernatant. It was reported that the lipid composition of A. gossypii grown on vegetable oil 
depended on and resembled the composition of the vegetable oil used as a substrate 
(Stahmann et al., 1994). Another NADPH-requiring enzyme during growth, glutamate 
dehydrogenase (GDH1 or GDH3), is absent in A. gossypii (Gomes et al., 2014; Ribeiro et al., 
2012) and thus, glutamate de novo synthesis occurs via the enzyme glutamate synthase 
(Chapter 4.4.4). Two isoforms of this enzyme exist, a NAD-dependent and a NADP-dependent 
form (EC 1.4.1.14 and EC 1.4.1.13, respectively) and are both annotated for A. gossypii as 
well as S. cerevisiae in the KEGG database (Kanehisa et al., 2017; Kanehisa and Goto, 2000; 
Kanehisa et al., 2016). While there is no experimental evidence on cofactor specificity for 
RESULTS AND DISCUSSION 
78 
 
A. gossypii, for S. cerevisiae, however, the enzyme was reported to be NAD-dependent 
(Guillamón et al., 2001; Vanoni and Curti, 2008). The glutamate synthase of the yeast 
Kluyveromyces marxianus, on the other hand, was proven to use NADP as cofactor (Nisbet 
and Slaughter, 1980). Thus, further studies are needed to unravel the cofactor requirement for 
glutamate biosynthesis in A. gossypii. Given the above mentioned data and the fact that most 
amino acids were readily taken up from the medium, the NADPH requirement of the cell is 
comparably low. Nonetheless, there are different potentially NADPH-generating enzymes in 
A. gossypii: isocitrate dehydrogenase (IDH), malic enzyme (MaE), and NADH kinase. In 
A. gossypii there are two isoforms of the IDH, which converts isocitrate into α-ketoglutarate: 
the mitochondrial isoenzyme is NAD-specific, whereas the NADP-dependent enzyme is 
localized to the peroxisome (Maeting et al., 2000), where it is thought to be involved in cofactor 
regeneration during oxidation of unsaturated fatty acids via 2,4-dienoyl-CoA reductase 
(Maeting et al., 2000). Three isoenzymes were detected in S. cerevisiae, two of which are 
localized to the mitochondria (NAD- and NADP-specific) and a third one, NAD-specific, is 
located in the cytosol (Haselbeck and McAlister-Henn, 1993). The NADP-dependent 
decarboxylation of malate to pyruvate, catalyzed by MaE, was confirmed for Aspergillus niger 
(Jernejc and Legisa, 2002). The MaE from S. cerevisiae has been reported to use both NAD 
as well as NADP as cofactors (Boles et al., 1998). The enzyme is annotated for A. gossypii 
(KEGG, AGL068W), however, no experimental data for the cofactor specificity are available in 
the literature (Kanehisa et al., 2017; Kanehisa and Goto, 2000; Kanehisa et al., 2016). Another 
interesting NADPH-providing reaction is the phosphorylation of NADH by NADH kinase. This 
reaction is located in the mitochondria and was described, among others, for S. cerevisiae and 
Aspergillus nidulans (Outten and Culotta, 2003; Panagiotou et al., 2009) and is annotated for 
A. gossypii (KEGG, AFL063W) (Kanehisa and Goto, 2000). 
 
The flux distribution presented here shows that the glyoxylate shunt plays an important role in 
carbon assimilation during growth on vegetable oil, which is then channeled into 
gluconeogenesis. The decreased carbon flux through the upper metabolism, i.e. 
gluconeogenesis and PP pathway, reflects the strong regulation of amino acid de novo 
biosynthesis due to the ample supply of amino acids as well as nucleotides in the culture 
supernatant (Zhang et al., 2003). While pioneering 13C flux studies used ethanol or glucose as 
carbon sources on semi-defined media (de Graaf et al., 2000; Jeong et al., 2015), this is the 
first report of a carbon flux distribution with A. gossypii on vegetable oil and complex medium 
during growth. The concerted action of the main carbon source vegetable oil and the complex 
substrate yeast extract regarding the formation of cell building blocks, illustrated by the flux 
map (Figure 27), highlights the complexity of the given process.  
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Figure 28: Detailed view of carbon fluxes into biomass for amino acids stemming from glutamate (A) or 
aspartate (B) during growth of A. gossypii B2 on vegetable oil and complex medium. Fluxes are given 
in mmol gCDW-1 h-1 and are normalized to the substrate uptake rate (0.430 mmol g-1 h-1). Flux calculations 
were derived from parallel 13C tracer studies with [13C2] glycine, [13C] formate, [13C5] glutamate, and 
[U13C] yeast extract (appendix Table 17, Table 18). The arrow thickness is proportional to the 
corresponding flux. The direction of net fluxes is indicated by size of arrow head. Dashed arrows 
represent fluxes into biomass. Reactions at the OAA/MAL and PEP/PYR node could not be resolved by 
this approach and represent lumped fluxes. The rate of the pyruvate dehydrogenase could not be 
determined. The contribution of intracellular glutamate or aspartate to glutamine and asparagine, 
respectively, could not be measured and was estimated based on the 13C labeling data for proline and 
threonine. The full figure is presented in Figure 27. 3PG, 3-phosphoplycerate; AcCoA, acetyl-CoA; AKG, α-
ketoglutarate; ALA, alanine; ARG, arginine; ASN, asparagine; ASP, aspartate; BM, biomass; CIT, citrate; GLN, 
glutamine; GLU, glutamate; MAL, malate; OAA, oxaloacetate; PEP, phosphoenolpyruvate; PRO, proline; PYR, 
pyruvate; THR, threonine; YE, yeast extract. 
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4.5 Unraveling the building blocks of riboflavin using LC/MS and 13C NMR 
After successful determination of carbon fluxes in the growth phase, the riboflavin production 
phase was investigated next. Since labeling analysis of riboflavin was not feasible with GC/MS, 
LC/MS and NMR were employed to quantify the impact of different tracers on the carbon 
skeleton of the vitamin. 
4.5.1 LC/MS measurements confirm glycine and formate as riboflavin building blocks 
An initial experiment verified that the mass isotopomer distribution of accumulated and partially 
purified riboflavin from a culture of A. gossypii B2 was accessible by LC/MS (Figure 29). Using 
naturally labeled medium ingredients, samples from the end of the production process after 
144 h were harvested, partially purified (Chapter 3.4.3) and analyzed via LC/MS. The observed 
mass isotopomer distribution of the vitamin, corrected for natural isotope abundance, exhibited 
the expected monoisotopic mass. Accordingly, the incorporation of individual tracers into the 
product could be quantified by this approach. Further adaptions in the labeling strategy were 
conducted in order to ensure that each tested precursor was still available during the 
production phase. Formate was largely consumed prior to riboflavin biosynthesis. Therefore, 
[13C] formate was added (i) at the beginning and (ii) in a parallel experiment after 48 h of 
cultivation. The latter experiment should compensate for eventual formate loss and dilution 
effects during the preceding growth phase, in order to ensure that the tracer was present at 
the delayed start of riboflavin production (Figure 13A). The tracer [13C2] glycine, which was 
present in the medium in high concentrations at all times (Figure 13B), had to be supplemented 
only at the beginning of the experiment. 
 
Riboflavin synthesized on fully 13C-labeled glycine was M+2 enriched, whereas the 
monoisotopic mass isotopomer (M+0) was strongly decreased (Figure 29A). This indicated the 
incorporation of glycine as two-carbon unit mainly. A small fraction was attributed to the M+1 
isotopomer. In contrast to M+0 and the M+2 mass isotopomer, the small M+1 peak suffered 
from a rather low signal quality of the underlying peak in the mass spectrometric analysis. It 
was therefore not fully clear, to which extent it represented the incorporation of a single 13C 
atom from the tracer or simply background interference. From the observed MID a summed 
fractional labeling of 9 % could be calculated for the total molecule. Considering that the 
maximum SFL for M+2 in riboflavin from [13C2] glycine equals 12 %, this corresponded to a 
total fraction of 79 % riboflavin molecules, which contained an entire glycine residue. The 
contribution of formate on riboflavin synthesis was strongly dependent on the point in time of 
tracer addition. When formate was added after 0 h of cultivation, formed riboflavin was so 
slightly enriched in 13C that it disappeared in signal background (Table 13, appendix Table 22 
and Table 23). This suggested that formate, initially present in the medium, had been taken up 
RESULTS AND DISCUSSION 
81 
 
and metabolized differently prior to riboflavin biosynthesis. Measurement of the formate 
concentration in the culture supernatant confirmed this assumption (data not shown). Thus, 
extracellular formate was not available during main riboflavin production. The 13C integration 
of formate was 100-fold greater, when the tracer was added after 48 h (Table 13). Here, the 
M+1 fragment in riboflavin was enriched, indicating that formate contributed to only one carbon 
atom of the vitamin (Figure 29B). 
 
Table 13: Summed fractional labeling (SFL) of riboflavin, derived from LC/MS based measurement of 
the product, extracted after 144 h from culture broth of A. gossypii B2, grown on different 13C tracers 
and naturally labeled complex medium with rapeseed oil. The SFL, which was corrected for naturally 
occurring isotopes, was determined using the original measurement data (appendix Table 22, Table 
23), and was corrected for the dilution of labeling through naturally labeled pre-culture medium at the 
beginning of the cultivation (SFLcorr). The right column displays the values for the respective contribution 
of the used 13C-labeled precursor, which also takes into consideration the possible carbon transition of 
the molecules. The correction is described in Chapter 3.5.2. Data denote mean values of three 
independent replicates. 
13C Tracer Time of addition SFL SFLcorr Contribution Ψ 
 [h] [%] [%] [%] 
Nat. lab. precursor 0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
[13C2] Glycine 0 9.0 ± 0.8 9.3 ± 0.8 79.1 ± 6.8 
[13C] Formate 0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
48 1.0 ± 0.1 1.0 ± 0.1 17.0 ± 1.7 
[3-13C] Serine 0 0.2 ± 0.0 0.3 ± 0.0 5.1 ± 0.2 
48 0.4 ± 0.0 0.4 ± 0.0 6.8 ± 0.3 
[13C3] Serine 0 1.2 ± 0.1 1.6 ± 0.1 9.1 ± 0.6 
48 1.9 ± 0.2 2.0 ± 0.2 11.3 ± 1.1 
[U13C] Yeast extract 0-32 4.5 ± 0.6 5.1 ± 0.7 n.d. 
32 8.0 ± 1.1 9.0 ± 1.2 n.d. 
 
 
4.5.2 NMR analyses yield higher resolution of glycine and formate as precursors 
Additional 13C experiments were run in order to resolve the molecular origin of the carbon 
atoms in riboflavin even more precisely using NMR analysis. This offered the great advantage 
that not only the number of labeled carbon atoms in riboflavin became accessible, but also the 
positional 13C enrichment. The latter appeared particularly valuable to clarify the single carbon 
incorporations, which could not be resolved by LC/MS. Prior to 13C labeling experiments, purity 
and structure of riboflavin were confirmed by two-dimensional NMR using commercially 
available riboflavin and naturally labeled riboflavin, recovered after 144 h from culture broth 
and subsequently purified. A 1H NMR spectrum in the first and a 13C NMR spectrum in the 
second dimension provided identical results (data not shown). Every peak could be attributed 
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to exactly one carbon atom. The peak areas for each carbon were identical, reflecting natural 
13C abundance. A 1D 13C NMR spectrum for naturally labeled riboflavin from A. gossypii is 
presented in Figure 29D. 
 
For cultivations preceding NMR analysis, the same tracer set-up was chosen as for LC/MS 
measurements: fully 13C-labeled glycine added after 0 h, and 13C-labeled formate added after 
(i) 0 h and (ii) 48 h in parallel experiments. The 13C NMR data of riboflavin, which were 
corrected for natural 13C labeling, are shown in Table 14 (raw data: appendix Table 24). Initial 
13C tracer enrichment was monitored and relative enrichments were corrected accordingly 
(Chapter 3.5.2). Riboflavin synthesized on medium, containing labeled glycine, yielded a 72 % 
positional enrichment at the carbons C4a (136.8 ppm chemical shift) and C10a (150.8 ppm 
chemical shift) in the pyrimidine ring (Table 14). Both peaks appeared as duplets due to 13C 
coupling of the neighboring carbon atoms (Figure 29G). This demonstrated that glycine was 
incorporated as entire two-carbon unit, which confirmed previous LC/MS results (Figure 29A, 
Table 13). There was no 13C enrichment at 155.5 ppm representing carbon atom C2, known to 
originate from folate-dependent one-carbon metabolism. This confirmed that the M+1 peak, 
which was observed in the LC/MS spectrum of riboflavin, could be attributed to background 
noise (Figure 29A). Addition of [13C] formate after 0 h and 48 h of cultivation yielded 4 % and 
12 % 13C enrichment at the C2 atom, respectively (Figure 29F, Table 14). Obviously, formate 
provided a single carbon atom to the vitamin. 
 
Several decades ago, glycine was identified as the donor of the neighboring carbons C4a and 
C10a in the pyrimidine ring of riboflavin (Plaut, 1954a). This pioneering study also tried to 
elucidate the contribution of glycine to the carbon C2 in the ring, which would have indicated 
the presence or absence of a glycine cleavage system, existing in yeasts such as S. cerevisiae 
(Piper et al., 2002). At the time, this could, however, not be proven due to experimental noise 
at the resulting low labeling enrichment. The genome annotation shows GCV1 as a missing 
gene for a glycine cleavage system (Gomes et al., 2014). However, until now there was no 
experimental proof for the absence or presence of a glycine cleavage system in A. gossypii 
apart from the gene annotations. Here, fully 13C-labeled glycine was incorporated into riboflavin 
exclusively at two carbon positions: the neighboring carbons C4a and C10a in the pyrimidine ring 
(Figure 29G, Figure 30A). In contrast, the carbon C2 did not receive any 13C label, while the 
labeled tracer was present throughout. The enrichment was exactly at the abundance of 
riboflavin from a non-labeled control experiment (Figure 29G) and also from a commercial 
standard (data not shown). It can be concluded from the NMR data that A. gossypii does not 
operate a glycine cleavage system. Thus, glycine cannot act as C1 donor. However, glycine 
contributes to the majority of the two-carbon unit in riboflavin. In the tracer study with fully 
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labeled glycine, the two atoms C4a and C10a exhibited a positional enrichment of 72 % (Figure 
30A). 
 
 
Figure 29: LC/MS spectra of riboflavin (m/z 377) (A-C) and proton-decoupled 13C NMR spectra of 
riboflavin (D-G) derived from cultures of riboflavin producing A. gossypii B2 grown on [13C2] glycine (A, 
G), [13C] formate (B, F), [13C3] serine (C), [3-13C] serine (E), and on naturally labeled precursors (D). 
Samples were harvested after 144 h. Riboflavin produced on naturally labeled medium is depicted in 
grey for LC/MS data, which were corrected for naturally occurring isotopes. Labeled glycine was added 
at the beginning of the cultivation, labeled formate and serine were added after 48 h. As higher mass 
isotopomers were below the detection limit, only the first five are depicted (A-C). Data were obtained 
from three independent experiments with a mean standard deviation of 5 % for 13C NMR data if 
riboflavin. 
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Table 14: Relative 13C enrichment of all seventeen carbon atoms of riboflavin produced by A. gossypii 
B2 from different 13C-labeled tracer substrates on complex medium with rapeseed oil. Riboflavin was 
recovered from the culture broth after 144 h. The labeling was analyzed by 13C NMR. The measurement 
data (uncorrected, appendix Table 24) were corrected values for naturally occurring isotopes and 
dilution through naturally labeled pre-culture medium. The time refers to the respective tracer addition. 
Data denote mean values of three independent replicates with a mean standard deviation of 8 %. For, 
formate; Glu, glutamate; Gly, Glycine; Ser, serine; YE, yeast extract.  
C-atom 
Chemical 
shift 
[ppm] 
Corrected relative enrichment [%] 
Nat. lab. 
precursors 
[13C] For [13C2] Gly [3-13C] Ser [U13C] YE [13C5] Glu 
0 h 0 h 48 h 0 h 48 h 32 h 0 h 
2 155.5 0.0 3.7 11.6 0.0 5.1 16.2 1.1 
4 159.9 0.0 0.0 0.0 0.0 0.0 12.1 1.8 
4a 136.8 0.0 0.0 0.0 72.1 0.0 19.6 0.0 
5a 134 0.0 0.0 0.0 0.0 0.0 4.2 1.9 
6 130 0.0 0.0 0.0 0.0 0.0 4.5 2.3 
7 137.1 0.0 0.0 0.0 0.0 0.0 3.0 1.8 
7α 18.8 0.0 0.0 0.0 0.0 0.0 3.0 1.7 
8 146 0.0 0.0 0.0 0.0 0.0 4.0 1.9 
8α 20.8 0.0 0.0 0.0 0.0 0.0 4.0 2.6 
9 117.4 0.0 0.0 0.0 0.0 0.0 3.1 0.7 
9a 132.1 0.0 0.0 0.0 0.0 0.0 3.0 0.3 
10a 150.8 0.0 0.0 0.0 71.6 0.0 19.7 0.0 
1’ 47.3 0.0 0.0 0.0 0.0 0.0 9.9 2.9 
2’ 68.8 0.0 0.0 0.0 0.0 0.0 8.7 4.1 
3’ 73.6 0.0 0.0 0.0 0.0 0.0 7.7 3.0 
4’ 72.8 0.0 0.0 0.0 0.0 0.0 8.1 3.9 
5’ 63.4 0.0 0.0 0.0 0.0 0.0 7.3 1.6 
 
4.5.3 The dual role of serine in riboflavin biosynthesis 
For A. gossypii, serine is neither typically added to the cultivation medium, nor is it an 
immediate precursor of riboflavin. However, since the addition of 13C serine to the growth 
phase of the fungus gave rise to 13C enrichment in glycine, it was considered to also participate 
in riboflavin production on some level. Tracer studies similar to the ones with glycine and 
formate, combining LC/MS, GC/MS, and NMR analyses were conducted in order to elucidate 
the impact of serine. In parallel studies, [13C3] serine and [3-13C] serine were used as tracers, 
the latter specifically fueling the one-carbon metabolism with the 13C label. The LC/MS 
spectrum of riboflavin, produced on fully labeled serine, showed a decreased monoisotopic 
mass isotopomer (Figure 29C). At the same time, M+1 and M+2 isotopomers were enriched 
as well as, however to a lesser extent, M+3. Consequently, serine probably functioned as 
glycine donor (M+2), C1 donor (M+1), and a combination of the two. GC/MS based analysis of 
the culture supernatant during the riboflavin biosynthetic phase revealed that exogenous 
serine contributed to about 8 % of the extracellular glycine pool (data not shown). Addition of 
[3-13C] serine yielded one 13C-enriched atom (M+1) (data not shown). As for formate, the 
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impact of serine on riboflavin was strongly time-dependent (Table 13). This indicated a loss or 
dilution of serine in the preceding growth phase.  
 
 
Figure 30: Theoretically possible and experimental 13C NMR spectra for riboflavin produced on 13C-
labeled glycine (A), serine (B), and formate (C). Asterisks indicate addition of the tracer after 48 h. 
Glycine was added at the beginning of the cultivation. Data denote the corrected relative 13C enrichment 
obtained from three independent replicates with a mean standard deviation of 8 %. Colored circles, 13C-
labeled carbon atoms; white circles, naturally labeled carbon. 
 
For subsequent 13C NMR measurements, only [3-13C] serine was chosen, because the role of 
serine as glycine precursor had been established via GC/MS. Thus, the impact of serine as a 
C1 donor was supposed to be investigated on a more molecular level. The 13C NMR spectrum 
of riboflavin revealed a single 13C relative enrichment at carbon C2 of 5 %, the atom known to 
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originate from the one-carbon metabolism (Figure 29E, Figure 30B, Table 14). Taken together, 
serine truly acted as one-carbon donor and glycine donor, but did not enter riboflavin on a 
different metabolic level. 
Hence, for serine, a dual role was identified. In this regard, A. gossypii shows a similar behavior 
as the related fungus Eremothecium ashbyii (Goodwin and Jones, 1956). Here, glycine is the 
immediate riboflavin precursor and serine plays a central role as supporting glycine pool. 
4.5.4 Yeast extract and glutamate contribute globally to the riboflavin carbon skeleton 
The addition of labeled glycine, formate, and serine gave very valuable insights into the 
riboflavin metabolism of A. gossypii B2. However, rapeseed oil and yeast extract, by far the 
two most abundant medium ingredients for the riboflavin production with A. gossypii remained 
to be tested. Since 13C-labeled rapeseed oil was unavailable, custom-synthesized fully labeled 
yeast extract (Chapter 4.4.4) studies were conducted. In order to be able to distinguish 
between incorporation of 13C labeling during the growth and subsequent riboflavin production 
phase, two cultivations were carried out in parallel: (i) growth on fully labeled yeast extract until 
32 h and (ii) growth on naturally labeled yeast extract until 32 h. Once growth had ceased and 
cells started to accumulate riboflavin, the cultures were centrifuged and the medium was 
exchanged. That way it could be distinguished, whether 13C-labeled yeast extract-based 
compounds were incorporated into riboflavin in the early riboflavin production phase (the first 
32 h of cultivation) or if the incorporation occurred after growth had ceased (32 h to 144 h). 
LC/MS measurements of partially purified riboflavin from the culture broth, harvested after 
144 h, verified the successful incorporation of the 13C-labeled yeast extract into riboflavin: 
9.0 % SFLcorr (Table 13). The diverse respective mass isotopomer distribution did not allow the 
positional 13C resolution of the vitamin (appendix Table 23). Therefore, at the end of the 
cultivation (144 h), positional 13C enrichment of riboflavin was analyzed via 13C NMR. The NMR 
results revealed that during growth, 13C incorporation into riboflavin was below the detection 
limit and thus negligible (data not shown). Replacement of the naturally labeled medium with 
medium containing [U13C] yeast extract (32 h post inoculation) resulted in different degrees of 
13C enrichment in every carbon atom of the vitamin (Table 14, Figure 31A). Obviously, yeast 
extract-related compounds, present in the medium at the beginning of riboflavin accumulation 
were used for the formation of the product. The labeling results can be lumped into three 
structural subunits of the vitamin: ribityl side chain, xylene ring, and pyrimidine ring. On average 
8.4 % of 13C labeling originating from 13C-labeled yeast extract could be detected in the ribityl 
side chain. Surprisingly, the xylene ring, which originates from the same intracellular precursor, 
the pentose 5-phosphate pool (Bacher et al., 2000; Bacher et al., 1983; Bacher et al., 1985), 
exhibited 2.3-fold less 13C incorporation (3.6 %). The pyrimidine ring, containing the four 
remaining carbon atoms C2, C4, C4a, and C10a, was labeled the most with 16.2 %, 12.1 %, 
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19.6 %, and 19.7 %, respectively. The 13C labeling of C4a and C10a most likely originated from 
glycine and serine present in the yeast extract. As previously discussed, serine is converted 
into glycine via the SHMT (Chapter 4.4), rendering a carbon-one unit, which is then also 
incorporated into the vitamin at carbon atom C2. There are two interesting details about the 
obtained labeling data: first, the heavy labeling of the C4 atom, which metabolically originates 
from carbon dioxide fixation in the purine biosynthesis and second, the difference in labeling 
between ribityl side chain and xylene ring. In a previous study investigating the carbon origin 
of the xylene ring using precursors such as [1,3-13C] or [2,3-13C] ribose, labeling between those 
two structural groups did not differ to such great extent (Bacher et al., 1983; Bacher et al., 
1985). However, in that study only the amount of de novo synthesized riboflavin from the 
respective precursor was assessed. In riboflavin, the xylene ring is the riboflavin-exclusive 
structural unit that contains eight carbon atoms. All other carbon is derived from the immediate 
riboflavin precursor GTP (Figure 32). Yeast extract is a complex nutrient, obtained from 
autolyzed yeast cells, which contains proteins to the largest extent, but also nucleotides or 
nucleobases from RNA or DNA and sugar compounds (Sørensen and Sondergaard, 2014; 
Zhang et al., 2003). The stronger 13C labeling in the ribityl side chain compared to the xylene 
ring as well as the heavy labeling of the C4 atom suggest that GTP or ATP were taken up from 
the yeast extract and incorporated into the vitamin. Thus, a maximum of 4 % 13C enrichment, 
i.e. the difference in labeling of the xylene ring and the ribityl side chain, could be attributed to 
nucleotides in the medium originating from yeast extract. Consequently, 8 % of 13C enrichment 
from 13C-labeled yeast extract at the C4 atom of riboflavin had to be attributed to a different 
origin. The 13C labeling could originate from 13CO2, which was produced during a 
decarboxylation reaction of a yeast extract compound. Considering the amount of 13C labeling 
(8 %) the more likely explanation would be that guanine or adenine, also present in yeast 
extracts (Zhang et al., 2003), was incorporated into riboflavin via the formation of GTP (Figure 
32). 
Yeast extract is a complex raw material that is often employed in large-scale industrial 
fermentation processes of various products. However, there are large lot-to-lot variations of a 
single yeast extract, not to mention differences between yeast extracts produced with different 
strains or on different media (Diederichs et al., 2014; Sørensen and Sondergaard, 2014). The 
recombinant production of immunoglobulin by S. cerevisiae was reported to be heavily 
dependent on a certain yeast extract (Zhang et al., 2003). Zhang et al. (2003) especially 
identified adenine as a ‘principle component’ in the yeast extract that had a great influence on 
production performance of the strain used. In total, yeast extract contributed about 8 % of 
carbon to riboflavin. Most metabolic engineering efforts for improved riboflavin production have 
focused on increasing the precursor supply of glycine (Monschau et al., 1998; Schlüpen et al., 
2003) and GTP (Jiménez et al., 2005; Jiménez et al., 2008; Ledesma-Amaro et al., 2015c; 
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Mateos et al., 2006), which are valuable components of yeast extract. In addition, the 
supplementation of culture media with hypoxanthine was reported to be beneficial for riboflavin 
production (Demain, 1972). Therefore, the yeast extract chosen for the production medium 
should be selected and screened carefully, since a nucleotide rich yeast extract would certainly 
be advantageous for an increased production performance. 
 
 
Figure 31: Experimental 13C enrichment of riboflavin produced by A. gossypii B2 on fully 13C-labeled 
yeast extract (A) and [13C5] glutamate (B) measured via 13C NMR. The initial naturally labeled medium 
was replaced by medium containing 13C-labeled yeast extract via centrifugation after 32 h of cultivation 
(A). The fully 13C-labeled glutamate replaced the naturally labeled glutamate in the medium at the 
beginning of a parallel experiment with otherwise naturally labeled medium compounds (B). Riboflavin 
was produced on complex medium with rapeseed oil and was harvested after 144 h. The circles of the 
riboflavin molecules depict carbon atoms. Colored circles denote the part of the riboflavin molecule 
under investigation. The colors purple and light blue in the bar charts represent the percentage 
originating from the respective 13C-labeled precursor, while the grey bars indicate origin from a different 
medium ingredient. Data denote values from three independent experiments with a mean standard 
deviation of 5 %. 
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Glutamate, which was also added to the medium in large amounts, was tested next as 13C 
tracer. It replaced the naturally labeled amino acid in the initial culture medium. The obtained 
13C NMR data of riboflavin revealed that glutamate – similarly to yeast extract – contributed 
13C labeling to almost all carbon atoms in riboflavin (Table 14, Figure 31B). Glutamate is not 
an immediate riboflavin precursor. However, GC/MS data of cell protein revealed a close 
connection between α-ketoglutarate and glutamate and due to that, glutamate contributes 
globally to the carbon core metabolism via the TCA cycle. Hence, there is also a strong de 
novo biosynthesis of glutamate, which diluted the 13C labeling of the intracellular pool. This 
resulted in only slight 13C enrichment of the respective carbon atoms of riboflavin: 3.1 %, 1.7 %, 
and 0.7 % on average for ribityl side chain, xylene ring, and pyrimidine ring, respectively 
(Figure 31B). Surprisingly, the ribityl side chain also exhibited about 2-fold more 13C enrichment 
than the xylene ring. Incorporation of labeled nucleotides could not explain that. So far 
unknown pathway activities might have resulted in the observed 13C enrichment pattern. 
 
For B. subtilis, the other industrially competitive riboflavin overproducer, glutamate addition 
has been reported for industrial media (Hohmann et al., 2011), unlike for riboflavin production 
with A. gossypii. Glutamate is metabolized by the cell and then slightly incorporated into the 
carbon backbone of riboflavin. Glutamate might be even more interesting when investigating 
the nitrogen metabolism of riboflavin: of the four nitrogen atoms, two come from glutamine, 
one from aspartate, and another one from glycine. Since the substitution of glutamate with 
glutamine led to decreased product titers (data not shown), glutamate probably resolves a 
potential bottleneck that cannot be eliminated by glutamine. 
 
 
Figure 32: Structures of riboflavin, guanosine triphosphate (GTP), and guanine. GTP shares nine of its 
ten carbon atoms with riboflavin. Guanine shares all five carbon atoms with GTP and four of those with 
riboflavin. The xylene ring (white circles in riboflavin) is the structurally exclusive unit only found in the 
vitamin compared to the other two compounds. Grey circles denote carbon atoms that are shared 
between GTP, guanine, and riboflavin. 
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4.6 Increasing production performance via time-resolved precursor feeding 
4.6.1 Extracellular formate ignites initial riboflavin overproduction 
As presented in the previous chapters, the only compounds contributing to the C1 pool in 
A. gossypii were yeast extract, serine, and formate. Glycine, however, did not function as C1 
donor. The combined contribution of the two medium ingredients yeast extract and formate to 
the C2 atom in riboflavin equaled 19.9 %. This included contribution from serine present in the 
yeast extract, as proven by additional serine supplementation to the medium and 13C NMR 
data of riboflavin. This left 80.1 % to another source fueling the one-carbon pool. In a tracer 
experiment with added [13C] formate, the labeling of the extracellular formate pool was 
significantly diluted over time (appendix Figure 42). This indicated the presence of substantial 
amounts of non-labeled intracellular formate, accumulating during riboflavin production and 
exchanging across the cell membrane with the extracellular pool. However, even when 13C 
NMR data of riboflavin were corrected for this dilution in input formate labeling, the combined 
contribution of yeast extract and extracellular formate only covered 25.8 % of the C2 atom in 
riboflavin. Endogenous formate is indeed formed as a by-product in the first step of riboflavin 
biosynthesis (Figure 3, Figure 4), nicely matching the observations. Therefore, in the labeling 
experiment with [13C] formate, the underlying biochemistry resulted in differently labeled 
intracellular and extracellular formate pools.  
 
4.6.1.1 Intracellular formate labeling is accessible from extracellular labeling data 
In order to quantify the labeling of the intracellular formate pool, extracellular 13C formate and 
riboflavin labeling information were combined. Extracellular formate was measured via 1H NMR 
as described in Chapter 3.4.4. Intracellular formate labeling had to be derived from the 
extracellular labeling and riboflavin labeling at carbon atom C2 from the precursors formate 
and yeast extract. Following considerations regarding intracellular 13C labeling of formate were 
made: 16.2 % 13C enrichment at the C2 of riboflavin originated from exogenous yeast extract, 
including serine, nucleotides, and nucleobases, taking into consideration the dilution of labeling 
in the culture supernatant due to naturally labeled pre-culture medium. Since serine in the 
yeast extract was not directly associated with riboflavin biosynthesis, intra- and extracellular 
labeling were assumed to be equilibrated. This left 83.8 % of positional enrichment to formate, 
whether endogenous or exogenous. The percentage of labeling at this carbon atom in 
riboflavin derived from extracellular formate added at 0 h was 3.7 % without taking into account 
dilution effects throughout the cultivation. Dilution of extracellular formate labeling started at 
the beginning of riboflavin biosynthesis as it is directly linked to it. Thus, with increasing 
riboflavin concentration, the amount of naturally labeled formate would increase and the 
degree of 13C dilution would increase in return. In order to now derive intracellular formate 
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labeling from extracellular formate labeling a linear correction function was applied. Assuming 
that during growth, formate production from unlabeled substrates was negligible (correction 
factor 1) and riboflavin biosynthesis is linear, the degree of dilution of labeling increased until 
the end of the cultivation (Figure 33). The value for the maximum correction factor was set as 
ratio between theoretical labeling from formate (83.8 %) and the experimental labeling from 
exogenous formate (3.7 %): 22.6. 
 
 
Figure 33: Function for the correction factor for estimation of intracellular 13C formate labeling from 
extracellular 13C enrichment of formate. Correction factor is constant during growth as it is assumed that 
only exogenous formate is fed into the metabolism. Once riboflavin production starts (after 36 h), formate 
synthesis from ribulose 5-phosphate begins in a linear manner giving rise to a linearly increasing 
correction factor. Depending on the point in time, extracellular 13C formate labeling is then divided by 
the corresponding factor. These data are then used in the model simulating the transmembrane flux 
(Figure 12, appendix Chapter 6.9). 
 
4.6.1.2 Formate labeling allows for transmembrane flux simulations 
Using a computational model, the data were used to simulate the transmembrane exchange 
flux of formate for different intervals during riboflavin biosynthesis (Figure 34). Formate was 
added at the beginning of the cultivation. During the first 36 h formate flux was directed into 
the cell with a net flux of 87 to 83 % (Figure 34A and Figure 34B). Nearly no formate was 
produced from the pentose 5-phosphate pool, since almost no riboflavin was formed during 
that period. The small amount of riboflavin that was synthesized was fed from a formate pool, 
which almost exclusively originated from exogenous formate. Within the next 12 h, more and 
more formate was released from the intracellular unlabeled carbon pool, giving rise to an 
increase in transmembrane formate exchange. As riboflavin biosynthesis progressed, formate 
derived from unlabeled carbon gained increasing importance, which is illustrated by the rising 
flux from the pentose 5-phosphate pool (583 % for 48 to 72 h and 1040 % for 72 to 96 h, Figure 
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34D and Figure 34E). Ultimately, this large flux from the unlabeled intracellular formate pool 
resulted in a net efflux of 334 % and subsequent accumulation of formate in the culture 
supernatant, which was confirmed by a final formate titer of 0.46 g L-1 in the culture broth (data 
not shown). The flux data showed that the initial biosynthetic phase of riboflavin heavily 
depends on exogenous formate. Availability of formate seemed a critical step in the early 
biosynthesis, however, during the later phase riboflavin production became independent from 
extracellular formate. 
 
As described for yeast, mainly S. cerevisiae, there are three donors for the folate-dependent 
C1 pool: formate, serine, and glycine (Piper et al., 2000), which enter C1 metabolism at different 
oxidation levels. In the set-up presented here, only yeast extract – containing serine, 
nucleotides, and nucleobases – and formate donated to one-carbon units in the cell and to the 
carbon atom C2 of riboflavin. Extracellular formate contributed 4 % to the C2 atom of riboflavin 
(Figure 30C, Table 14), whereas yeast extract contributed 16 % (Figure 31A, Table 14), 12 % 
of which probably stemmed from nucleotides and nucleobases with the remaining 4 % 
originating from serine. The inspection of all data, including the surprisingly heavy dilution of 
the 13C labeling of formate in the medium (appendix Figure 42), suggested that the intracellular 
formate pool is far less 13C-labeled and contributes the remaining 80 % of the C2 atom in 
riboflavin. Where does the non-labeled formate come from? Net formate synthesis is directly 
associated with riboflavin biosynthesis: ribulose 5-phosphate is converted to DHBP (Figure 3, 
Figure 4), which releases one formate, originating from the sugar moiety (Bacher et al., 1998). 
A second GTP-derived formate, transiently released during riboflavin biosynthesis (Bacher et 
al., 2000), already stems from the intracellular 10-CHO-THF pool and does not contribute 
likewise. In the given tracer set-up, the on-going riboflavin biosynthesis, thus, inherently 
accumulates increasing amounts of non-labeled formate, matching the NMR data. On this 
basis, ultimately yeast extract and formate remained as exclusive carbon-one donors. 
Simulation of transmembrane fluxes of formate unraveled a crucial contribution of exogenous 
formate availability to the riboflavin biosynthesis. In the early phase of production, extracellular 
formate displayed the dominant source of the carbon-one pool. The direction of flux was from 
the medium into the cell. In later phases, the biosynthetic pathway more and more provided its 
own one-carbon unit, which further supported riboflavin biosynthesis in an autocatalytic 
manner. Towards the end of the cultivation, the flux was reverted and exported excess formate.  
In S. cerevisiae formate transport across the membrane was described as proton-symport, 
which requires energy, as well as transporter independent diffusion of the protonated acid 
(Casal et al., 1996; Geertman et al., 2006). Most important, the obvious impact on the early 
production phase suggested to add formate to the medium formulation. 
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Figure 34: Transmembrane formate flux at different states of riboflavin production by A. gossypii B2. 
Cultures were grown on complex medium with [13C] formate. The 13C enrichment of extracellular formate 
(white diamonds) was measured using 1H NMR. Intracellular formate labeling (black diamonds) was 
derived from 1H NMR data of exogenous formate and 13C NMR data of riboflavin. Red arrows indicate 
the net transmembrane flux. Values in brackets indicate degree of reversibility. All fluxes are expressed 
as molar percentages of the corresponding specific formate uptake rate represented by the net flux of 
formate across the plasma membrane (A: 71.6 μmol g-1 h-1, B: 135.0 μmol g-1 h-1, C: 9.1 μmol g-1 h-1, D: 
0.1 μmol g-1 h-1, E: -0.9 μmol g-1 h-1,). The errors represent 90 % confidence intervals and were 
calculated by Monte-Carlo analysis. Gray boxes depict the time interval for the corresponding 
transmembrane flux distribution. All fluxes are given in percent. FA, fatty acids; FOREX, formate pool for 
metabolite balancing; FOREXTR, extracellular formate pool; FORP5P formate pool from ribulose 5-phosphate; FORRF, 
formate pool entering riboflavin as C1 unit; RF, riboflavin. 
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At this stage, it cannot be excluded that formate, beyond being a key carbon-one donor for 
riboflavin, also causes other, more indirect effects that stimulate product formation. As 
example, formate was reported to influence phosphorylation of the formate dehydrogenase 
(FDH) in yeast (Bykova et al., 2003). Further work will be needed to completely understand its 
role. Its impact, however, is without doubt. 
4.6.2 The C1 metabolism displays a bottleneck of initial riboflavin overproduction 
4.6.2.1 Formate specifically added during initial riboflavin production increased 
performance 
The flux simulations and labeling data from the previous chapters showed that extracellular 
formate has an impact on riboflavin biosynthesis, which is strongly time-dependent. Thus, the 
effect of time-resolved formate addition was assessed for that specific time frame in a series 
of experiments. Formate (2 g L-1, 30 mM) was added to the medium not at the beginning of 
cultivation, but after 12 h, 24 h, and 36 h, respectively (Figure 35A). The standard cultivation 
with formate in the initial medium served as control. Formate addition after 12 h resulted in a 
final riboflavin titer increase of 45 %. Feeding formate at a later point in time did not increase 
riboflavin titer significantly. These results underlined the formate flux data: availability of 
exogenous formate is important during an early phase of cultivation and is able to increase 
riboflavin concentration drastically, when fed at a very specific point during the cultivation. The 
formate concentration applied in this study was not found inhibitory, but growth was unaffected. 
Even when 60 mM formate (4 g L-1) were added (data not shown), growth was not impaired. 
 
4.6.2.2 Serine supplementation supports riboflavin production 
Data presented in the previous chapters demonstrated the dual role of serine: a one-carbon 
as well as a glycine donor. Replacement of glycine by serine led to a decreased final riboflavin 
concentration (data not shown) and was not profitable for the process. Here, the capacities of 
serine as C1 donor were investigated. Since the targeted formate addition successfully 
increased productivity of A. gossypii B2, the impact of serine was investigated in a similar 
manner. For that, formate was substituted by serine in the medium and serine was added in a 
time-resolved mode. Unlike formate, addition of serine at the very beginning of cultivation (0 h) 
was very effective as the final riboflavin titer could be increased again by 45 % compared to 
the standard cultivation (Figure 35B). Addition of serine after 12 h and 24 h was still beneficial 
with an increase of 33 % each. Regarding positive effects of formate and serine on riboflavin 
biosynthesis, both compounds shared the same trend: addition in the early cultivation phase 
was advantageous. Formate exhibited a narrow time optimum, whereas the positive influence 
of serine showed a broader range between 0 to 24 h. Selected experiments revealed that this 
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type of formate and serine supplementation was also advantageous for the A. gossypii WT 
(data not shown). 
Since the time specific addition of each of the C1 donors resulted in such a tremendous 
increase in riboflavin titer, the combined addition of the two donors was tested. For a medium, 
which contained formate, serine addition was most advantageous, when added after 36 h (data 
not shown). Thus, the final combinatorial set-up was cultivation on a medium with neither 
formate nor serine. After 12 h formate was added, followed by serine supplementation after 
36 h. This fine-tuned approach resulted in a final product titer increase of 56 % (data not 
shown). While this set-up boosted the production performance of the overproducing strain by 
another 11 %, feasibility of an industrial process relies on profit margins and the use of an 
additional medium component must be carefully considered with regard to substrate costs and 
product price. 
 
4.6.2.3 Improved performance relies on intracellular precursor availability 
As shown above, targeted addition of formate after 12 h of cultivation and substitution of 
formate with serine in the initial culture medium both led to improved product formation (Figure 
35). In order to gain a deeper understanding of the underlying mechanisms, intracellular 
concentrations of amino acids and formate were measured. A. gossypii was grown under three 
different conditions. This included a control (addition of formate to the initial medium) and the 
two identified optimal conditions: formate addition after 12 h, and substitution of initial formate 
with serine. Samples were taken throughout the riboflavin biosynthetic phase from 48 to 120 h 
and analyzed for the intracellular levels of the riboflavin precursors: glycine, serine, and 
formate (Figure 35C-E). Both improved production conditions exhibited a strongly enhanced 
intracellular formate pool after 48 h: 251 % and 120 % increase, respectively. Since the 
intracellular formate level increased throughout riboflavin production in the control condition, 
pool sizes of the different conditions were converging toward the later riboflavin phase (Figure 
35C). Regarding amino acid concentrations, addition of formate after 12 h had the most 
pronounced effects compared to the control. After 72 h, glycine and alanine concentrations 
were increased by 77.5 % and 65.7 %, respectively (Figure 35D and F). The difference in 
serine was even more remarkable: 167.8 μmol gCDW-1 (control: 37.8 μmol gCDW-1) (Figure 35E). 
Substitution of formate by serine only led to a few significant changes compared to the control: 
intracellular serine was 4.2-fold increased after 48 h with regards to the control (Figure 35E). 
In addition, glutamate and alanine concentrations were elevated after 48 h with 
144.9 μmol gCDW-1 and 15.0 μmol gCDW-1 (control: 112.3 μmol gCDW-1 and 12.2 μmol gCDW-1, 
respectively) (Figure 35F and G). Thus, intracellular availability of the three precursors 
(formate, serine, and glycine) played a crucial role in improved performance of riboflavin 
production.  
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Figure 35: Time-resolved addition of formate (A) and serine (B) to A. gossypii B2 cultures led to 
increased product titers. Formate was added at various points in time in parallel experiments and 
riboflavin titer was determined after 144 h. Formate added at 0 h served as control (light grey). Serine 
replaced formate in the medium and was added after different times during cultivation. Riboflavin titer 
was determined after 144 h and a culture with formate added at 0 h instead of serine was used as control 
(light grey). Intracellular metabolites were sampled at various points in time and were measured via 1H 
NMR (C) or HPLC (D-G) for three different conditions: control condition with formate added at 0 h (light 
grey), formate addition after 12 h (red), and substitution of formate with serine at 0 h (green). 
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Comparison of intracellular amino acid levels with different yeasts shows that while the 
glutamate pool is large in all strains, increased intracellular glycine and serine concentrations, 
with one exception, are unique to A. gossypii (Figure 36). Compared to S. cerevisiae, glycine 
is increased 3-fold (A. gossypiiC) or even 5-fold (A. gossypiiF12) (Bolten and Wittmann, 
2008).This emphasizes the importance of elevated intracellular glycine and serine pools for 
riboflavin overproduction. 
 
 
Figure 36: Comparison of intracellular amino acid concentrations in various yeast strains. Size of circle 
correlates with amino acid concentration in μmol gCDW-1. A. gossypii was grown on complex medium and 
vegetable oil as described above. Samples were taken after 48 h. The yeast strains were cultivated on 
minimal medium and glucose, which was supplemented with yeast extract and tryptone for all strains, 
but S. cerevisiae. A. gossypiiC, A. gossypii cultivated under standard conditions; A. gossypiiF12, 
A. gossypii cultivated on medium with formate addition after 12 h; A. gossypiiS0, A. gossypii cultivated 
on medium with substitution of initial formate by serine; S. cerevisiae, Saccharomyces cerevisiae; 
P. pastoris, Pichia pastoris; S. pombe, Schizosaccharomyces pombe (Bolten and Wittmann, 2008). 
 
Based on the 13C labeling data, formate and serine were identified as donors of the carbon-
one pool. Moreover, the studied producing strain made efficient use of extracellular formate 
during the early production phase, which indicated a potential limitation of the carbon-one pool 
inside the cells. These observations displayed a rational basis to improve the formation of the 
vitamin: the extra supply of carbon-one precursors in a way that enhances their intracellular 
availability specifically at the time point, when they were needed most. The time-resolved 
addition of formate obviously was a smart and easy way to reach that. Supplementation with 
about 2 g L-1 (30 mM) formate after 12 h boosted the riboflavin titer by 45 % (Figure 35A), 
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whereas initial and also later addition did not cause significant changes, nicely matching the 
ignition hypothesis. In a similar manner, also replacement of the initial formate by serine had 
a positive effect and led to substantial titer increase. The specific addition of the two nutrients 
resulted in increased intracellular pools of all three key precursors, i.e. glycine, serine, and 
formate, which can be regarded as highly beneficial for production performance (Figure 35). 
So far, both compounds have not been considered as part of production media, but glycine 
has largely been the major supplement (Sahm et al., 2013). There are different reports on the 
toxicity of formate in fungi or yeast. The minimum inhibitory concentrations vary depending on 
the process or the strain under investigation (Babel et al., 1983; Du et al., 2008; Lastauskienė 
et al., 2014). Here, formate was not found inhibitory. Hereby, the understanding of the 
molecular details required to add only a small amount at one specific time point, which was 
then quickly consumed. This might have been beneficial to avoid toxic effects. For industrial 
production, time-resolved supplementation seems easily applicable. Considering that 
riboflavin production with A. gossypii is already operated in fed-batch mode with a preceding 
batch phase (Schwechheimer et al., 2016), delayed formate addition appears straightforward. 
Addition of serine to the initial production medium could be realized instantly, however, 
economic feasibility of such a process also needs to be considered with respect to substrate 
availability and profit margins. 
4.7 The complete picture: riboflavin biosynthesis on vegetable oil 
Resolving the metabolic fluxes from various potential building blocks of a complex medium 
towards riboflavin biosynthesis is a challenging task. Pioneering labeling studies have focused 
on the addition of single tracer compounds to the cultivation, which were mostly done using 
glucose or other sugars as main carbon source (Bacher et al., 1998; Jeong et al., 2015; Plaut, 
1954a; Plaut, 1954b; Plaut and Broberg, 1956; Schlüpen et al., 2003). While this early work 
delivered important details about the biosynthetic pathway, the full picture was still missing. In 
this work, 13C labeling studies were embedded into a sophisticated framework of experimental 
design, multi-readout 13C labeling analysis by a combination of different MS and NMR 
techniques, and model-based data processing. This facilitated the use of a complex medium 
and rapeseed oil as a carbon source, which resembled industrial process conditions. The 
integrated rich data set now enabled the calculation of a metabolic flux map, comprising the 
respective contributions of single medium ingredients to riboflavin in this environment (Figure 
37). A specific approach for data processing and carbon balancing was chosen to finally derive 
the flux distribution. Different from conventional flux studies on only one substrate, with precise 
molecular fluxes (Kohlstedt et al., 2014; Lange et al., 2017), this work had to consider the 
positional contribution of individual precursors to specific parts or even single carbon atoms of 
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the riboflavin molecule. That is, why the flux estimation here was taken to the level of single 
carbon atoms, and fluxes were split into fluxes from individual carbon atoms of nutrients, which 
converged within the metabolism to form molecules or parts of the vitamin. This perfectly 
matched the type of labeling information, i.e. positional 13C enrichment that was available to 
great detail from the conducted labeling studies. The positional 13C enrichments of the single 
tracer experiments (Table 14) were integrated with the pathway stoichiometry. In addition, 
carbon balancing was applied. The assumption of steady-state, required for this approach, 
appeared justified, considering that the change of intracellular metabolite pools was small 
compared to fluxes through those pools, similar to a previous approach (Krömer et al., 2004). 
Together this rendered a flux distribution based on single carbon atoms (Figure 37). Therefore, 
the flux into a single carbon atom was set to 1. Likewise, the flux into riboflavin equaled 17, 
since the vitamin contains seventeen carbon atoms and the flux of e.g. GTP, a ten-carbon 
molecule, toward riboflavin biosynthesis corresponded to the value 10. Accordingly, fluxes 
between other metabolites were based on the sum of the fluxes of their carbon atoms and 
additionally, considering the 13C labeling from the respective 13C tracers. For each carbon atom 
of riboflavin, the metabolic precursor was determined (Figure 45, Figure 46, Figure 47). The 
way, in which the individual medium ingredients, e.g. yeast extract, would contribute to that 
metabolic precursor was evaluated and for each case, the entry point into the metabolism was 
chosen based on literature (Bacher et al., 1998; Plaut, 1954a; Plaut, 1954b; Plaut and Broberg, 
1956) as well as data obtained in this study (Table 14). As an example, the C4a atom of 
riboflavin is derived from intracellular glycine (Figure 45) (Plaut, 1954a). In the presented set-
up, glycine could originate from extracellular glycine, which was supplemented to the medium, 
glycine from yeast extract, but also serine from yeast extract, adenine/guanine and ATP/GTP 
from yeast extract or from rapeseed oil, via 3-phosphoglycerate and serine (appendix Chapter 
6.10, Figure 45). Thus, the glycine unit of riboflavin could be derived from three different 
medium compounds, i.e. glycine, vegetable oil, and yeast extract, and four different 
metabolites, i.e. glycine, serine, adenine/guanine, or ATP/GTP. Adenine/guanine as well as 
ATP/GTP are treated as one group, respectively, since the data did not allow a distinction 
between the individual compounds. Analogous considerations were made for every carbon 
atom and fluxes were calculated accordingly (Chapter 6.10). 
 
The full picture of carbon contribution to riboflavin in its biosynthetic phase is depicted in Figure 
37. It is important to note that only the carbon assimilation reactions directly fueling riboflavin 
biosynthesis are considered for this approach. While the single carbon fluxes in Figure 37 are 
expressed as single carbon atoms based on calculations as described in the appendix 
(Chapter 6.10), these fluxes were then converted into molar fluxes: first, each flux was divided 
by the number of carbon atoms of the respective metabolite, then, the flux into riboflavin was 
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set to 100 % and represented the specific riboflavin production rate (8.7 μmol g-1 h-1 
± 2.3 μmol g-1 h-1). Subsequently, all other fluxes were normalized to that flux into riboflavin. 
The resulting relative carbon fluxes are given in Figure 38. Rapeseed oil was cleaved via the 
extracellular lipase into one mole glycerol and three moles fatty acids (Stahmann et al., 1994). 
A high flux through the ß-oxidation pathway (1160 %) and the glyoxylate shunt (580 %) could 
be observed. Acetyl-CoA generated in the ß-oxidation pathway was then converted into malate 
through the glyoxylate shunt in order to enter gluconeogenesis and subsequently serve as 
carbon donor from vegetable oil for riboflavin. Therefore, all carbon in riboflavin that was 
derived from rapeseed oil, was assimilated via the glyoxylate shunt. Glutamate most likely 
entered the metabolism through α-ketoglutarate with a flux of 12 %, which resulted in a 
comparably low flux from α-ketoglutarate to oxaloacetate (12 %). A flux of 592 % was directed 
through the lower gluconeogenic pathway. Here, the map representing single carbon atoms 
(Figure 37), highlights the loss of carbon (5.9) via decarboxylation of the OAA/malate pool to 
the PEP/pyruvate pool. The assembly of two three-carbon units to one six-carbon molecule 
resulted in a decreased flux (288 %) in the upper gluconeogenesis (Figure 38). Another 
decarboxylation reaction resulted in loss of carbon upon entry into the PP pathway (2.88) 
(Figure 37). The carbon flux of 288 % was split at ribulose 5-phosphate, an immediate 
precursor of riboflavin. The exact pathway used to synthesize this pool, gluconeogenesis or 
PP pathway, could not be distinguished by this approach. The combined carbon flux from 
ribulose 5-phosphate pool, which contributes eight carbon atoms in total to riboflavin, towards 
riboflavin was 200 %, with a corresponding carbon flux towards the intracellular formate pool 
of 100 % each. The second branch from ribulose 5-phosphate was directed into purine 
biosynthesis (96 %). The flux through the complete de novo biosynthesis of purines (GTP pool) 
equaled 88 %. Throughout that pathway, one-carbon units as well as carbon dioxide and 
glycine were incorporated into the final GTP molecule. Nucleotides from yeast extract (ATP or 
GTP) donated another 4 % to that pool. However, 13C labeling data also suggested that 
adenine or guanine from the supplemented yeast extract together with ribose 5-phosphate 
contributed 8 % to the GTP pool of riboflavin (Figure 38). The carbon flux distribution highlights 
the dominant role of vegetable oil in riboflavin biosynthesis. Indeed, the overall flux of rapeseed 
oil into riboflavin equaled 13.8 carbon atoms (81 % of the molecule). However, the contribution 
of other medium ingredients to riboflavin, especially to the pyrimidine ring, was as high as 
19 %. This especially included glycine and C1 donors. As shown in the previous chapter, 
overcoming a limitation in the one-carbon pool, which makes up only 6 % (1 carbon atom) of 
the vitamin, can have a great impact on product titers. Consequently, the knowledge gained in 
such 13C tracer studies conveys a valuable starting point for rational strain engineering as well 
as carefully designed process control. 
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Figure 37: Carbon contribution of medium ingredients to riboflavin based on combined parallel 13C-
labeled tracer studies using [13C2] glycine, [13C] formate, [13C5] glutamate, and [U13C] yeast extract. 
Riboflavin was synthesized by A. gossypii B2 grown on complex medium with rapeseed oil. Riboflavin 
was obtained at the end of the growth phase of riboflavin producing A. gossypii after 144 h. Data are 
derived from positional 13C enrichment obtained from 13C NMR measurements (Table 14), corrected for 
natural labeling and dilution effects through unlabeled pre-culture medium. Values denote carbon atoms 
and are normalized to 17 carbon atom influx into riboflavin. All values were multiplied by the number of 
carbon atoms of the reactants. The arrow thickness is proportional to the corresponding flux. The 
direction of net fluxes is indicated by size of arrow head. Note that the model is simplified and cannot 
distinguish between carbon flux through e.g. gluconeogenesis or lower PP pathway as well as pyruvate 
dehydrogenase. Reaction between OAA/MAL and PEP/PYR pool is a lumped flux. Only reactions 
necessary for riboflavin biosynthesis were considered and all reactions represent net fluxes. Note that 
the conversion of citrate to isocitrate via aconitase most likely does not occur in the peroxisome 
(Murakami and Yoshino, 1997). 3PG, 3-phosphoplycerate; AcCoAP/M, peroxisomal/mitochondrial acetyl-CoA; 
AKG, α-ketoglutarate; ArP, 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione; CH2-THF, 5,10-
methylenetetrahydrofolate; CHO-THF, 10-formyltetrahydrofolate; FA, fatty acids (here: three C17.3 FA); FOR, 
formate; GAR, glycineamide ribonucleotide; GLU, glutamate; GLY, glycine; GLYINTR, intracellular glycine pool; GTP, 
guanosine triphosphate; PRA, 5-phosphoribosylamine; PYR, pyruvate; R5P, ribose 5-phosphate; Ru5P, ribulose 5-
phosphate; RFV, riboflavin stored in the vacuole; SER, serine; THF, tetrahydrofolate; YE, yeast extract. 
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The fluxes presented here (Figure 37, Figure 38), considered riboflavin biosynthetic reactions 
and were based on 13C labeling information obtained through 13C NMR analyses. All other 
reactions regarding the metabolism such as maintenance could not be captured. Keeping that 
in mind, the fact that 23.2 carbon atoms from vegetable oil have to be assimilated in the 
glyoxylate shunt in order to obtain 14.4 carbon atoms for riboflavin biosynthesis in the PP 
pathway illustrates the extent to which carbon is lost to carbon dioxide (Figure 37). This can 
be expressed by the biosynthetic efficiency of riboflavin production under the given conditions, 
which is based on stoichiometry and equals 73 % with regard to rapeseed oil and 60 % 
regarding all carbon sources, i.e. oil, yeast extract, glycine, glutamate, and formate. Thus, 
73 % of all oil-derived carbon needed for riboflavin biosynthesis actually ended up in the 
vitamin itself, the rest mainly lost to decarboxylation. The basic biosynthetic efficiency for 
riboflavin biosynthesis from vegetable oil is 61 %, which means that all carbon needed for 
riboflavin biosynthesis is derived from vegetable oil and riboflavin is, therefore, fully de novo 
synthesized. The efficiency calculated for riboflavin with regard to oil for the set-up presented 
here is increased by the factor 1.2, therefore indicating that not only rapeseed oil is used for 
the formation of the vitamin. This was obviously shown through the combination of extensive 
13C tracer experiments. The maximum biosynthetic efficiency, i.e. the assembly of riboflavin 
from the medium-derived compounds GTP and pentoses, equals 85 %. Even though, yeast-
extract based substrates as well as supplemented glycine were also incorporated into 
riboflavin under the given conditions, the overall biosynthetic efficiency is minimal (60 %). This 
is in part due to decarboxylation, however, also the inefficient use of glycine (potential storage 
in vacuole or degradation in the metabolism) (Messenguy et al., 1980; Schlüpen et al., 2003) 
as well as production of formate during riboflavin biosynthesis as previously shown (Chapter 
4.6) result in loss of carbon.  
 
The overall yield for riboflavin biosynthesis on oil was 0.28 molRF molOil-1 (Table 6). The 
conversion of the molar yield into a C-molar yield rendered 0.09 C-molRF C-molOil-1, i.e. 9 %. 
Therefore, 91 % of carbon from rapeseed oil, which was taken up by the cell, did not contribute 
to riboflavin biosynthesis. Cells were stationary during riboflavin biosynthesis (Figure 13A) and 
conversely, significant growth or accumulation of intracellular storage lipids could also be ruled 
out as carbon consuming reaction. Since no significant by-products could be measured, the 
carbon that was still taken up during the production phase, i.e. fatty acids and glutamate 
amongst others (Figure 13), was likely also decarboxylated via a highly active TCA cycle, as 
shown for the growth phase of A. gossypii on oil (Figure 27). Yet, the question remains, why 
the TCA cycle is so active. During growth, most cellular building blocks were taken up from the 
medium, thus resulting in a low ATP demand (Figure 27). During riboflavin biosynthesis, 9-fold 
more oil-based carbon was taken up than was used for the product. Little is known about the 
RESULTS AND DISCUSSION 
103 
 
TCA cycle activity of riboflavin producing A. gossypii on vegetable oil or pathway activity of 
other microorganisms on oil as a substrate. It was shown that A. gossypii accumulates 
intracellular trans-aconitate during growth (Sugimoto et al., 2014). This known inhibitor of the 
enzyme aconitase, which catalyzes the conversion of citrate to isocitrate via the intermediate 
cis-aconitate, is apparently formed spontaneously from cis-aconitate (Sugimoto et al., 2014). 
During the riboflavin production phase, expression levels of another enzyme, trans-aconitate 
3-methyltransferase, were increased nearly 3-fold compared to the growth phase. Through 
methylation of trans-aconitate, this enzyme relieved the inhibition of the TCA cycle enzyme 
aconitase and consequently, enabled an increased flux through the TCA cycle as well as the 
glyoxylate shunt (Sugimoto et al., 2014). In a study with mice that were put on a high-fat diet, 
liver metabolism was investigated (Satapati et al., 2012). The consequences of the fatty diet 
were increasing hepatic insulin resistance due to the lipid overload, but also an increased TCA 
cycle as well as elevated gluconeogenesis. The increased flux through the TCA cycle possibly 
compensated for an inefficiently coupled oxygen consumption and ATP synthesis, i.e. a 
dysfunctional mitochondrial respiration. The authors also observed the production of reactive 
oxygen species, thereby linking the induction of a highly active TCA cycle to oxidative stress 
(Satapati et al., 2012). Indeed, mitochondria produce reactive oxygen species when e.g. the 
NADH pool is reduced as a result of low ATP demand (Murphy, 2009). This is especially 
interesting, because riboflavin biosynthesis in A. gossypii is associated with oxidative stress 
(Kavitha and Chandra, 2009; Kavitha and Chandra, 2014). These studies provide evidence for 
an increased TCA cycle flux during growth on lipid-rich media, which might also apply for 
A. gossypii. However, while these connections offer interesting starting points for a deeper 
assessment of the underlying mechanisms, further work will undoubtedly be needed to resolve 
the fine structures of riboflavin biosynthesis with A. gossypii on rapeseed oil. 
 
As shown, the combined analysis of parallel 13C tracer experiment allowed the calculation of a 
carbon flux distribution for riboflavin producing A. gossypii. In a complex cultivation set-up, 
containing rapeseed oil and yeast extract, in addition to other supplements, the contribution of 
each medium ingredient to riboflavin could be quantified precisely. The data showed that while 
yeast extract was the main carbon source for growth (Figure 23), its impact on riboflavin 
biosynthesis was still significant with an overall contribution of 8 %. In addition, glycine as two-
carbon unit, which is readily incorporated into the vitamin, also made up 8.5 % of the product. 
By far the greatest impact had rapeseed oil (81 %), which is also described as superior carbon 
source compared to glucose (Demain, 1972). 
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Figure 38: Intracellular carbon fluxes of riboflavin production with A. gossypii B2 on rapeseed oil and complex 
medium, which were determined by four parallel 13C-labeled tracer studies using [13C2] glycine, [13C] formate, 
[13C5] glutamate, and [U13C] yeast extract. The carbon fluxes were normalized to the specific riboflavin production 
rate (8.7 μmol g-1 h-1 ± 2.3 μmol g-1 h-1), which was set to 100 %. Riboflavin was obtained at the end of the growth 
phase of riboflavin producing A. gossypii after 144 h. Data are derived from positional 13C enrichment obtained from 
13C NMR measurements (Table 14), corrected for natural labeling and dilution effects through unlabeled pre-culture 
medium. Note that the model is simplified and cannot distinguish between carbon flux through e.g. gluconeogenesis 
or lower PP pathway as well as pyruvate dehydrogenase. The arrow thickness is proportional to the corresponding 
flux. The direction of net fluxes is indicated by size of arrow head. Reaction between OAA/MAL and PEP/PYR pool 
is a lumped flux. Only reactions necessary for riboflavin biosynthesis were considered and all reactions represent 
net fluxes. Note that some reactions as shown in Figure 37 can be expressed as a single reaction, i.e. all 
decarboxylation reactions and in general all reactions with more than one educt or product can be expressed as a 
single flux. All fluxes from the medium into the cell are not fluxes based on concentrations, but solely derived from 
13C labeling of riboflavin. Note that the conversion of citrate to isocitrate via aconitase most likely does not occur in 
the peroxisome (Murakami and Yoshino, 1997). 3PG, 3-phosphoplycerate; AcCoAP/M, peroxisomal/mitochondrial 
acetyl-CoA; AKG, α-ketoglutarate; ArP, 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione; DRL, 6,7-dimethyl-8-
ribityllumazine; CH2-THF, 5,10-methylenetetrahydrofolate; CHO-THF, 10-formyltetrahydrofolate; FA, fatty acids 
(here: three C17.3 FA); FOR, formate; GAR, glycineamide ribonucleotide; GLU, glutamate; GLY, glycine; GLYINTR, 
intracellular glycine pool; GTP, guanosine triphosphate; PRA, 5-phosphoribosylamine; PYR, pyruvate; R5P, ribose 
5-phosphate; Ru5P, ribulose 5-phosphate; RFV, riboflavin stored in the vacuole; SER, serine; THF, tetrahydrofolate; 
YE, yeast extract. 
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5 CONCLUSION AND OUTLOOK 
The industrial production of riboflavin is one of the great success stories in biotechnology and 
metabolic engineering (Revuelta et al., 2016). Within just a few years, fermentative synthesis 
completely replaced the more than 50-year old chemical synthesis of this vitamin 
(Schwechheimer et al., 2016). However, in order to keep up with constantly increasing market 
demands, continuous improvement of production strains and process conditions is 
fundamental. 
 
In this work, growth and production behavior of riboflavin producing wild type A. gossypii WT 
and overproducing mutant A. gossypii B2 were investigated on different substrates with the 
combined use of GC/MS, LC/MS as well as NMR. Pioneering work on A. gossypii and riboflavin 
metabolism were only feasible on glucose or ethanol as main carbon source (Bacher et al., 
1998; de Graaf et al., 2000; Jeong et al., 2015; Plaut, 1954a; Plaut, 1954b; Plaut and Broberg, 
1956; Schlüpen et al., 2003). For the first time, the results presented here gave an insight into 
the metabolism of the fungus under industrially relevant conditions (Sahm et al., 2013), which 
uses a complex medium with vegetable oil as main carbon source, supplemented with yeast 
extract and glycine. 
 
A detailed analysis of carbon fluxes during growth and riboflavin production in a very complex 
cultivation set-up using A. gossypii was presented in this work. The ubiquitous industrial 
medium ingredient yeast extract was 13C-labeled for the first time and thus, its impact on the 
metabolism studied in greater detail. Yeast extract could be identified as the main carbon 
source during growth, while rapeseed oil was the main carbon source during riboflavin 
production. However, the 13C labeling data and resulting carbon fluxes demonstrated that yeast 
extract also contributed a significant amount of carbon to the product. Other industrial 
processes also rely heavily on yeast extract as complex nitrogen source (Papagianni, 2004; 
Zhang et al., 2003). The commercial production of L-lysine with bacteria uses yeast extract as 
medium ingredient (Kojima et al., 2000) as well as the antibiotics fermentation with filamentous 
fungi (Papagianni, 2004; Posch et al., 2012). Bacillus thuringiensis is industrially employed as 
insecticide producer, a process which depends on complex compounds such as corn steep 
liquor or soybean meal. Since those ingredients might not be readily available at every 
production site, yeast extract was tested as alternative complex nutrient (Saksinchai et al., 
2001). These studies highlight the importance of complex media for industrial fermentation 
processes and the need for a more sophisticated experimental set-up in order to study and 
improve such systems in great detail. The 13C labeling approach presented here, provides an 
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excellent and promising starting point for the improvement of other microbial processes under 
complex and commercial cultivation conditions. 
 
Regarding riboflavin biosynthesis with A. gossypii there are still several issues that need to be 
investigated further. As presented in this work, intracellular availability of riboflavin precursors 
is crucial. Along with that intracellular localization of metabolites clearly has an effect on 
productivity. Regarding A. gossypii, little is known about the exact transport mechanisms for 
amino acids or formate, whether transport across the plasma membrane or transport in and 
out of the vacuole are concerned. A. gossypii and S. cerevisiae were reported to store large 
amounts of glycine in their vacuole (Förster et al., 1998; Messenguy et al., 1980), thus making 
it inaccessible for riboflavin production. Here, fine-tuned transport systems might overcome 
this limitation. Disruption of vacuolar transport of riboflavin successfully increased product titers 
(Förster et al., 1999), but the transport mechanism across the plasma membrane still needs to 
be elucidated. Recently, new bacterial riboflavin transporters have been identified and 
characterized (Gutiérrez-Preciado et al., 2015), however, the process and regulation of 
riboflavin secretion into the culture medium still needs to be further investigated. 
 
The results presented here, identified glutamate as a key player in the metabolism, however, 
it only slightly contributed to biomass and riboflavin. With regard to the four nitrogen atoms 
present in riboflavin, it would be very interesting to resolve the underlying metabolism. Urea, 
which was present in the medium in large amounts, certainly also feeds the intracellular 
nitrogen pool. In light of environmental awareness and hazards, optimization of producing 
strains to use second and third generation raw materials might be of great research interest. 
As example, A. gossypii is able to utilize waste activated bleaching earth, a waste disposal of 
vegetable oil manufacturers. Riboflavin titers of 1 to 2 g L-1 were reported for A. gossypii using 
these solid waste substrates compared to rapeseed or palm oil (Ming et al., 2003; Park et al., 
2004; Park and Ming, 2004).  
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6 APPENDIX 
6.1 Abbreviations 
 
(10-)CHO-THF 10-Formyltetrahydrofolate 
(5,10-)CH2-THF 5,10-Methylenetetrahydrofolate 
3PG 3-Phosphoglycerate 
AAT Gene encoding aspartate transaminase 
Ac Acetate 
ACES N-(2-Acetamido)-2-aminoethanesulfonic acid 
Acetal Acetaldehyde 
Acetyl-CoA/AcCoA Acetyl coenzyme A 
acs Gene encoding acetyl-CoA-synthetase 
ADE1 Gene encoding phosphoribosylaminoimidazole-succinocarboxamide synthase 
ADE12 Gene encoding adenylosuccinate synthase 
ADE4 Gene encoding PRPP amidotransferase 
ADY2 Gene encoding potential acetate transporter 
AGX1 Gene encoding alanine-glyoxylate aminotransferase 
Ala Alanine 
ALT1/2 Gene encoding alanine transaminase 1/2 
AMP Adenosine monophosphate 
Arg Arginine 
ArP 5-Amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione 
ArPP 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione 5-phosphate 
Asp Aspartic acid 
ATCC American type culture collection 
ATP Adenosine triphosphate 
BAS1 Gene encoding Myb-related transcription factor 
BSTFA N,O-Bis-trimethylsilyl-trifluoroacetamide 
cAMP Cyclic adenosine monophosphate 
ccpn Gene encoding transcriptional regulator of gapB and pckA 
CDW Cell dry weight 
Cit Citric acid 
CTP Cytidine triphosphate 
cyd Gene encoding cytochrome bd oxidase 
DAK1/2 Genes encoding dihydroxyacetone kinase 1/2 
DArPP 2,5-Diamino-6-ribitylamino-pyrimidinone 
DARPP 2,5-Diamino-6-ribosylamino-4(3H)-pyrimidinone 
dATP Deoxyadenosine triphosphate 
dCTP Deoxycytidine triphosphate 
dGTP Deoxyguanosine triphosphate 
DHAP Dihydroxyacetone phosphate 
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DHBP 3,4-Dihydroxy-2-butanone 4-phosphate 
DMF Dimethylformamide 
DRL 6,7-Dimethyl-8-ribityllumazine 
dTTP Deoxythymidine triphosphate 
E4P Erythrose 4-phosphate 
eda Gene encoding multifunctional 2-keto-3-deoxygluconate 6-phosphate aldolase and 
2-keto-4-hydroxyglutarate aldolase and oxaloacetate decarboxylase 
edd Gene encoding phosphogluconate dehydratase 
EMU Elementary mode units 
F6P Fructose 6-phosphae 
FA Fatty acid 
FAD Flavin adenine dinucleotide 
fbp Gene encoding fructose-1,6-bisphosphatase 
FID Free induction decay 
FMN Flavin mononucleotide 
For Formic acid 
G3P Glyceraldehyde 3-phosphate 
G6P Glucose 6-phosphate 
GAP1 Gene encoding general amino acid permease 
gapB Gene encoding glyceraldehyde-3-phosphate dehydrogenase 
GAR Glycineamide ribonucleotide 
GC/MS Gas chromatography/mass spectrometry 
GCS Glycine cleavage system 
gdh Gene encoding glucose dehydrogenase 
GDH1/3 Gene encoding NADP-dependent glutamate dehydrogenase 1/3 
GDH2 Gene encoding NAD-dependent glutamate dehydrogenase 
Glc Glucose 
Glu Glutamic acid 
Gly Glycine 
GLY1 Gene encoding threonine aldolase 
Glyc Glycerol 
Glyox Glyoxylate 
GMP Guanosine monophosphate 
gnd Gene encoding 6-phosphogluconate dehydrogenase 
GTP Guanosine triphosphate 
Gua Guanine 
guaA Gene encoding GMP synthase 
guaB Gene encoding IMP dehydrogenase 
GUT1 Gene encoding glycerol kinase  
GUT2 Gene encoding FAD-dependent glycerol 3-phosphate dehydrogenase 
HCl Hydrogen chloride 
His Histidine 
HPLC High performance liquid chromatography 
HXT Genes encoding hexose transporters 
Icit Isocitric acid 
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ICL Isocitrate lyase 
IDH Isocitrate dehydrogenase 
Ile Isoleucine 
IMP Inosine monophosphate 
IMPDH Gene encoding IMP dehydrogenase 
JEN1 Gene encoding an acetate permease 
KEGG Kyoto Encyclopedia of Genes and Genomes 
LC/MS Liquid chromatography/mass spectrometry 
Leu Leucine 
Lys Lysine 
MaE Malic enzyme 
Mal Malate 
MBDSTFA N-Methyl-N-tert-butyl-dimethylsilyl-trifluoroacetamide 
MFA Metabolic flux analysis 
MFS Major facilitator superfamily 
MID Mass isotopomer distribution 
MLS1 Gene encoding malate synthase 
MOPS 3-(N-Morpholino)propanesulfonic acid 
NAD/NADH Nicotinamide adenine dinucleotide ox/red 
NADP/NADPH Nicotinamide adenine dinucleotide phosphate ox/red 
NaOH Sodium hydroxide 
NMR Nuclear magnetic resonance 
OAA Oxaloacetic acid 
OMP Orotidine monophosphate 
P5P Pentose 5-phosphate 
PEP Phosphoenolpyruvate 
pgi Gene encoding glucose-6-phosphate isomerase 
pgl Gene encoding 6-phosphogluconolactonase 
Phe Phenylalanine 
PP pathway Pentose phosphate pathway 
PRA 5-Phosphoribosylamine 
Pro Proline 
PRPP Phosphoribosylpyrophosphate 
PRS Gene encoding PRPP synthetase 
PTS Phosphotransferase system 
purA Gene encoding adenylosuccinate synthetase 
purD Gene encoding phosphoribosylglycinamide synthetase 
purF Gene encoding glutamine phosphoribosylpyrophosphate amidotransferase 
purH Gene encoding phosphoribosylaminoimidazole carboxy formylformyltransferase/IMP 
cyclohydrolase 
purM Gene encoding phosphoribosylaminoimidazole synthetase 
purN Gene encoding phosphoribosylglycinamide formyltransferase 
purR Gene encoding transcriptional repressor of pur operon 
Pyr Pyruvate 
R5P Ribose 5-phosphate 
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RF Riboflavin 
RIB1 Gene encoding GTP cyclohydrolase II 
RIB2 Gene encoding DArPP deaminase 
RIB3 Gene encoding DHBP synthase 
RIB4 Gene encoding lumazine synthase 
RIB5 Gene encoding riboflavin synthase 
RIB7 Gene encoding DARPP reductase 
ribA Gene encoding GTP cyclohydrolase II and DHBP synthase 
ribC Trans-acting regulator of the rib operon 
ribF Gene encoding riboflavin kinase 
ribG Gene encoding DARPP reductase and DArPP deaminase 
ribGBAHT rib operon 
ribR Regulatory gene of rib operon 
rpm Revolutions per minute 
RQ Respiration quotient 
Ru5P Ribulose 5-phosphate 
S7P Sedoheptulose 7-phosphate 
SCO Single cell oil 
SEP 3-Phosphoserine 
Ser Serine 
SFL Summed fractional labeling 
SHM Gene encoding serine hydroxymethyltransferase 
SHMT Serine hydroxymethyltransferase 
sigH Gene encoding sigma factor H 
SIM Selective ion monitoring 
SP Sporulation 
Sug Sugar 
TBDMS tert-Butyl-dimethylsilyl 
TCA cycle Tricarboxylic acid cycle 
THF Tetrahydrofolate 
Thr Threonine 
TMS Trimethylsilyl 
TSP-d4 2-(Trimethylsilyl)propionic-2,2,3,3-d4 acid  
Tyr Tyrosine 
UK United Kingdom 
UMP Uridine monophosphate 
URA3 Gene encoding orotidine-5-phosphate decarboxylase 
US(A) United States (of America) 
UTP Uridine triphosphate 
UV Ultraviolet 
Val Valine 
VMA1 Gene encoding vacuolar ATPase subunit A 
X Biomass 
XMP Xanthosine monophosphate 
Xu5P Xylulose 5-phosphate 
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YAP1 Gene encoding transcriptional regulator 
YE Yeast extract 
ywlF Gene encoding ribose-5-phosphate isomerase 
 
 
6.2 Symbols 
 
%13C Positional 13C enrichment of a carbon atom [%] 
[RF] Riboflavin concentration [g L-1] 
μ Specific growth rate [h-1] 
c Concentration [g L-1] or [mol L-1] 
m Mass [g] 
m/z Mass-to-charge ratio [-] 
P Purity of a 13C tracer [%] 
qP Specific product formation rate [μmol g-1 h-1] 
QP Volumetric product formation rate [μmol L-1 h-1] 
qS Specific substrate uptake rate [mmol g-1 h-1] 
T Temperature [°C] 
t Time [h] 
v Flux [%] or [mmol g-1 h-1] or [Carbon atom] 
YP/S Product yield [mol mol-1] 
YX/S Biomass yield [g mol-1] 
ζ Flux reversibility [-] 
λ Wavelenght [nm] 
ΨTR Contribution of a 13C tracer to a target molecule [%] 
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6.3 Isotope experiments conducted in this study 
Table 15: Overview of 13C tracer studies performed in this work. Time point refers to the tracer addition. 
All cultivations were carried out in complex medium and glucose (No. 1, 2), glycerol:acetate (No. 3-5) or 
rapeseed oil (No. 6-16) as carbon source. 
No. Tracer Time point [h] Strain Reference 
1 [13C6] Glucose 0 WT Chapter 4.2 
2 [13C6] Glucose 0 B2 Chapter 4.2 
3 [13C3] Glycerol 0 WT Chapter 4.3 
4 [13C2] Sodium acetate 0 B2 Chapter 4.3 
5 [13C3] Glycerol 0 WT Chapter 4.3 
6 [13C2] Sodium acetate 0 B2 Chapter 4.3 
7 [13C2] Glycine 0 B2 Chapters 4.4, 4.5 
8 [13C3] Serine 0 B2 Chapters 4.4, 4.5 
9 [13C3] Serine 48 B2 Chapter 4.5 
10 [3-13C] Serine 0 B2 Chapter 4.5 
11 [3-13C] Serine 48 B2 Chapter 4.5 
12 [13C] Sodium formate 0 B2 Chapters 4.4, 4.5 
13 [13C] Sodium formate 48 B2 Chapter 4.5 
14 [U13C] Yeast extract 0 – 32a B2 Chapter 4.4 
15 [U13C] Yeast extract 32 – 144b B2 Chapters 4.5 
16 [13C5] Glutamic acid 0 B2 Chapters 4.4, 4.5 
17 [U13C] Yeast extract, 
[13C2] glycine, 
[13C5] glutamic acid, 
[13C] sodium formate 
0 B2 Chapters 4.4, 4.5 
a Medium was exchanged with naturally labeled medium after 32 h 
b Naturally labeled medium was exchanged with [U13C] yeast extract containing medium after 32 h 
6.4 Data from GC/MS analyses 
Ala Gly Val Leu Ile Pro Ser Thr Phe Asp Glu Lys Arg Tyr His
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Figure 39: Summed fractional labeling (SFL) derived from GC/MS measurements of the culture 
supernatant of A. gossypii B2 cells grown on complex medium with [U13C] yeast extract, [13C2] glycine, 
[13C] formate, and [13C5] glutamate in a single experiment. Labeling data derived from that cultivation 
are depicted in dark grey while the light grey bars indicate the resulting contribution of non-labeled pre-
culture medium to the supernatant. Data were obtained from three individual replicates and denote mean 
values with a mean standard deviation of 5 %. 
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Table 16: Relative mass isotopomer fractions of amino acids from hydrolyzed cell protein of A. gossypii 
WT and B2 grown on naturally labeled complex medium and 99 % [13C6] glucose, [13C2] acetate, or 
[13C3] glycerol. Data denote corrected labeling patterns. Data were corrected for fraction of unlabeled 
biomass in the inoculum as well as occurrence of natural isotopes. The mass isotopomer M+0 
represents the relative amount of non-labeled, M+1 the amount of singly-labeled mass isotopomer 
fraction and so on. Data were obtained from three individual replicates. 
   WT   B2  
Analyte  [13C6] Glc [13C2] Ac [13C3] Glyc [13C6] Glc [13C2] Ac [13C3] Glyc 
Ala_260 M+0 0.40 ± 0.02 0.77 ± 0.05 0.72 ± 0.04 0.36 ± 0.02 0.75 ± 0.07 0.84 ± 0.06 
 M+1 0.02 ± 0.00 0.05 ± 0.00 0.04 ± 0.00 0.01 ± 0.00 0.05 ± 0.03 0.04 ± 0.02 
 M+2 0.02 ± 0.00 0.06 ± 0.00 0.01 ± 0.00 0.02 ± 0.00 0.06 ± 0.03 0.01 ± 0.00 
 M+3 0.56 ± 0.03 0.12 ± 0.01 0.23 ± 0.01 0.60 ± 0.04 0.14 ± 0.10 0.11 ± 0.01 
 SFL [%] 57.81 ± 2.71 17.31 ± 1.21 25.26 ± 1.41 61.92 ± 3.44 19.42 ± 1.90 12.77 ± 0.91 
 SFLcorr [%] 57.31 ± 2.69 16.40 ± 1.04 24.44 ± 1.36 61.46 ± 3.41 18.53 ± 1.81 11.82 ± 0.84 
Gly_246 M+0 0.97 ± 0.00 0.97 ± 0.00 0.98 ± 0.00 0.97 ± 0.00 0.97 ± 0.00 0.98 ± 0.00 
 M+1 0.03 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 
 M+2 0.01 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 2.15 ± 0.10 1.69 ± 0.07 1.23 ± 0.06 1.46 ± 0.08 1.48 ± 0.08 1.20 ± 0.05 
 SFLcorr [%] 1.09 ± 0.05 0.62 ± 0.03 0.16 ± 0.01 0.39 ± 0.02 0.42 ± 0.02 0.13 ± 0.01 
Val_288 M+0 0.91 ± 0.02 0.94 ± 0.00 0.94 ± 0.00 0.94 ± 0.00 0.94 ± 0.00 0.95 ± 0.01 
 M+1 0.05 ± 0.00 0.05 ± 0.00 0.05 ± 0.00 0.05 ± 0.00 0.05 ± 0.00 0.05 ± 0.00 
 M+2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+5 0.03 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 4.52 ± 0.41 1.39 ± 0.10 1.41 ± 0.13 1.79 ± 0.13 1.44 ± 0.14 1.30 ± 0.12 
 SFLcorr [%] 3.49 ± 0.32 0.32 ± 0.02 0.34 ± 0.02 0.72 ± 0.05 0.38 ± 0.04 0.23 ± 0.02 
Leu_274 M+0 0.94 ± 0.00 0.94 ± 0.00 0.95 ± 0.00 0.95 ± 0.00 0.95 ± 0.00 0.95 ± 0.00 
 M+1 0.06 ± 0.00 0.05 ± 0.00 0.05 ± 0.00 0.05 ± 0.00 0.05 ± 0.00 0.05 ± 0.00 
 M+2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+5 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 1.12 ± 0.05 1.13 ± 0.06 1.08 ± 0.00 1.09 ± 0.01 1.12 ± 0.04 1.10 ± 0.03 
 SFLcorr [%] 0.13 ± 0.01 0.08 ± 0.00 0.08 ± 0.00 0.07 ± 0.00 0.09 ± 0.00 0.08 ± 0.00 
Ile_274 M+0 0.92 ± 0.01 0.93 ± 0.00 0.94 ± 0.00 0.93 ± 0.00 0.93 ± 0.00 0.94 ± 0.00 
 M+1 0.07 ± 0.00 0.06 ± 0.00 0.06 ± 0.00 0.07 ± 0.00 0.06 ± 0.00 0.06 ± 0.00 
 M+2 0.01 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+5 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 1.75 ± 0.12 1.47 ± 0.10 1.51 ± 0.06 1.64 ± 0.16 1.53 ± 0.14 1.39 ± 0.11 
 SFLcorr [%] 0.24 ± 0.02 0.14 ± 0.01 0.24 ± 0.01 0.19 ± 0.02 0.27 ± 0.02 0.33 ± 0.03 
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Table 16: Relative mass isotopomer fractions of amino acids from hydrolyzed cell protein of 
A. gossypii WT and B2 grown on naturally labeled complex medium and 99 % [13C6] glucose, 
[13C2] acetate, or [13C3] glycerol (continued). 
   WT   B2  
Analyte  [13C6] Glc [13C2] Ac [13C3] Glyc [13C6] Glc [13C2] Ac [13C3] Glyc 
Pro_258 M+0 0.90 ± 0.01 n.d. n.d. 0.91 ± 0.01 n.d. n.d. 
 M+1 0.04 ± 0.00 n.d. n.d. 0.04 ± 0.00 n.d. n.d. 
 M+2 0.01 ± 0.00 n.d. n.d. 0.01 ± 0.00 n.d. n.d. 
 M+3 0.01 ± 0.00 n.d. n.d. 0.01 ± 0.00 n.d. n.d. 
 M+4 0.04 ± 0.00 n.d. n.d. 0.03 ± 0.00 n.d. n.d. 
 SFL [%] 5.81 ± 0.21 n.d. n.d. 5.19 ± 0.30 n.d. n.d. 
 SFLcorr [%] 4.79 ± 0.17 n.d. n.d. 4.16 ± 0.24 n.d. n.d. 
Ser_390 M+0 0.90 ± 0.01 0.94 ± 0.00 0.97 ± 0.00 0.96 ± 0.00 0.94 ± 0.00 0.97 ± 0.00 
 M+1 0.05 ± 0.00 0.06 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 0.05 ± 0.00 0.03 ± 0.00 
 M+2 0.01 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.05 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 6.90 ± 0.51 2.34 ± 0.10 1.27 ± 0.08 1.36 ± 0.09 2.02 ± 0.11 1.25 ± 0.08 
 SFLcorr [%] 5.89 ± 0.44 1.29 ± 0.06 0.20 ± 0.01 0.30 ± 0.02 0.96 ± 0.05 0.18 ± 0.01 
Thr_404 M+0 0.90 ± 0.02 0.96 ± 0.00 0.96 ± 0.00 0.94 ± 0.01 0.96 ± 0.00 0.96 ± 0.00 
 M+1 0.04 ± 0.00 0.04 ± 0.00 0.04 ± 0.00 0.04 ± 0.00 0.04 ± 0.00 0.04 ± 0.00 
 M+2 0.05 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.02 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.01 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 4.26 ± 0.22 1.08 ± 0.01 0.92 ± 0.10 2.43 ± 0.10 1.50 ± 0.11 1.11 ± 0.05 
 SFLcorr [%] 3.23 ± 0.17 0.02 ± 0.00 -0.16 ± 0.02 1.38 ± 0.06 0.43 ± 0.03 0.04 ± 0.00 
Phe_336 M+0 0.91 ± 0.00 0.91 ± 0.00 0.91 ± 0.00 0.91 ± 0.00 0.91 ± 0.00 0.91 ± 0.00 
 M+1 0.09 ± 0.00 0.09 ± 0.00 0.09 ± 0.00 0.09 ± 0.00 0.09 ± 0.00 0.09 ± 0.00 
 M+2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+5 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+6 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+7 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+8 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+9 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 1.09 ± 0.01 1.07 ± 0.00 1.23 ± 0.10 1.09 ± 0.03 1.10 ± 0.03 1.12 ± 0.06 
 SFLcorr [%] 0.02 ± 0.00 0.00 ± 0.00 0.16 ± 0.01 0.02 ± 0.00 0.03 ± 0.00 0.05 ± 0.00 
Asp_418 M+0 0.45 ± 0.04 0.47 ± 0.03 0.86 ± 0.04 0.54 ± 0.03 0.50 ± 0.04 0.93 ± 0.01 
 M+1 0.03 ± 0.00 0.04 ± 0.00 0.08 ± 0.00 0.03 ± 0.00 0.05 ± 0.00 0.05 ± 0.00 
 M+2 0.04 ± 0.00 0.09 ± 0.00 0.04 ± 0.00 0.03 ± 0.00 0.08 ± 0.00 0.01 ± 0.00 
 M+3 0.10 ± 0.00 0.12 ± 0.01 0.02 ± 0.00 0.08 ± 0.00 0.11 ± 0.00 0.01 ± 0.00 
 M+4 0.39 ± 0.02 0.27 ± 0.02 0.00 ± 0.00 0.33 ± 0.03 0.26 ± 0.01 0.00 ± 0.00 
 SFL [%] 48.96 ± 3.45 41.91 ± 2.96 5.62 ± 2.33 40.59 ± 2.26 39.75 ± 3.18 2.53 ± 0.03 
 SFLcorr [%] 48.37 ± 3.41 41.26 ± 2.91 4.59 ± 1.90 39.92 ± 2.22 39.07 ± 3.73 1.47 ± 0.02 
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Table 16: Relative mass isotopomer fractions of amino acids from hydrolyzed cell protein of 
A. gossypii WT and B2 grown on naturally labeled complex medium and 99 % [13C6] glucose, 
[13C2] acetate, or [13C3] glycerol (continued). 
   WT   B2  
Analyte  [13C6] Glc [13C2] Ac [13C3] Glyc [13C6] Glc [13C2] Ac [13C3] Glyc 
Glu_432 M+0 0.14 ± 0.01 0.20 ± 0.01 0.80 ± 0.01 0.20 ± 0.01 0.17 ± 0.01 0.90 ± 0.01 
 M+1 0.01 ± 0.00 0.02 ± 0.00 0.10 ± 0.00 0.01 ± 0.00 0.02 ± 0.00 0.07 ± 0.00 
 M+2 0.08 ± 0.00 0.11 ± 0.00 0.07 ± 0.00 0.08 ± 0.00 0.11 ± 0.00 0.03 ± 0.00 
 M+3 0.08 ± 0.00 0.10 ± 0.00 0.01 ± 0.00 0.07 ± 0.00 0.11 ± 0.00 0.00 ± 0.00 
 M+4 0.15 ± 0.00 0.18 ± 0.00 0.00 ± 0.00 0.15 ± 0.00 0.18 ± 0.00 0.00 ± 0.00 
 M+5 0.54 ± 0.04 0.39 ± 0.03 0.00 ± 0.00 0.49 ± 0.02 0.41 ± 0.04 0.00 ± 0.00 
 SFL [%] 74.43 ± 6.45 64.08 ± 6.30 6.56 ± 2.11 68.29 ± 3.85 66.63 ± 6.70 2.95 ± 0.05 
 SFLcorr [%] 74.10 ± 6.42 63.65 ± 6.24 5.55 ± 1.77 67.90 ± 3.83 66.22 ± 6.66 1.90 ± 0.03 
Lys_431 M+0 0.94 ± 0.00 0.94 ± 0.00 0.95 ± 0.01 0.94 ± 0.00 0.94 ± 0.00 0.94 ± 0.00 
 M+1 0.06 ± 0.00 0.06 ± 0.00 0.05 ± 0.00 0.06 ± 0.00 0.06 ± 0.00 0.06 ± 0.00 
 M+2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+5 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+6 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 1.06 ± 0.01 1.01 ± 0.05 0.89 ± 0.10 0.96 ± 0.08 0.98 ± 0.08 0.95 ± 0.10 
 SFLcorr [%] -0.01 ± 0.00 -0.06 ± 0.00 -0.18 ± 0.02 -0.11 ± 0.01 -0.09 ± 0.01 -0.12 ± 0.01 
Arg_442 M+0 0.91 ± 0.02 0.94 ± 0.00 0.94 ± 0.00 0.94 ± 0.00 0.94 ± 0.00 0.94 ± 0.00 
 M+1 0.06 ± 0.00 0.05 ± 0.00 0.06 ± 0.00 0.05 ± 0.00 0.05 ± 0.00 0.06 ± 0.00 
 M+2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+5 0.01 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+6 0.01 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 3.19 ± 0.20 1.01 ± 0.06 1.15 ± 0.07 1.21 ± 0.10 1.16 ± 0.08 1.01 ± 0.06 
 SFLcorr [%] 2.14 ± 0.13 -0.06 ± 0.00 0.08 ± 0.00 0.14 ± 0.01 0.09 ± 0.01 -0.06 ± 0.00 
Tyr_466 M+0 0.63 ± 0.04 0.79 ± 0.05 0.74 ± 0.03 0.73 ± 0.04 0.84 ± 0.01 0.83 ± 0.02 
 M+1 0.05 ± 0.00 0.09 ± 0.00 0.07 ± 0.00 0.06 ± 0.00 0.08 ± 0.00 0.08 ± 0.00 
 M+2 0.00 ± 0.00 0.03 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 0.02 ± 0.00 0.01 ± 0.00 
 M+3 0.00 ± 0.00 0.03 ± 0.00 0.02 ± 0.00 0.00 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 
 M+4 0.00 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 
 M+5 0.00 ± 0.00 0.02 ± 0.00 0.03 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 
 M+6 0.00 ± 0.00 0.01 ± 0.00 0.03 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 
 M+7 0.01 ± 0.00 0.01 ± 0.00 0.02 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
 M+8 0.03 ± 0.00 0.01 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+9 0.27 ± 0.02 0.00 ± 0.00 0.04 ± 0.00 0.18 ± 0.01 0.00 ± 0.00 0.01 ± 0.00 
 SFL [%] 31.35 ± 1.99 6.54 ± 0.41 13.93 ± 0.56 20.90 ± 1.15 4.65 ± 0.06 5.56 ± 0.13 
 SFLcorr [%] 30.59 ± 1.94 5.53 ± 0.35 12.99 ± 0.52 20.03 ± 1.10 3.61 ± 0.05 4.54 ± 0.11 
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Table 16: Relative mass isotopomer fractions of amino acids from hydrolyzed cell protein of 
A. gossypii WT and B2 grown on naturally labeled complex medium and 99 % [13C6] glucose, 
[13C2] acetate, or [13C3] glycerol (continued). 
   WT   B2  
Analyte  [13C6] Glc [13C2] Ac [13C3] Glyc [13C6] Glc [13C2] Ac [13C3] Glyc 
His_440 M+0 0.90 ± 0.01 0.92 ± 0.00 n.d. 0.74 ± 0.03 0.92 ± 0.00 0.93 ± 0.00 
 M+1 0.07 ± 0.00 0.07 ± 0.00 n.d. 0.15 ± 0.01 0.07 ± 0.00 0.05 ± 0.00 
 M+2 0.01 ± 0.00 0.01 ± 0.00 n.d. 0.05 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 
 M+3 0.01 ± 0.00 0.00 ± 0.00 n.d. 0.03 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 n.d. 0.02 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+5 0.00 ± 0.00 0.00 ± 0.00 n.d. 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+6 0.00 ± 0.00 0.00 ± 0.00 n.d. 0.01 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 2.42 ± 0.04 1.53 ± 0.01 n.d. 7.61 ± 0.35 1.87 ± 0.02 1.61 ± 0.02 
 SFLcorr [%] 1.36 ± 0.02 0.47 ± 0.00 n.d. 6.60 ± 0.30 0.81 ± 0.01 0.54 ± 0.01 
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Table 17: Relative mass isotopomer fractions of amino acids from hydrolyzed cell protein of A. gossypii 
B2 grown on naturally labeled vegetable oil and 99 % [13C2] glycine, [13C3] serine, or [13C] formate. 
Cultivation of A. gossypii on naturally labeled medium served as control. Data denote corrected labeling 
patterns. Data were corrected for fraction of unlabeled biomass in the inoculum as well as occurrence 
of natural isotopes. The mass isotopomer M+0 represents the relative amount of non-labeled, M+1 the 
amount of singly-labeled mass isotopomer fraction and so on. Data were obtained from three individual 
replicates. 
Analyte  Control [13C2] Gly [13C] For [13C3] Ser 
Ala_260 M+0 0.96 ± 0.00 0.91 ± 0.00 0.91 ± 0.00 0.92 ± 0.00 
 M+1 0.03 ± 0.00 0.03 ± 0.00 0.09 ± 0.00 0.04 ± 0.00 
 M+2 0.00 ± 0.00 0.06 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.03 ± 0.00 
 SFL [%] 1.15 ± 0.08 5.17 ± 0.11 3.01 ± 0.11 4.89 ± 0.11 
 SFLcorr [%] 0.08 ± 0.01 4.22 ± 0.08 2.00 ± 0.07 4.05 ± 0.09 
Gly_246 M+0 0.98 ± 0.00 0.15 ± 0.06 0.98 ± 0.00 0.89 ± 0.12 
 M+1 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 
 M+2 0.00 ± 0.00 0.83 ± 0.11 0.00 ± 0.00 0.08 ± 0.01 
 SFL [%] 1.15 ± 0.08 84.07 ± 10.64 1.09 ± 0.16 9.44 ± 1.13 
 SFLcorr [%] 0.08 ± 0.01 85.41 ± 10.81 0.16 ± 0.02 8.92 ± 1.07 
Val_288 M+0 0.95 ± 0.00 0.94 ± 0.00 0.94 ± 0.00 0.94 ± 0.00 
 M+1 0.05 ± 0.00 0.05 ± 0.00 0.05 ± 0.00 0.05 ± 0.00 
 M+2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+5 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 1.12 ± 0.03 1.3 ± 0.04 1.24 ± 0.13 1.24 ± 0.11 
 SFLcorr [%] 0.05 ± 0.00 0.21 ± 0.01 0.15 ± 0.02 0.15 ± 0.01 
Leu_302 M+0 0.93 ± 0.00 0.93 ± 0.00 0.93 ± 0.00 0.93 ± 0.00 
 M+1 0.07 ± 0.00 0.07 ± 0.00 0.06 ± 0.00 0.07 ± 0.00 
 M+2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+5 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+6 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 1.16 ± 0.04 1.17 ± 0.01 1.21 ± 0.08 1.21 ± 0.10 
 SFLcorr [%] 0.09 ± 0.00 0.07 ± 0.00 0.12 ± 0.01 0.12 ± 0.01 
Ile_302 M+0 0.93 ± 0.00 0.93 ± 0.00 0.93 ± 0.00 0.93 ± 0.00 
 M+1 0.06 ± 0.00 0.07 ± 0.00 0.07 ± 0.00 0.06 ± 0.00 
 M+2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+5 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+6 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 1.15 ± 0.08 1.19 ± 0.01 1.20 ± 0.03 1.20 ± 0.10 
 SFLcorr [%] 0.05 ± 0.00 0.09 ± 0.00 0.10 ± 0.00 0.11 ± 0.01 
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Table 17: Relative mass isotopomer fractions of amino acids from hydrolyzed cell protein of 
A. gossypii B2 grown on naturally labeled vegetable oil and 99 % [13C2] glycine, [13C3] serine, or 
[13C] formate (continued). 
Analyte  Control [13C2] Gly [13C] For [13C3] Ser 
Pro_286 M+0 0.94 ± 0.00 0.95 ± 0.00 0.94 ± 0.00 0.95 ± 0.00 
 M+1 0.05 ± 0.00 0.05 ± 0.00 0.06 ± 0.00 0.05 ± 0.00 
 M+2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+5 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 1.09 ± 0.12 1.05 ± 0.05 1.13 ± 0.02 1.13 ± 0.01 
 SFLcorr [%] 0.02 ± 0.00 -0.05 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 
Ser_390 M+0 0.97 ± 0.00 0.37 ± 0.03 0.57 ± 0.02 0.29 ± 0.04 
 M+1 0.03 ± 0.00 0.02 ± 0.00 0.43 ± 0.03 0.14 ± 0.02 
 M+2 0.00 ± 0.00 0.6 ± 0.03 0.01 ± 0.00 0.04 ± 0.01 
 M+3 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 0.53 ± 0.07 
 SFL [%] 1.05 ± 0.11 41.59 ± 2.29 14.68 ± 0.85 60.13 ± 3.61 
 SFLcorr [%] -0.02 ± 0.00 41.67 ± 2.29 14.25 ± 0.82 63.13 ± 3.79 
Thr_404 M+0 0.96 ± 0.00 0.96 ± 0.00 0.96 ± 0.00 0.95 ± 0.00 
 M+1 0.04 ± 0.00 0.04 ± 0.00 0.04 ± 0.00 0.04 ± 0.00 
 M+2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
 SFL [%] 1.07 ± 0.03 1.21 ± 0.03 1.04 ± 0.03 1.04 ± 0.01 
 SFLcorr [%] 0.00 ± 0.00 0.11 ± 0.00 -0.06 ± 0.00 -0.06 ± 0.00 
Phe_336 M+0 0.91 ± 0.00 0.90 ± 0.00 0.91 ± 0.00 0.90 ± 0.00 
 M+1 0.09 ± 0.00 0.08 ± 0.00 0.09 ± 0.00 0.09 ± 0.00 
 M+2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+5 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+6 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+7 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+8 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+9 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 1.06 ± 0.03 1.39 ± 0.33 1.06 ± 0.01 1.06 ± 0.03 
 SFLcorr [%] -0.01 ± 0.00 0.30 ± 0.07 -0.04 ± 0.00 -0.04 ± 0.00 
Asp_418 M+0 0.96 ± 0.00 0.96 ± 0.00 0.96 ± 0.00 0.95 ± 0.00 
 M+1 0.04 ± 0.00 0.04 ± 0.00 0.04 ± 0.00 0.04 ± 0.00 
 M+2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 0.99 ± 0.08 1.17 ± 0.05 1.13 ± 0.10 1.13 ± 0.05 
 SFLcorr [%] -0.08 ± 0.01 0.07 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 
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Table 17: Relative mass isotopomer fractions of amino acids from hydrolyzed cell protein of 
A. gossypii B2 grown on naturally labeled vegetable oil and 99 % [13C2] glycine, [13C3] serine, or 
[13C] formate (continued). 
Analyte  Control [13C2] Gly [13C] For [13C3] Ser 
Glu_432 M+0 0.94 ± 0.00 0.94 ± 0.00 0.94 ± 0.00 0.94 ± 0.00 
 M+1 0.05 ± 0.00 0.06 ± 0.00 0.05 ± 0.00 0.06 ± 0.00 
 M+2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+5 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 1.10 ± 0.10 1.30 ± 0.11 1.29 ± 0.10 1.31 ± 0.09 
 SFLcorr [%] 0.03 ± 0.03 0.21 ± 0.02 0.20 ± 0.02 0.22 ± 0.02 
Lys_431 M+0 0.90 ± 0.02 0.94 ± 0.00 0.94 ± 0.00 0.94 ± 0.00 
 M+1 0.06 ± 0.00 0.06 ± 0.00 0.05 ± 0.00 0.06 ± 0.00 
 M+2 0.04 ± 0.02 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+5 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+6 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 1.77 ± 0.68 1.06 ± 0.05 1.06 ± 0.09 1.06 ± 0.01 
 SFLcorr [%] 0.70 ± 0.27 -0.04 ± 0.00 -0.04 ± 0.00 -0.04 ± 0.00 
Arg_442 M+0 0.94 ± 0.00 0.94 ± 0.00 0.93 ± 0.00 0.93 ± 0.00 
 M+1 0.06 ± 0.00 0.06 ± 0.00 0.07 ± 0.00 0.06 ± 0.00 
 M+2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+5 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+6 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 1.12 ± 0.06 1.08 ± 0.06 1.11 ± 0.09 1.11 ± 0.09 
 SFLcorr [%] 0.05 ± 0.00 -0.02 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 
Tyr_466 M+0 0.92 ± 0.00 0.90 ± 0.00 0.91 ± 0.00 0.90 ± 0.00 
 M+1 0.07 ± 0.00 0.09 ± 0.00 0.09 ± 0.00 0.09 ± 0.00 
 M+2 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+5 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+6 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+7 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+8 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+9 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 1.00 ± 0.03 1.27 ± 0.16 1.08 ± 0.03 1.08 ± 0.07 
 SFLcorr [%] -0.07 ± 0.00 0.17 ± 0.02 -0.02 ± 0.00 -0.02 ± 0.00 
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Table 18: Relative mass isotopomer fractions of amino acids from hydrolyzed cell protein of A. gossypii 
B2 grown on naturally labeled vegetable oil and 99 % [U13C] yeast extract, [13C5] glutamate, or the 
combined addition of [13C2] glycine, [13C] formate, [13C5] glutamate, and [U13C] yeast extract. Cultivation 
of A. gossypii on naturally labeled medium served as control. Data denote corrected labeling patterns. 
Data were corrected for fraction of unlabeled biomass in the inoculum as well as occurrence of natural 
isotopes. The mass isotopomer M+0 represents the relative amount of non-labeled, M+1 the amount of 
singly-labeled mass isotopomer fraction and so on. Data were obtained from three individual replicates. 
Analyte  Control [U13C] YE [13C5] Glu 
[U13C] Gly, For, 
Glu, YE 
Ala_260 M+0 0.97 ± 0.00 0.31 ± 0.02 0.94 ± 0.05 0.22 ± 0.03 
 M+1 0.03 ± 0.00 0.05 ± 0.00 0.05 ± 0.00 0.04 ± 0.00 
 M+2 0.00 ± 0.00 0.04 ± 0.00 0.01 ± 0.00 0.04 ± 0.00 
 M+3 0.00 ± 0.00 0.61 ± 0.06 0.01 ± 0.00 0.7 ± 0.08 
 SFL [%] 1.13 ± 0.05 65.06 ± 4.01 2.71 ± 0.17 73.96 ± 3.04 
 SFLcorr [%] 0.03 ± 0.00 71.89 ± 4.43 1.69 ± 0.04 81.89 ± 3.37 
Gly_246 M+0 0.98 ± 0.00 0.86 ± 0.09 0.98 ± 0.00 0.01 ± 0.00 
 M+1 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 
 M+2 0.00 ± 0.00 0.12 ± 0.01 0.00 ± 0.00 0.97 ± 0.00 
 SFL [%] 1.11 ± 0.04 12.95 ± 1.25 1.23 ± 0.05 97.89 ± 2.64 
 SFLcorr [%] 0.01 ± 0.00 12.20 ± 1.18 0.13 ± 0.01 99.61 ± 2.69 
Val_288 M+0 0.95 ± 0.00 0.07 ± 0.00 0.95 ± 0.00 0.07 ± 0.00 
 M+1 0.05 ± 0.00 0.01 ± 0.00 0.05 ± 0.00 0.01 ± 0.00 
 M+2 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
 M+3 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
 M+4 0.00 ± 0.00 0.05 ± 0.01 0.00 ± 0.00 0.05 ± 0.00 
 M+5 0.00 ± 0.00 0.86 ± 0.8 0.00 ± 0.00 0.86 ± 0.9 
 SFL [%] 1.09 ± 0.03 91.05 ± 7.50 1.15 ± 0.02 90.89 ± 9.01 
 SFLcorr [%] -0.01 ± 0.00 103.92 ± 8.56 0.05 ± 0.01 103.74 ± 10.28 
Leu_274 M+0 0.95 ± 0.00 0.06 ± 0.00 0.95 ± 0.00 0.07 ± 0.00 
 M+1 0.05 ± 0.00 0.00 ± 0.00 0.05 ± 0.00 0.00 ± 0.00 
 M+2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.05 ± 0.00 0.00 ± 0.00 0.05 ± 0.00 
 M+5 0.00 ± 0.00 0.88 ± 0.10 0.00 ± 0.00 0.87 ± 0.08 
 SFL [%] 1.09 ± 0.01 92.16 ± 4.36 1.11 ± 0.02 91.42 ± 5.47 
 SFLcorr [%] -0.01 ± 0.00 104.33 ± 4.94 0.05 ± 0.01 103.48 ± 6.19 
Ile_274 M+0 0.94 ± 0.00 0.09 ± 0.01 0.93 ± 0.07 0.09 ± 0.02 
 M+1 0.06 ± 0.00 0.01 ± 0.00 0.06 ± 0.00 0.01 ± 0.00 
 M+2 0.00 ± 0.00 0.04 ± 0.00 0.00 ± 0.00 0.04 ± 0.00 
 M+3 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
 M+4 0.00 ± 0.00 0.05 ± 0.00 0.00 ± 0.00 0.05 ± 0.00 
 M+5 0.00 ± 0.00 0.8 ± 0.07 0.00 ± 0.00 0.79 ± 0.08 
 SFL [%] 1.24 ± 0.12 86.35 ± 6.53 1.39 ± 0.21 86.08 ± 10.11 
 SFLcorr [%] 0.14 ± 0.01 98.87 ± 7.48 0.10 ± 0.02 98.56 ± 11.58 
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Table 18: Relative mass isotopomer fractions of amino acids from hydrolyzed cell protein of 
A. gossypii B2 grown on naturally labeled vegetable oil and 99 % [U13C] yeast extract, 
[13C5] glutamate, or the combined addition of [13C2] glycine, [13C] formate, [13C5] glutamate, and 
[U13C] yeast extract (continued). 
Analyte  Control [U13C] YE [13C5] Glu 
[U13C] Gly, For, 
Glu, YE 
Pro_258 M+0 0.95 ± 0.00 n.d. 0.85 ± 0.09 0.26 ± 0.03 
 M+1 0.05 ± 0.00 n.d. 0.08 ± 0.02 0.06 ± 0.00 
 M+2 0.00 ± 0.00 n.d. 0.02 ± 0.00 0.03 ± 0.00 
 M+3 0.00 ± 0.00 n.d. 0.00 ± 0.00 0.03 ± 0.00 
 M+4 0.00 ± 0.00 n.d. 0.04 ± 0.00 0.62 ± 0.05 
 SFL [%] 1.17 ± 0.10 n.d. 7.59 ± 0.60 67.25 ± 4.02 
 SFLcorr [%] 0.07 ± 0.01 n.d. 6.81 ± 0.54 76.00 ± 4.54 
Ser_390 M+0 0.97 ± 0.00 0.58 ± 0.04 0.96 ± 0.02 0.01 ± 0.00 
 M+1 0.03 ± 0.00 0.17 ± 0.02 0.04 ± 0.00 0.02 ± 0.00 
 M+2 0.00 ± 0.00 0.08 ± 0.00 0.00 ± 0.00 0.11 ± 0.01 
 M+3 0.00 ± 0.00 0.17 ± 0.01 0.00 ± 0.00 0.87 ± 0.09 
 SFL [%] 1.08 ± 0.05 28.01 ± 1.32 1.33 ± 0.11 94.47 ± 6.78 
 SFLcorr [%] -0.02 ± 0.01 31.52 ± 1.49 0.24 ± 0.02 109.38 ± 7.85 
Thr_404 M+0 0.96 ± 0.00 0.16 ± 0.02 0.94 ± 0.03 0.13 ± 0.02 
 M+1 0.04 ± 0.00 0.02 ± 0.00 0.05 ± 0.00 0.02 ± 0.00 
 M+2 0.00 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 
 M+3 0.00 ± 0.00 0.04 ± 0.00 0.00 ± 0.00 0.04 ± 0.00 
 M+4 0.00 ± 0.00 0.77 ± 0.06 0.01 ± 0.00 0.79 ± 0.08 
 SFL [%] 1.09 ± 0.03 81.01 ± 7.98 2.26 ± 0.35 83.14 ± 4.41 
 SFLcorr [%] -0.01 ± 0.00 87.60 ± 8.63 1.22 ± 0.19 89.93 ± 4.77 
Phe_336 M+0 0.91 ± 0.00 0.06 ± 0.00 0.91 ± 0.00 0.06 ± 0.00 
 M+1 0.08 ± 0.00 0.01 ± 0.00 0.09 ± 0.00 0.01 ± 0.00 
 M+2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+5 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+6 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+7 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
 M+8 0.00 ± 0.00 0.08 ± 0.00 0.00 ± 0.00 0.08 ± 0.00 
 M+9 0.00 ± 0.00 0.85 ± 0.09 0.00 ± 0.00 0.84 ± 0.08 
 SFL [%] 1.14 ± 0.07 92.29 ± 6.52 1.05 ± 0.02 91.9 ± 8.71 
 SFLcorr [%] 0.04 ± 0.00 104.11 ± 6.99 0.00 ± 0.00 103.67 ± 9.83 
Asp_418 M+0 0.96 ± 0.00 0.56 ± 0.05 0.87 ± 0.08 0.49 ± 0.06 
 M+1 0.04 ± 0.00 0.07 ± 0.00 0.07 ± 0.00 0.10 ± 0.01 
 M+2 0.00 ± 0.00 0.04 ± 0.00 0.03 ± 0.00 0.06 ± 0.00 
 M+3 0.00 ± 0.00 0.02 ± 0.00 0.00 ± 0.00 0.03 ± 0.00 
 M+4 0.00 ± 0.00 0.3 ± 0.02 0.02 ± 0.00 0.32 ± 0.04 
 SFL [%] 1.00 ± 0.08 35.62 ± 2.44 5.6 ± 0.52 39.72 ± 2.02 
 SFLcorr [%] -0.10 ± 0.01 43.11 ± 2.95 4.71 ± 0.44 48.23 ± 2.45 
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Table 18: Relative mass isotopomer fractions of amino acids from hydrolyzed cell protein of 
A. gossypii B2 grown on naturally labeled vegetable oil and 99 % [U13C] yeast extract, 
[13C5] glutamate, or the combined addition of [13C2] glycine, [13C] formate, [13C5] glutamate, and 
[U13C] yeast extract (continued). 
Analyte  Control [U13C] YE [13C5] Glu 
[U13C] Gly, For, 
Glu, YE 
Glu_432 M+0 0.95 ± 0.00 0.73 ± 0.07 0.78 ± 0.09 0.57 ± 0.07 
 M+1 0.05 ± 0.00 0.10 ± 0.01 0.09 ± 0.02 0.13 ± 0.02 
 M+2 0.00 ± 0.00 0.05 ± 0.00 0.02 ± 0.00 0.06 ± 0.00 
 M+3 0.00 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 0.05 ± 0.00 
 M+4 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
 M+5 0.00 ± 0.00 0.09 ± 0.01 0.08 ± 0.00 0.17 ± 0.01 
 SFL [%] 1.03 ± 0.04 14.78 ± 1.12 12.32 ± 1.31 26.11 ± 1.03 
 SFLcorr [%] -0.07 ± 0.00 14.33 ± 1.09 11.76 ± 1.25 26.21 ± 1.03 
Lys_431 M+0 0.94 ± 0.00 0.07 ± 0.00 0.94 ± 0.00 0.07 ± 0.00 
 M+1 0.05 ± 0.00 0.00 ± 0.00 0.06 ± 0.01 0.00 ± 0.00 
 M+2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+4 0.00 ± 0.00 0.04 ± 0.00 0.00 ± 0.00 0.02 ± 0.00 
 M+5 0.00 ± 0.00 0.07 ± 0.00 0.00 ± 0.00 0.06 ± 0.00 
 M+6 0.00 ± 0.00 0.81 ± 0.09 0.00 ± 0.00 0.84 ± 0.09 
 SFL [%] 0.98 ± 0.12 89.61 ± 9.01 0.94 ± 0.20 90.68 ± 8.69 
 SFLcorr [%] -0.12 ± 0.01 110.19 ± 11.08 0.00 ± 0.00 111.51 ± 10.69 
Arg_442 M+0 0.94 ± 0.00 0.14 ± 0.01 0.85 ± 0.08 0.08 ± 0.00 
 M+1 0.05 ± 0.00 0.03 ± 0.00 0.09 ± 0.01 0.03 ± 0.00 
 M+2 0.00 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 
 M+3 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 
 M+4 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
 M+5 0.00 ± 0.00 0.08 ± 0.00 0.02 ± 0.00 0.08 ± 0.01 
 M+6 0.00 ± 0.00 0.73 ± 0.08 0.00 ± 0.00 0.79 ± 0.08 
 SFL [%] 1.10 ± 0.04 80.83 ± 4.74 5.04 ± 0.67 87.24 ± 10.41 
 SFLcorr [%] 0.00 ± 0.00 83.87 ± 4.92 4.13 ± 0.55 90.61 ± 10.81 
Tyr_466 M+0 0.92 ± 0.00 0.07 ± 0.00 0.8 ± 0.09 0.06 ± 0.00 
 M+1 0.08 ± 0.00 0.02 ± 0.00 0.13 ± 0.03 0.02 ± 0.00 
 M+2 0.00 ± 0.00 0.01 ± 0.00 0.04 ± 0.00 0.01 ± 0.00 
 M+3 0.00 ± 0.00 0.01 ± 0.00 0.02 ± 0.00 0.01 ± 0.00 
 M+4 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 
 M+5 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+6 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 M+7 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
 M+8 0.00 ± 0.00 0.08 ± 0.01 0.00 ± 0.00 0.07 ± 0.00 
 M+9 0.00 ± 0.00 0.80 ± 0.07 0.00 ± 0.00 0.81 ± 0.09 
 SFL [%] 1.14 ± 0.05 88.17 ± 6.35 3.45 ± 0.31 89.8 ± 11.04 
 SFLcorr [%] 0.04 ± 0.00 92.08 ± 6.63 2.47 ± 0.22 93.80 ± 11.53 
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Table 18: Relative mass isotopomer fractions of amino acids from hydrolyzed cell protein of 
A. gossypii B2 grown on naturally labeled vegetable oil and 99 % [U13C] yeast extract, 
[13C5] glutamate, or the combined addition of [13C2] glycine, [13C] formate, [13C5] glutamate, and 
[U13C] yeast extract (continued). 
Analyte  Control [U13C] YE [13C5] Glu 
[U13C] Gly, For, 
Glu, YE 
His_440 M+0 0.93 ± 0.00 0.07 ± 0.00 0.93 ± 0.00 n.d. 
 M+1 0.06 ± 0.00 0.05 ± 0.00 0.06 ± 0.00 n.d. 
 M+2 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 n.d. 
 M+3 0.00 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 n.d. 
 M+4 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 n.d. 
 M+5 0.00 ± 0.00 0.06 ± 0.02 0.00 ± 0.00 n.d. 
 M+6 0.00 ± 0.00 0.80 ± 0.10 0.00 ± 0.00 n.d. 
 SFL [%] 1.21 ± 0.13 86.75 ± 4.01 1.43 ± 0.35 n.d. 
 SFLcorr [%] 0.11 ± 0.01 103.64 ± 4.79 0.34 ± 0.08 n.d. 
Glc_554 M+0 0.94 ± 0.00 0.73 ± 0.07 0.74 ± 0.08 0.55 ± 0.06 
 M+1 0.05 ± 0.00 0.17 ± 0.02 0.16 ± 0.02 0.23 ± 0.02 
 M+2 0.00 ± 0.00 0.05 ± 0.00 0.05 ± 0.00 0.11 ± 0.01 
 M+3 0.00 ± 0.00 0.04 ± 0.00 0.04 ± 0.00 0.09 ± 0.01 
 M+4 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 0.02 ± 0.00 
 M+5 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
 M+6 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 SFL [%] 1.14 ± 0.10 7.24 ± 0.50 7.12 ± 0.39 13.78 ± 1.52 
 SFLcorr [%] 0.04 ± 0.00 6.20 ± 0.43 6.30 ± 0.35 12.81 ± 1.41 
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Figure 40: Change in summed fractional labeling (SFL) in the culture supernatant for various 
experiments throughout the course of the cultivation: cultivation of A. gossypii B2 on complex medium 
with naturally labeled rapeseed oil and [13C2] glycine (A) (dark blue), [3-13C] serine after 48 h (B) (green), 
[13C3] serine (C) (green), [U13C] yeast extract added from 0-32 h (D-O) (open circles), [U13C] yeast 
extract added from 32-144 h (D-O) (purple), [13C5] glutamate (D-O) (light blue), and a combination of 
[U13C] yeast extract, [13C2] glycine, [13C5] glutamate, and [13C] formate (D-O) (grey). Unless otherwise 
indicated, tracers were added at the beginning of the cultivation. For experiments with labeled serine and glycine 
(without other labeled compounds), only the 13C labeling of the respective tracer was measured in the supernatant. 
For experiments with glutamate and yeast extract several amino acids were measured regarding 13C enrichment 
(D-O). Labeling information of serine (B) refers to the terminal carbon atom only and 33 % of labeling were set to 
100 %. Data denote mean values from three individual replicates with a mean standard deviation of 5 %. 
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6.5 Biomass composition of A. gossypii for flux calculations 
 Table 19: Anabolic precursor demand of A. gossypii for biomass synthesis derived from the genome-
scale metabolic model (Ledesma-Amaro et al., 2014a), adjusted for the content and composition of lipids 
for growth on vegetable oil (Stahmann et al., 1994) and underlying pathway stoichiometry for riboflavin 
production during the growth phase (Bacher et al., 2000; Kanehisa et al., 2017; Kanehisa and Goto, 
2000; Kanehisa et al., 2016). 3PG, 3-phosphoglycerate; AcCoA, acetyl-CoA; AKG, α-ketoglutarate; 
G3P, glyceraldehyde 3-phosphate; G6P, glucose 6-phosphate; E4P, erythrose 4-phosphate; F6P, 
fructose 6-phosphate; OAA, oxaloacetate; PEP, phosphoenolpyruvate; PYR, pyruvate; R5P, ribose 5-
phosphate. 
Precursor Demand G6P F6P R5P E4P G3P 3PG PEP PYR AcCoA OAA AKG 
 [μmol g-1]            
Alanine 357.3        1    
Arginine 135.8           1 
Asparagine 171.5          1  
Aspartate 171.5          1  
Cysteine 42.9      1      
Glutamine 268.0           1 
Glutamate 268.0           1 
Glycine 325.2      1      
Histidine 75.0   1         
Isoleucine 171.5        1  1  
Leucine 250.1        2 1   
Lysine 239.4        1  1  
Methionine 50.0          1  
Phenylalanine 114.3    1   2     
Proline 128.6           1 
Serine 253.7      1      
Threonine 196.5          1  
Tryptophan 28.0   1 1   1     
Tyrosine 96.5    1   2     
Valine 257.3        2    
Protein  0 0 103 239 0 622 450 1783 250 1001 800 
ATP 51.0   1   1      
GTP 20.0   1   1      
CTP 51.0   1       1  
UTP 67.0   1       1  
RNA  0 0 189 0 0 71 0 0 0 118 0 
dATP 3.6   1   1      
dGTP 2.4   1   1      
dCTP 2.4   1       1  
dTTP 3.6   1       1  
DNA  0 0 12 0 0 6 0 0 0 6 0 
Lipid 240.4     1    26   
Glycogen 581.5 1           
Mannan 821.0  1          
Trehalose 23.3 1           
Riboflavin 8.6   3   1      
Total  605 821 330 239 240 707 450 1783 6573 1125 800 
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Table 20: Contribution of nutrient uptake from the medium and de novo synthesis of precursors to the supply of cellular building 
blocks for A. gossypii. Values for the precursor demand were taken from Ledesma-Amaro et al. (2014a) and adjusted for growth 
on vegetable oil based on Stahmann et al. (1994). Correlation of the demand values with experimental summed fractional labeling 
(SFL) data from combined results of parallel 13C isotope studies (appendix Table 17 and Table 18) yielded the de novo precursor 
demand for growth on complex medium and rapeseed oil. The full length bar indicates the total precursor demand: the purple 
fraction depicts the measured percentage taken up from the medium, while the grey fraction depicts the resulting de novo 
biosynthetic fraction of the precursor. Since the 13C labeling could not be measured for all metabolites, following assumptions 
were made. For the amino acids cysteine, methionine, and tryptophan 100 % uptake were defined, since measured amino acids 
with a complex biosynthesis were taken up from the medium (e.g. phenylalanine, isoleucine). Since the purine and pyrimidine 
biosyntheses are feedback regulated pathways (Burns, 1964; Lacroute, 1968; Rolfes, 2006), the presence of nucleotides in yeast 
extract has been reported (Zhang et al., 2003) and could also be measured in riboflavin samples even at a late stage of cultivation 
(after 144 h), uptake of DNA and RNA building blocks as well as the GTP-precursor for riboflavin (Figure 32) was defined as 
100 %. For trehalose the same ratio was assumed as for the glycogen pool, since the two building blocks share the same precursor 
glucose 6-phosphate. For the flux calculations lipids were considered to be completely de novo synthesized, however the more 
likely scenario is that fatty acids are taken up by the cell and re-esterified with glycerol inside the cell. Stahmann et al. (1994) 
reported that the lipid composition of the substrate oil resembled the lipid composition of storage triacylglycerides in A. gossypii 
cells. Due to that, the acetyl-CoA de novo demand is not specified in this table. ATP, adenosine triphosphate; CTP, cytidine 
triphosphate; dATP, deoxyadenosine triphosphate; dCTP, deoxycytidine triphosphate; dGTP, deoxyguanosine triphosphate; 
dTTP, deoxythymidine triphosphate; GTP, guanosine triphosphate; UTP, uridine triphosphate. 
Precursor Total demand  Uptake De novo 
biosynthesis 
Resulting de novo 
demand 
 [μmol g-1]  [%] [%] [μmol g-1] 
Alanine 357.3  80 ± 5 20 ± 5 71.5 ± 15.4 
Arginine 135.8  90 ± 4 10 ± 4 13.6 ± 5.4 
Asparagine 171.5  89 ± 9 11 ± 9 18.9 ± 14.3 
Aspartate 171.5  48 ± 4 52 ± 4 89.4 ± 5.2 
Cysteine‡ 42.9  100 0 0.0 
Glutamine 268.0  74 ± 4 26 ± 4 69.7 ± 9.4 
Glutamate 268.0  27 ± 2 74 ± 2 197.0 ± 4.0 
Glycine 325.2  98 ± 1 2 ± 1 6.5 ± 30.5 
Histidine 75.0  100 ± 5 0 ± 5 0.0 ± 0.0 
Isoleucine 171.5  100 ± 7 0 ± 7 0.0 ± 0.0 
Leucine 250.1  100 ± 4 0 ± 4 0.0 ± 0.0 
Lysine 239.4  100 ± 11 0 ± 11 0.0 ± 0.1 
Methionine 50.0  100 0 0.0 
Phenylalanine 114.3  100 ± 7 0 ± 7 0.0 
Proline 128.6  74 ± 4 26 ± 4 33.4 ± 4.8 
Serine 253.7  88 ± 3 12 ± 3 30.4 ± 8.0 
Threonine 196.5  89 ± 9 11 ± 9 21.6 ± 17.5 
Tryptophan‡ 28.0  100 0 0.0 
Tyrosine 96.5  95 ± 7 5 ± 7 4.8 ± 6.7 
Valine 257.3  100 ± 9 0 ± 9 0.0 ± 0.0 
ATP‡ 51.0  100 0 0.0 
GTP‡ 20.0  100 0 0.0 
CTP‡ 51.0  100 0 0.0 
UTP‡ 67.0  100 0 0.0 
dATP‡ 3.6  100 0 0.0 
dGTP‡ 2.4  100 0 0.0 
dCTP‡ 2.4  100 0 0.0 
dTTP‡ 3.6  100 0 0.0 
Lipid 240.4  n.d. n.d. n.d. 
Glycogen 581.5  13 ± 0 88 ± 0 508.8 ± 2.6 
Mannan‡ 821.0  0 100 821.0 
Trehalose 23.3  13 ± 0 88 ± 0 20.4 ± 0.0 
Riboflavin‡ 8.6  53 47 4.0 
‡ The demand for the precursor is assumed. Therefore, no standard deviation could be calculated for the according values. 
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6.6 Determination of measured fluxes and metabolite balances for flux calculations 
during growth of A. gossypii 
 
Figure 41: Metabolic network of A. gossypii, including extracellular reactions, reactions between 
intermediary metabolite pools, and anabolic reactions. The reactions numbers refer to the formulation 
of metabolite balances (see below). The direction of net reactions is indicated by size of arrow head. 
For abbreviations see Figure 27. 
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In order to calculate carbon fluxes during the growth phase of A. gossypii, the following 
balances were formulated for the network, depicted in Figure 41, and represent growth on 
vegetable oil and yeast extract. Metabolite balances were expressed, using the numbering of 
the reactions as presented in Figure 41. 
 
FAP 0 = 26 v1 – v2 (Eq. 15) 
AcCoAP 0 = v2 – v3 – v4 – v5 – v6 (Eq. 16) 
ICIT 0 = v6 – v7 (Eq. 17) 
GLYOX 0 = v7 – v5 (Eq. 18) 
SUC 0 = v7 – v8 (Eq. 19) 
MAL 0 = v5 + v8 – v6 –v9 (Eq. 20) 
OAA/MAL 0 = v9 + v20 – v10 – v21 (Eq. 21) 
AcCoAM 0 = v4 – v10 (Eq. 22) 
CIT 0 = v10 – v11 (Eq. 23) 
AKG 0 = v11 + v13 – v12 – v20 (Eq. 24) 
GLUINTR 0 = v12 + v14 – v13 – v15 (Eq. 25) 
OAA 0 = v21 – v22 – v26 (Eq. 26) 
PEP/PYR 0 = v26 + v33 – v27 – v31 (Eq. 27) 
3PG 0 = v31 – v32 – v39 (Eq. 28) 
SERINTR 0 = v32 + v34 + v36 – v33 – v35 (Eq. 29) 
GLYINTR 0 = v37 – v36 – v38 – v55 (Eq. 30) 
G3P 0 = v39 + v43 – v40 – v41 – v42 – v44 – v45 (Eq. 31) 
DHAP 0 = v41 – v44 (Eq. 32) 
F6P 0 = v44 – v43 – v45 – v46 – v47 (Eq. 33) 
S7P 0 = v43 – v42 (Eq. 34) 
E4P 0 = v45 – v43 – v53 (Eq. 35) 
G6P 0 = v47  – v48 – v50 (Eq. 36) 
Ru5P 0 = v50 + v52 – v51 – v63 – v64 (Eq. 37) 
Xu5P 0 = v42 + v45 – v52 (Eq. 38) 
R5P 0 = v42 + v51 – v54 – v55 (Eq. 39) 
IMP 0 = v55 – v58 – v59 (Eq. 40) 
GTP 0 = v58 + v61 – v60 – v63 (Eq. 41) 
DRL 0 = v63 – v64 (Eq. 42) 
RF 0 = v64 – v65 (Eq. 43) 
 
The stoichiometric factor for v1 in Equation (15) is derived from the assumption that one 
molecule oil is composed of one molecule glycerol and three fatty acid chains with a chain 
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length of 17.3 carbon atoms each. Thus, all three chains would contribute 52 carbon atoms, 
which are degraded to 26 molecules acetyl-CoA. The rank of the stoichiometric matrix, 
formulated for the Equations (15) to (43) equaled 29. This confirmed that the 29 metabolite 
balances were linearly independent. Since the complete network comprised a total of 65 fluxes, 
additional 36 pieces of information were required in addition to the stoichiometric balances. 
Anabolic fluxes based on the biomass composition of A. gossypii (Table 19), which were 
correlated with the amount of precursor taken up by the cell versus the amount of de novo 
biosynthesis (i.e. 13C labeling information, Table 19, Table 20), delivered another 28 measured 
fluxes (v3, v15, v16, v17, v18; v19, v22, v23, v24, v25, v27, v28, v29, v30, v35, v38, v40, v46, v48; v49, v53, v54, 
v56, v57, v59, v60, v61, v62). The remaining 8 pieces of information were obtained through the 
measurement of extracellular fluxes, i.e. substrate uptake rates (v1, v14, v37) and riboflavin 
secretion rate (v65), and the measurement of intracellular fluxes derived from additional 13C 
labeling information (v12, v33, v34, v36) (Table 17, Table 18). Anabolic fluxes were calculated by 
multiplying the anabolic demand with the biomass yield, YX/Oil, and the uptake rate of the main 
carbon source, qS,Oil (Table 6). In total, 65 pieces of information were obtained, which rendered 
a fully determined metabolic network. 
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6.7 Data from LC/MS analyses 
 
 
Table 21: Relative mass isotopomer fractions of riboflavin (m/z 377) from culture supernatants of 
A. gossypii WT and B2 grown on naturally labeled complex medium and [13C6] glucose. The control 
represents the labeling data for A. gossypii grown on fully naturally labeled medium. Data denote 
experimental LC/MS data (exp) and corrected labeling patterns (corr). Data were corrected for 
occurrence of natural isotopes. The mass isotopomer M+0 represents the relative amount of non-
labeled, M+1 the amount of singly-labeled mass isotopomer fraction and so on. Data were obtained 
from three individual replicates. 
m/z 377 Control WT B2 
 exp corr exp corr exp corr 
M+0 0.82 ± 0.03 0.82 ± 0.02 0.07 ± 0.01 0.07 ± 0.01 0.05 ± 0.01 0.05 ± 0.01 
M+1 0.15 ± 0.00 0.16 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 
M+2 0.02 ± 0.00 0.02 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 
M+3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 
M+4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 
M+5 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 0.05 ± 0.01 0.05 ± 0.01 
M+6 0.00 ± 0.00 0.00 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 0.07 ± 0.02 0.07 ± 0.02 
M+7 0.00 ± 0.00 0.00 ± 0.00 0.03 ± 0.01 0.04 ± 0.01 0.08 ± 0.02 0.08 ± 0.02 
M+8 0.00 ± 0.00 0.00 ± 0.00 0.07 ± 0.02 0.07 ± 0.02 0.12 ± 0.03 0.12 ± 0.03 
M+9 0.00 ± 0.00 0.00 ± 0.00 0.07 ± 0.01 0.07 ± 0.01 0.10 ± 0.02 0.10 ± 0.02 
M+10 0.00 ± 0.00 0.00 ± 0.00 0.09 ± 0.02 0.09 ± 0.02 0.11 ± 0.03 0.11 ± 0.03 
M+11 0.00 ± 0.00 0.00 ± 0.00 0.15 ± 0.03 0.16 ± 0.03 0.12 ± 0.02 0.12 ± 0.02 
M+12 0.00 ± 0.00 0.00 ± 0.00 0.17 ± 0.03 0.18 ± 0.03 0.11 ± 0.02 0.11 ± 0.02 
M+13 0.00 ± 0.00 0.00 ± 0.00 0.25 ± 0.05 0.25 ± 0.05 0.11 ± 0.02 0.11 ± 0.02 
M+14 0.00 ± 0.00 0.00 ± 0.00 0.03 ± 0.01 0.02 ± 0.01 0.01 ± 0.00 0.01 ± 0.00 
M+15 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
M+16 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
M+17 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
SFL [%]  1.2 ± 0.10  59.1 ± 8.44  51.8 ± 9.10 
SFLcorr [%]  0.1 ± 0.01  59.3 ± 8.47  51.8 ± 9.10 
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Table 22: Relative mass isotopomer fractions of riboflavin (m/z 377) from culture supernatants of 
A. gossypii B2 grown on naturally labeled vegetable oil and 99 % [13C2] glycine or [13C] formate. The 
control represents the labeling data for A. gossypii grown on fully naturally labeled medium. Time points 
indicate cultivation time after which the respective tracer was added. Data denote experimental LC/MS 
data (exp) and corrected labeling patterns (corr). Data were corrected for occurrence of natural isotopes. 
The mass isotopomer M+0 represents the relative amount of non-labeled, M+1 the amount of singly-
labeled mass isotopomer fraction and so on. As higher mass isotopomers were below the detection 
limit, only the first eleven are listed. Data were obtained from three individual replicates. 
m/z 377 Control [13C2] Gly [13C] For 
Time [h] 0 0 0 48 
M+0 exp 0.82 ± 0.03 0.16 ± 0.01 0.82 ± 0.04 0.67 ± 0.03 
 corr 0.99 ± 0.03 0.21 ± 0.07 1.00 ± 0.05 0.82 ± 0.02 
M+1 exp 0.15 ± 0.00 0.05 ± 0.00 0.16 ± 0.01 0.27 ± 0.02 
 corr 0.01 ± 0.00 0.04 ± 0.01 0.00 ± 0.00 0.18 ± 0.00 
M+2 exp 0.02 ± 0.00 0.60 ± 0.05 0.02 ± 0.00 0.05 ± 0.00 
 corr 0.00 ± 0.00 0.74 ± 0.13 0.00 ± 0.00 0.00 ± 0.00 
M+3 exp 0.00 ± 0.00 0.16 ± 0.01 0.00 ± 0.00 0.01 ± 0.00 
 corr 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
M+4 exp 0.00 ± 0.00 0.03 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 corr 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
M+5 exp 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 corr 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
M+6 exp 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 corr 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
M+7 exp 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 corr 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
M+8 exp 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 corr 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
M+9 exp 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 corr 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
M+10 exp 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 corr 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
SFL [%] 0.0 ± 0.0 9.0 ± 0.8 0.0 ± 0.0 1.0 ± 0.1 
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Table 23: Relative mass isotopomer fractions of riboflavin (m/z 377) from culture supernatants of 
A. gossypii B2 grown on naturally labeled vegetable oil and [3-13C] serine, [13C3] serine, or [U13C] yeast 
extract. Time points indicate cultivation time after which the respective tracer was added. Data denote 
experimental LC/MS data (exp) and corrected labeling patterns (corr). Data were corrected for 
occurrence of natural isotopes. The mass isotopomer M+0 represents the relative amount of non-
labeled, M+1 the amount of singly-labeled mass isotopomer fraction and so on. As higher mass 
isotopomers were below the detection limit, only the first eleven are listed. Data were obtained from 
three individual replicates. 
m/z 377 [3-13C] Ser [13C3] Ser [U13C] YE 
Time [h] 0 48 0 48 0-32 32 
M+0 exp 0.80 ± 0.04 0.76 ± 0.04 0.73 ± 0.04 0.68 ± 0.03 0.63 ± 0.06 0.46 ± 0.05 
 corr 0.98 ± 0.05 0.93 ± 0.05 0.88 ± 0.04 0.81 ± 0.07 0.65 ± 0.07 0.48 ± 0.05 
M+1 exp 0.18 ± 0.01 0.21 ± 0.02 0.17 ± 0.01 0.18 ± 0.01 0.21 ± 0.02 0.21 ± 0.02 
 corr 0.03 ± 0.00 0.07 ± 0.01 0.05 ± 0.00 0.08 ± 0.07 0.21 ± 0.02 0.21 ± 0.01 
M+2 exp 0.03 ± 0.00 0.04 ± 0.00 0.08 ± 0.01 0.11 ± 0.01 0.07 ± 0.01 0.13 ± 0.01 
 corr 0.00 ± 0.00 0.00 ± 0.00 0.07 ± 0.01 0.09 ± 0.01 0.06 ± 0.01 0.13 ± 0.01 
M+3 exp 0.00 ± 0.00 0.00 ± 0.00 0.02 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 0.06 ± 0.01 
 corr 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 0.05 ± 0.00 
M+4 exp 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 0.03 ± 0.00 0.06 ± 0.01 
 corr 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.03 ± 0.00 0.06 ± 0.01 
M+5 exp 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 0.03 ± 0.00 
 corr 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 0.03 ± 0.00 
M+6 exp 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
 corr 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
M+7 exp 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
 corr 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
M+8 exp 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
 corr 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 
M+9 exp 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 
 corr 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 
M+10 exp 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
 corr 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
SFL [%] 0.2 ± 0.1 0.4 ± 0.0 1.2 ± 0.1 1.9 ± 0.2 4.5 ± 0.6 8.0 ± 1.1 
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6.8 Data from NMR analyses 
 Table 24: Relative 13C enrichment of all seventeen carbon atoms of riboflavin produced by A. gossypii 
B2 from different 13C-labeled tracer substrates on complex medium with rapeseed oil. Riboflavin was 
recovered from the culture broth after 144 h. The labeling was analyzed by 13C NMR. The time refers to 
the time point of respective tracer addition. For, formate; Glu, glutamate; Gly, Glycine; Ser, serine; YE, 
yeast extract. Data denote mean values for three independent replicates with a mean standard deviation 
of 5 %. 
C-atom 
Chemical 
shift 
[ppm] 
Relative enrichment [%] 
Nat. lab. 
precursors 
[13C] For [13C2] Gly [3-13C] Ser [U13C] YE [13C5] Glu 
0 h 0 h 48 h 0 h 48 h 32 h 0 h 
2 155.5 1.1 4.7 12.3 1.1 5.9 15.4 2.1 
4 159.9 1.1 1.1 1.1 1.0 1.0 11.8 2.8 
4a 136.8 1.1 1.3 0.9 71.2 0.9 18.4 1.1 
5a 134 1.1 1.1 0.9 1.4 1.0 4.8 2.9 
6 130 1.1 1.1 1.1 1.0 1.1 5.0 3.3 
7 137.1 1.1 0.9 0.7 1.3 0.8 3.7 2.8 
7α 18.8 1.3 1.1 1.2 1.1 1.1 3.8 2.7 
8 146 1.1 1.0 0.9 1.3 0.9 4.6 2.9 
8α 20.8 1.3 1.1 1.2 1.1 1.1 4.7 3.6 
9 117.4 1.0 1.5 1.0 0.9 1.2 3.9 1.8 
9a 132.1 1.1 1.1 0.9 1.6 0.9 3.7 1.4 
10a 150.8 1.1 1.0 0.8 70.7 0.9 18.5 1.0 
1’ 47.3 1.2 1.1 1.0 1.0 1.0 9.9 3.9 
2’ 68.8 1.1 1.1 1.0 1.2 1.0 8.8 5.0 
3’ 73.6 1.2 1.1 0.9 1.5 0.9 7.9 3.9 
4’ 72.8 1.3 1.1 1.0 0.8 0.9 8.3 4.8 
5’ 63.4 1.0 1.1 1.1 0.8 1.1 7.5 2.7 
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Figure 42: Change in summed fractional labeling (SFL) for formate added at 0 h (A) and formate added 
at 48 h (B) in the culture supernatant of A. gossypii B2 grown on complex medium, rapeseed oil, and 
[13C] formate. Labeling data for formate were measured via 1H NMR. Riboflavin data were interpolated 
for certain points in time. Numbers indicate single intervals, for which the maximum 13C enrichment of 
riboflavin at carbon atom C2 was calculated (Chapters 3.5.2 and 4.6.1). Data were obtained from three 
individual replicates. 
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6.9 Data from 13C formate flux simulations 
Table 25: Input model for OpenFLUX for the transmembrane formate flux. 
rxnID rxnEQ cTrans rates type basis 
R01 FOR_FEED = FOR_EXTR a = a  F 100.0 
R02 FOR_EXTR = FOR_INTR a = a  FR  
R03 FOR_INTR = FOR_EXTR a = a  R X 
R04 FOR_P5P = FOR_INTR a = a  F X 
R05 FOR_INTR = FOR_RF   B  
R06 FOR_EXTR = FOR_EX   B  
excludedMetabolites 
FOR_FEED      
FOR_P5P      
FOR_RF      
FOR_EX      
simulatedMDVs 
FOR_EXTR#1      
FOR_INTR#1      
inputSubstrates 
FOR_P5P      
FOR_FEED      
RxnID, reaction identification; cTrans, carbon transition; rates, known reaction rates, type, reaction type (F = 
irreversible, FR = forward reaction of a reversible reaction, R = backward reaction, B = excluded from the isotopomer 
balance); basis, invariant flux basis; excludedMetabolites, metabolites excluded from the balance model; 
simulatedMDVs, simulated mass isotopomer distribution vectors; inputSubstrates, compounds that are used as 
substrates. 
 
 
Table 26: Relative mass isotopomer fractions of formate from culture supernatants and flux simulation 
of A. gossypii B2 grown on vegetable oil and 99 % [13C] formate added at 0 h. Data denote experimental 
1H NMR data (exp) and simulated labeling patterns (sim) corresponding to the optimal flux fit. The mass 
isotopomer M+0 represents the relative amount of non-labeled, M+1 the amount of singly-labeled mass 
isotopomer fraction. The time intervals t1, t2 etc. correspond to the intervals shown in Figure 34. Data 
denote mean values from independent replicates with a mean standard deviation of 5 %. 
   t1 t2 t3 t4 t5 
ForEXTR M+0 exp 0.037 0.084 0.145 0.410 0.786 
  sim 0.037 0.084 0.145 0.410 0.786 
 M+1 exp 0.963 0.916 0.855 0.590 0.214 
  sim 0.963 0.916 0.855 0.590 0.214 
FORINTR M+0 exp 0.037 0.084 0.436 0.855 0.976 
  sim 0.037 0.085 0.441 0.858 0.976 
 M+1 exp 0.963 0.916 0.564 0.145 0.024 
  sim 0.963 0.915 0.559 0.142 0.024 
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6.10 Determination of measured carbon fluxes and carbon balances for carbon flux 
calculations during the riboflavin biosynthetic phase of A. gossypii 
 
 
Figure 43: Metabolic network of riboflavin production in A. gossypii, including extracellular reactions, 
reactions between intermediary metabolite pools, and riboflavin biosynthetic reactions. The reaction 
numbers refer to the formulation of metabolite balances (see below). The direction of net reactions is 
indicated by size of arrow head. For abbreviations see Figure 37. 
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During riboflavin biosynthesis on vegetable oil (Figure 43), the fluxes to be determined were 
calculated and expressed as fluxes of single carbon atoms. This facilitated flux calculations, 
because every carbon atom of riboflavin had a unique labeling fingerprint obtained from the 
four tracer studies with [13C2] glycine, [13C] formate, [13C5] glutamate, and [U13C] yeast extract. 
Since a single carbon atom of riboflavin could originate from a number of different medium 
components as well as intracellular metabolites, single carbon atom balancing met the 
challenges of complex data handling the best. Therefore, for every carbon atom in riboflavin, 
the metabolic precursor carbon atom and other donor atoms were considered (Figure 45, 
Figure 46, Figure 47) and the flux (v) into the respective carbon atom was set to 1 and 
formulated as follows: 
 
 
ݒ௜ ൌ෍ݒ௜ǡ௝
ହ
௝ୀଵ
ൌ ͳ 
(Eq. 44) 
 ݒ௜ǡ௝ ൌ  ݔ௜ǡ௝ (Eq. 45) 
 ݒ௜ǡீ௟௬ ൌ ݔ௜ǡீ௟௬ (Eq. 46) 
 ݒ௜ǡி௢௥ ൌ ݔ௜ǡி௢௥ (Eq. 47) 
 ݒ௜ǡீ௟௨ ൌ ݔ௜ǡீ௟௨ (Eq. 48) 
 ݒ௜ǡ௒ா ൌ ݔ௜ǡ௒ா (Eq. 49) 
 ݒ௜ǡை௜௟ ൌ ͳ െ ݒ௜ǡீ௟௬ െ ݒ௜ǡி௢௥ െ ݒ௜ǡீ௟௨ െ ݒ௜ǡ௒ா (Eq. 50) 
 
with 
 vi  carbon atom of riboflavin with number i 
j index specifying the 13C tracer used in each of the four parallel isotope 
experiments (1: glycine; 2: formate; 3: glutamate; 4: yeast extract (YE); 5: oil) 
xi specific 13C enrichment at carbon atom i of riboflavin from the corresponding 
13C tracer j 
 
Note that oil was not used as 13C tracer, but the enrichment (xOil) was a result of the combined 
enrichment of all 13C tracers used (formate, glycine, glutamate, and yeast extract). The 
Equations (44) to (50) could then be applied in detail to every carbon atom in riboflavin. Carbon 
atom C4 of riboflavin will be discussed exemplary in greater detail below, followed by the other 
carbon atoms of riboflavin, however, to a less extensive extent. 
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Considerations regarding carbon atom C4: 
 
Equation (51) was specified for carbon atom C4, based on Equation (44): 
 
 
ݒସ ൌ෍ݒସǡ௝
ହ
௝ୀଵ
ൌ ݒସǡீ௟௬ ൅ ݒସǡி௢௥ ൅ ݒସǡீ௟௨ ൅ ݒସǡ௒ா ൅ ݒସǡை௜௟ ൌ ͳ 
(Eq. 51) 
 
The carbon origin of C4 of riboflavin is depicted in Figure 44. Since its biosynthetic de novo 
origin is carbon dioxide, the oil and the glutamate fraction of Equation (51) are defined as 
fraction derived from carbon dioxide instead, which is why the combined flux equals flux V49 of 
the network (Equation 52) (Figure 43), i.e. the uptake of single carbon atoms from oil. Carbon 
dioxide is produced from rapeseed oil (naturally labeled) and glutamate (13C-labeled) through 
decarboxylation reactions in the TCA cycle as well as at the pyruvate node. Note that the 
equality in Equation (52) is straightforward, as only single carbon atoms are considered. 
 
 ݒସǡ஼ைమ ൌ ݒସǡை௜௟ ൅ ݒସǡீ௟௨ ൌ ସܸଽ (Eq. 52) 
 
For the carbon flux from the yeast extract to C4, two potential building blocks were considered: 
GTP (or ATP, however, since this study could not distinguish between the two, only GTP is 
used) or guanine (or adenine). GTP as well as guanine are part of the yeast extract and are 
incorporated into riboflavin almost as whole molecule only releasing one carbon atom (Figure 
32). Therefore, the flux from the yeast extract could be formulated as follows: 
 
 ݒସǡ௒ா ൌ ݒସǡ௒ாಸ೅ು ൅ ݒସǡ௒ாಸೆಲ  (Eq. 53) 
 
with 
 YEGTP  GTP (or ATP) originating from 13C-labeled yeast extract 
 YEGUA  guanine (or adenine) originating from 13C-labeled yeast extract 
 
GTP shares nine of its ten carbon atoms with riboflavin. The remaining eight carbon atoms 
comprise the xylene ring and are exclusive carbon atoms for the vitamin. Thus, the carbon flux 
from GTP from the yeast extract can be expressed as the difference between 13C labeling from 
[U13C] yeast extract of carbon atoms of the ribityl side chain (C1’ to C5’) and carbon atoms of 
the xylene ring (C5a to C9a). In order to simplify the complexity, mean values derived from the 
structural subunits were used (ݒଵᇲିହᇲǡ௒ாതതതതതതതതതതത and ݒହ௔ିଽ௔ǡ௒ாതതതതതതതതതതതത, respectively). 
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 ݒସǡ௒ா ൌ ൫ݒଵᇲିହᇲǡ௒ாതതതതതതതതതതത െ ݒହ௔ିଽ௔ǡ௒ாതതതതതതതതതതതത൯ ൅ ݒସǡ௒ாಸೆಲ  (Eq. 54) 
   
Rearrangement of Equation (54) leads to the carbon flux from yeast extract-based guanine to 
carbon atom C4: 
 
 ݒସǡ௒ாಸೆಲ ൌ ݒସǡ௒ா െ ݒଵᇲିହᇲǡ௒ாതതതതതതതതതതത ൅ ݒହ௔ିଽ௔ǡ௒ாതതതതതതതതതതതത (Eq. 55) 
 
Since guanine is incorporated into riboflavin as a whole, it can be assumed that the carbon flux 
from yeast extract-derived guanine into C4 also equals the carbon flux into the other three 
carbon atoms of riboflavin that originate from guanine (C2, C4a, C10a). This correlation is 
expressed by Equation (56).  
 
 ݒସǡ௒ாಸೆಲ ൌ ݒଶǡ௒ாಸೆಲ ൌ ݒସ௔ǡ௒ாಸೆಲ ൌ ݒଵ଴௔ǡ௒ாಸೆಲ  (Eq. 56) 
 
In a likewise manner, this can be applied to the carbon flux from yeast extract-based GTP to 
carbon atom C4:  
 
 ݒସǡ௒ாಸ೅ು ൌ ݒ௜ǡ௒ாಸ೅ು                                               with i = 2, 4a, 10a, 1’ – 5’ (Eq. 57) 
 
 
 
Figure 44: Metabolic origin of carbon atom C4 of the pyrimidine ring in riboflavin. Grey circles denote 
the carbon atom of interest and its origin in the metabolic precursor or donor to the precursor. The 
numbering is specific for the molecule, therefore, e.g. carbon atom 4 of riboflavin does not equal carbon 
atom 4 of GTP. GTP, guanosine triphosphate; Gua, guanine. This is an excerpt of Figure 45. 
 
 
Considerations regarding reactions involved in the formation of carbon atom C2: 
 
 
ݒଶ ൌ෍ݒଶǡ௝
ହ
௝ୀଵ
ൌ ͳ 
(Eq. 58) 
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 ݒଶǡ௒ா ൌ ݒଶǡ௒ாಸ೅ು ൅ ݒଶǡ௒ாಸೆಲ ൅ ݒଶǡ௒ாೄಶೃ (Eq. 59) 
 ݒଶǡ௒ாೄಶೃ ൌ ݒଶǡ௒ா െ ݒଶǡ௒ாಸ೅ು െ ݒଶǡ௒ாಸೆಲ ൌ ݒସ௔ǡ௒ாೄಶೃ ൌ ݒଵ଴௔ǡ௒ாೄಶೃ (Eq. 60) 
 ݒଶǡை௜௟ ൌ  ݒଶǡை௜௟ೃೠఱು ൅ ݒଶǡை௜௟ೄಶೃ (Eq. 61) 
 ݒଶǡை௜௟ೄಶೃ ൌ ݒସ௔ǡை௜௟ (Eq. 62) 
 ݒଶǡை௜௟ೃೠఱು ൌ  ݒଶǡை௜௟ െ ݒସ௔ǡை௜௟ (Eq. 63) 
 
with 
 OilRu5P  ribulose 5-phosphate originating from vegetable oil 
 OilSER  serine originating from vegetable oil, i.e. 3PG 
 YESER  serine originating from 13C-labeled yeast extract 
 
 
Considerations regarding reactions involved in the formation of carbon atom C4a: 
 
 
ݒସ௔ ൌ෍ݒସ௔ǡ௝
ହ
௝ୀଵ
ൌ ͳ 
(Eq. 64) 
 ݒସ௔ǡ௒ா ൌ ݒସ௔ǡ௒ாಸ೅ು ൅ ݒସ௔ǡ௒ாಸೆಲ ൅ ݒସ௔ǡ௒ாೄಶೃ ൅ ݒସ௔ǡ௒ாಸ೗೤ (Eq. 65) 
 ݒସ௔ǡை௜௟ ൌ  ݒସ௔ǡை௜௟ೄ೐ೝ (Eq. 66) 
 
with 
 YEGLY  glycine originating from 13C-labeled yeast extract 
 
Since the considerations for the formation of carbon atom C10a equal the ones for carbon atom 
C4a, they will not be described. 
 
 
Considerations regarding reactions involved in the formation of carbon atom C5a: 
 
 
ݒହ௔ ൌ෍ݒହ௔ǡ௝
ହ
௝ୀଵ
ൌ ͳ 
(Eq. 67) 
 ݒହ௔ǡோ௨ହ௉ ൌ ݒହ௔ǡை௜௟ ൅ ݒହ௔ǡீ௟௨ ൅ ݒହ௔ǡ௒ா ൌ ͳ (Eq. 68) 
 ݒହ௔ǡௗ௘௡௢௩௢ ൌ ݒହ௔ǡை௜௟ ൅ ݒହ௔ǡீ௟௨ (Eq. 69) 
 ݒହ௔ǡௗ௘௡௢௩௢ ൌ 
ͳ
ʹ ݒହ௔ǡை஺஺ ൌ ݒହ௔ǡீ଺௉ 
(Eq. 70) 
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with 
 v5a,de novo C5a atom originating from de novo biosynthesis through glyoxylate or 
TCA cycle and gluconeogenesis 
 v5a,OAA  C5a atom originating from the C2 atom of oxaloacetate 
 v5a,G6P  C5a atom originating from the C2 atom of glucose 6-phosphate 
 
Since the considerations for the formation of carbon atom C5 through C9a occurred in a likewise 
manner as the ones for carbon atom C5a, they will not be described. 
 
 
Considerations regarding reactions involved in the formation of carbon atom C1’: 
 
 
ݒଵᇱ ൌ෍ݒଵᇱǡ௝
ହ
௝ୀଵ
ൌ ͳ 
(Eq. 71) 
 ݒଵᇲǡ௒ா ൌ ݒଵᇲǡ௒ாೄೆಸಲೃ ൅ ݒଵᇲǡ௒ாಸ೅ು (Eq. 72) 
 ݒଵᇲǡோ௨ହ௉ ൌ ݒଵᇲǡை௜௟ ൅ ݒଵᇲǡ௒ாೄೆಸಲೃ ൅ ݒଵᇲǡீ௟௨ (Eq. 73) 
 ݒଵᇱǡௗ௘௡௢௩௢ ൌ ݒଵᇱǡை௜௟ ൅ ݒଵᇱǡீ௟௨ (Eq. 74) 
 ݒଵᇱǡௗ௘௡௢௩௢ ൌ 
ͳ
ʹ ݒଵᇱǡை஺஺ ൌ ݒଵᇱǡீ଺௉ 
(Eq. 75) 
 
with 
 YESUGAR Sugar originating from 13C-labeled yeast extract 
v1’,de novo  C1’ atom originating from de novo biosynthesis through glyoxylate or 
TCA cycle and gluconeogenesis 
 v1’,OAA  C1’ atom originating from the C1 atom of oxaloacetate 
 v1’,G6P  C1’ atom originating from the C1 atom of glucose 6-phosphate 
 
Since the considerations for the formation of carbon atom C2’ through C5’ equal the ones for 
carbon atom C1’, they will not be described. 
 
Based on the carbon atom fluxes, the calculation of fluxes between metabolites (designated 
by a capital V), i.e. a sum of several carbon atoms, could then be formulated for the three major 
structural units that comprise the vitamin (Figure 45, Figure 46, Figure 47). Note that riboflavin 
contains 17 carbon atoms in total, the xylene ring eight carbon atoms, the ribityl side chain five 
carbon atoms, and the pyrimidine ring four carbon atoms: 
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ହܸହ ൌ ோܸி ൌ෍ݒ௜
ଵ଻
௜ୀଵ
ൌ෍෍ݒ௜ǡ௝
ହ
௝ୀଵ
ଵ଻
௜ୀଵ
ൌ ͳ͹ 
(Eq. 76) 
 
ସܸ଴ ൌ ௑ܸ௬௟௘௡௘ ൌ ෍ ݒ௜
ଽ௔
௜ୀହ௔
ൌ ෍ ෍ݒ௜ǡ௝
ହ
௝ୀଵ
ଽ௔
௜ୀହ௔
ൌ ͺ 
(Eq. 77) 
 
ோܸ௜௕௜௧௬௟ ൌ ෍ ݒ௜
ହᇱ
௜ୀଵᇱ
ൌ ෍෍ݒ௜ǡ௝
ହ
௝ୀଵ
ହᇱ
௜ୀଵᇱ
ൌ ͷ 
(Eq. 78) 
 ௉ܸ௬௥௜௠௜ௗ௜௡௘ ൌ ݒଶ ൅ ݒସ ൅ ݒସ௔ ൅ ݒଵ଴௔ ൌ Ͷ (Eq. 79) 
 ହܸସ ൌ  ோܸ௜௕௜௧௬௟ ൅ ௉ܸ௬௥௜௠௜ௗ௜௡௘ (Eq. 80) 
 
These sums of carbon atoms provide three out of 55 pieces of information required for a fully 
determined metabolic network that consisted of a total of 55 fluxes (V55, V40, V54) (Figure 43). 
Another piece of information was defined in Equation (52) (V49). The labeling data for all 
seventeen carbon atoms of riboflavin from four different labeling experiments (Table 14 and 
appendix Table 24) and underlying pathway stoichiometry allowed the calculation of 28 fluxes. 
The calculation of those fluxes is given in Equations (81) to (107) (V2, V8, V9, V12, V13, V16, V18, 
V19, V20, V21, V22, V23, V24, V25, V26, V34, V36, V37, V38, V39, V41, V42, V43, V46, V47, V50, V51, V53). It 
should be noted that most of the numbers are derived from carbon atom stoichiometry (e.g. 
52FA designates that FA contains 52 carbon atoms, if it is defined as three FA chains of average 
length of 17.3 carbon atoms). In those cases, the origin of those carbon atoms is specified by 
the index (for abbreviations refer to Chapter 6.1). Some carbon fluxes are presented as mean 
carbon flux from a structural group, e.g. xylene ring (ݒହ௔ିଽ௔ǡீ௟௨തതതതതതതതതതതതത and ݒହ௔ିଽ௔ǡ௒ாതതതതതതതതതതതത) or two-carbon 
unit of riboflavin (ݒସ௔Ǣଵ଴௔ǡீ௟௬തതതതതതതതതതതതത and ݒସ௔Ǣଵ଴௔ǡ௒ாಸ೗೤തതതതതതതതതതതതതതതത). This was done in order to simplify the calculations 
and does not affect their outcome. The carbon fluxes ݒீ௎஺ఴ in Equation (102) and ݒீ்௉ఴ in 
Equation (106) refer to the flux of the carbon atom number 8 in guanine or GTP (Figure 44), 
respectively. Their values equal the ones in Equation (56) and Equation (57), respectively. 
 
 
ଶܸ ൌ  ଷܸ ή
͵ீ௅௒஼
ͷʹி஺
 
(Eq. 81) 
 ଼ܸ ൌ  ଵܸଵʹீ௅௒ை௑
 
(Eq. 82) 
 ଽܸ ൌ  ଵܸଵ (Eq. 83) 
 
ଵܸଶ ൌ  ଵܸହ ή
ݒହ௔ିଽ௔ǡீ௟௨തതതതതതതതതതതതത
ͳ െ ݒହ௔ିଽ௔ǡ௒ாതതതതതതതതതതതത
ή ͷீ௅௎Ͷை஺஺
 
(Eq. 84) 
 
ଵܸଷ ൌ  ଵܸଶͷீ௅௎
 
(Eq. 85) 
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ଵܸ଺ ൌ  ଵܸହͶை஺஺
 
(Eq. 86) 
 
ଵ଼ܸ ൌ  ଶܸଶ ή
ݒଶǡை௜௟ೄಶೃ
ݒଶǡ௒ாೄಶೃ ൅ ݒଶǡை௜௟ೄಶೃ
 (Eq. 87) 
 
ଵܸଽ ൌ  ଶܸଶ ή
ݒଶǡ௒ாೄಶೃ
ݒଶǡ௒ாೄಶೃ ൅ ݒଶǡை௜௟ೄಶೃ
 (Eq. 88) 
 
ଶܸ଴ ൌ  ሺ ଶ଼ܸ ൅ ସܸ଺ሻ ή
ݒସ௔Ǣଵ଴௔ǡீ௟௬തതതതതതതതതതതതത
ͳ െ ݒସ௔Ǣଵ଴௔ǡ௒ாಸ೅ುതതതതതതതതതതതതതതതത െ ݒସ௔Ǣଵ଴௔ǡ௒ாಸೆಲതതതതതതതതതതതതതതതത
 
(Eq. 89) 
 
ଶܸଵ ൌ  ሺ ଶ଼ܸ ൅ ସܸ଺ሻ ή
ݒସ௔Ǣଵ଴௔ǡ௒ாಸ೗೤തതതതതതതതതതതതതതതത
ͳ െ ݒସ௔Ǣଵ଴௔ǡ௒ாಸ೅ುതതതതതതതതതതതതതതതത െ ݒସ௔Ǣଵ଴௔ǡ௒ாಸೆಲതതതതതതതതതതതതതതതത
 
(Eq. 90) 
 ଶܸଶ ൌ ͵ௌாோ ή ଶܸଷ (Eq. 91) 
 ଶܸଷ ൌ ʹ ή ൫ݒଶǡ௒ாೄಶೃ ൅ ݒଶǡை௜௟ೄಶೃ൯ (Eq. 92) 
 ଶܸସ ൌ ʹீ௅௒ ή ଶܸଷ (Eq. 93) 
 ଶܸହ ൌ ʹ ή ൫ݒଶǡை௜௟ೃೠఱು ൅ ݒଶǡி௢௥൯ (Eq. 94) 
 
ଶܸ଺ ൌ  ଷܸଽ ή
ݒଶǡி௢௥
ݒଶǡை௜௟ೃೠఱು
 (Eq. 95) 
 
ଷܸସ ൌ  ଷܸଷ͸ீ଺௉
 
(Eq. 96) 
 
ଷܸ଺ ൌ ෍ ݒ௜ǡ௒ாೄೆಸಲೃ
ହᇲ
௜ୀଵᇲ
൅ ෍ ݒ௜ǡ௒ா
ଽ௔
௜ୀହ௔
 
(Eq. 97) 
 
ଷܸ଻ ൌ ෍ ݒ௜ǡோ௨ହ௉
ହᇱ
௜ୀଵᇱ
 
(Eq. 98) 
 ଷ଼ܸ ൌ  ଷܸଽ ൅ ସܸ଴ (Eq. 99) 
 
ଷܸଽ ൌ  ସܸ଴Ͷ஽ு஻௉
 
(Eq. 100) 
 ସܸଵ ൌ  ସܸଶ (Eq. 101) 
 ସܸଶ ൌ  ݒଶǡ௒ாಸೆಲ ൅ ݒସǡ௒ாಸೆಲ ൅ ݒସ௔ǡ௒ாಸೆಲ ൅ ݒଵ଴௔ǡ௒ாಸೆಲ ൅ ݒଵᇲǡ௒ாಸೆಲ
൅ ݒଶᇲǡ௒ாಸೆಲ ൅ ݒଷᇲǡ௒ாಸೆಲ ൅ ݒସᇲǡ௒ாಸೆಲ ൅ ݒହᇲǡ௒ாಸೆಲ ൅ ݒீ௎஺ఴ 
(Eq. 102) 
 ସܸଷ ൌ  ସܸଵ ൅ ସܸଶ (Eq. 103) 
 ସܸ଺ ൌ  ൫ݒସ௔ െ ݒସ௔ǡ௒ாಸೆಲ െ ݒସ௔ǡ௒ாಸ೅ು൯
൅ ൫ݒଵ଴௔ െ ݒଵ଴௔ǡ௒ாಸೆಲ െ ݒଵ଴௔ǡ௒ாಸ೅ು൯ 
(Eq. 104) 
 ସܸ଻ ൌ  ହܸ଴ ൌ ݒଶ െ ݒଶǡ௒ாಸೆಲ െ ݒଶǡ௒ாಸ೅ು (Eq. 105) 
 ହܸଵ ൌ ݒଶǡ௒ாಸ೅ು ൅ ݒସǡ௒ாಸ೅ು ൅ ݒସ௔ǡ௒ாಸ೅ು ൅ ݒଵ଴௔ǡ௒ாಸ೅ು ൅ ݒଵᇲǡ௒ாಸ೅ು
൅ ݒଶᇲǡ௒ாಸ೅ು ൅ ݒଷᇲǡ௒ாಸ೅ು ൅ ݒସᇲǡ௒ாಸ೅ು ൅ ݒହᇲǡ௒ாಸ೅ು ൅ ݒீ்௉ఴ 
(Eq. 106) 
 
ହܸଷ ൌ  ହܸଶͳͲீ்௉
 
(Eq. 107) 
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Together with the four fluxes determined above (V40, V49, V54, V55) this rendered 32 fluxes. 
Thus, at least 23 pieces of information were still required to obtain a fully determined network. 
Therefore, following balances were formulated for the metabolic network depicted in Figure 
43, which represents riboflavin production on vegetable oil and yeast extract. Metabolite 
balances were expressed using the numbering of the reactions as presented in Figure 43. 
 
FA 0 = V1 – V2 – V3 (Eq. 108) 
FAP 0 = V3 – V4 (Eq. 109) 
AcCoAP 0 = V4 – V6 – V10 (Eq. 110) 
ICIT 0 = V7 – V8 – V9 (Eq. 111) 
MAL 0 = V9 + V10 + V8 – V5 – V11 (Eq. 112) 
OAA/MAL 0 = V11 + V14 – V15 – V16 (Eq. 113) 
AKG 0 = V12 – V13 – V14 (Eq. 114) 
PEP/PYR 0 = V15 – V17 (Eq. 115) 
3PG 0 = V17 – V18 – V29 (Eq. 116) 
G3P 0 = V29 – V30 – V31 (Eq. 117) 
DHAP 0 = V30 – V32 (Eq. 118) 
F6P 0 = V31 + V32 – V33 (Eq. 119) 
G6P 0 = V33 – V34 – V35 (Eq. 120) 
Ru5P 0 = V35 + V36 – V37 – V38 (Eq. 121) 
R5P 0 = V37 – V41 – V44 (Eq. 122) 
PRA 0 = V44 + V46 – V45 (Eq. 123) 
GAR 0 = V45 + V47 + V49 + V50 – V48 (Eq. 124) 
GTP 0 = V43 + V48 + V51 – V52 (Eq. 125) 
ArP 0 = V40 + V54 – V55 (Eq. 126) 
GLY 0 = V20 + V21 + V24 – V28 – V46 (Eq. 127) 
SER 0 = V18 + V19 – V22 (Eq. 128) 
FOR 0 = V26 + V39 + V53 – V25 – V27 (Eq. 129) 
CHO-THF 0 = V23 + V25 – V47 – V50 (Eq. 130) 
 
The rank of the stoichiometric matrix formulated for Equations (108) to (130) was 23. This 
demonstrated that the 23 metabolite balances were linearly independent. Since the complete 
network comprised a total of 55 fluxes the combined 55 pieces of information obtained through 
metabolite balancing and labeling information rendered a fully determined network for flux 
calculations.  
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Figure 45: Metabolic origin of carbon atoms of the pyrimidine ring in riboflavin. Grey circles denote the 
carbon atom of interest and its origin in the metabolic precursor or donor to the precursor. The numbering 
is specific for the molecule, therefore, e.g. carbon atom 2 of riboflavin does not equal carbon atom 2 of 
GTP. CHO-THF, 10-formyltetrahydrofolate; For (extr.), formate (extracellular); Gly, glycine; GTP, 
guanosine triphosphate; Gua, guanine; Ru5P, ribulose 5-phosphate; Ser, serine. 
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Figure 46: Metabolic origin of carbon atoms of the xylene ring in riboflavin. Grey circles denote the 
carbon atom of interest and its origin in the metabolic precursor or donor to the precursor. The numbering 
is specific for the molecule, therefore, e.g. carbon atom 2 of riboflavin does not equal carbon atom 2 of 
Ru5P. Glu, glutamate; Ru5P, ribulose 5-phosphate; Ser, serine; SugarsYE, sugars derived from yeast 
extract. 
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Figure 47: Metabolic origin of carbon atoms of the ribityl side chain of riboflavin. Grey circles denote the 
carbon atom of interest and its origin in the metabolic precursor or donor to the precursor. The numbering 
is specific for the molecule, therefore, e.g. carbon atom 2 of riboflavin does not equal carbon atom 2 of 
GTP. Glu, glutamate; GTP, guanosine triphosphate; R5P, ribose 5-phosphate; SugarsYE, sugars derived 
from yeast extract. 
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